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Preface 
Why must we age and die?  This might be the oldest question humans have asked, it is 
certainly one of the most recurrent. One might think that a century after the discovery of 
genetics set off rapid advancements in biology that have led to atomic level 
understanding of many mechanisms underlying development, physiology, and pathology, 
that it would have a satisfying answer.  It doesn’t.   
One way inside the mystery of aging has been provided by the discovery that a single 
mutation which reduces the activity of an insulin  receptor family member can 
dramatically extend longevity and delay all visible signs of aging in the simple nematode 
C. elegans. The delay in aging requires increased activity of another gene, daf-16, that 
encodes a FoxO family transcription factor.  DAF-16 is the switch that controls a genetic 
program; it turns up the levels of many other gene products and turns down the levels of 
others.  If we can understand this downstream program, maybe can understand why aging 
is delayed when DAF-16 is on, and from there we can get a real answer as to what causes 
aging in the first place.  If we can find good ways to regulate activity of daf-16-like genes 
in humans, we might be able to delay or prevent multiple age-related pathologies and 
increase the number of years we can spend in good health.   
This dissertation is comprised of two parallel strategies.  Chapters One and Two will 
discuss a strategy that was designed to identify novel mechanisms that regulate DAF-16 
activity.  Chapters Three and Four will discuss a strategy that was designed to find genes 
that act downstream of DAF-16 to regulate aging.  Thus, Chapters One and Three will 
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review context and background material relevant to each approach, while Chapters Two 
and Four will discuss experimental work.   
Design and conception of most experiments was performed independently under the 
guidance of Dr. Patrick Hu, with additional guidance from Dr. Scott Leiser.  Chapter Two 
includes a forward genetic screen that was performed by Dr. Kathleen Dumas, and some 
initial mapping experiments that were carried out by Dr. Albert Chen. Chapter Four 
contains transcriptome profiling and quantitative-pcr experiments that were initially 
carried out by Dr. Albert Chen, with support from members of the University of 
Michigan DNA Sequencing Core and Bioinformatics Core, including Ana Rodrigues, 
Richard McEachin, and Manjusha Pande. Dr. Shohei Mitani (Tokyo Women’s Medical 
University) created some mutant strains that were used in Chapter 4. Testing and 
outcrossing of candidate mutations in Chapter 4 was a collaborative effort that included 
Dr. Albert Chen, Ian Waters, Chun-Fang Guo, Breane Budaitis, and myself.  Some 
confocal microscope images used in Chapter 4 were acquired with training and assistance 
from Dr. Colin Delaney
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Abstract 
Age related diseases are leading causes of mortality worldwide.  Environmental 
interventions such as dietary restriction can both extend lifespan and delay or ameliorate 
age related pathologies.  Dietary restriction and other environmental stresses activate 
conserved stress response mechanisms that can delay many aspects of biological aging.  
Understanding the regulation of these stress responses and characterizing their biological 
mechanisms could enable the design of therapeutics to treat or prevent age-related 
diseases by directly targeting the aging process.   
Reductions in the activity of the conserved insulin and insulin-like growth factor 
signaling pathway (IIS) extend longevity across taxa. IIS antagonizes FoxO transcription 
factors, and increased FoxO activity promotes increased longevity in multiple organisms. 
Polymorphisms in human FoxO genes are associated with longevity, and FoxO 
transcription factors likely modulate various age-related diseases.  Thus, an improved 
understanding of the mechanisms regulating FoxO activity and the mechanisms through 
which FoxO activity increases lifespan may be relevant to human health.   
The short-lived nematode Caenorhabditis elegans provides a useful model for studying 
FoxO regulation and aging.  In C. elegans, the sole FoxO family member DAF-16 is 
inhibited by signals from an insulin-like growth factor receptor (IGFr) family member, 
DAF-2, and by signals from the germline. Disinhibition of DAF-16/FoxO activity during 
development causes entry into a larval diapause called dauer.  Increasing DAF-16/FoxO 
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activity during adulthood via loss of function mutations in daf-2/IGFr or ablation of the 
germline dramatically increases lifespan.  Thus, the dauer diapause represents a valuable 
system for understanding how DAF-16/FoxO activity is regulated, while studies of adult 
longevity can be used to understand how DAF-16/FoxO activation increases lifespan.  
Reductions in IIS increase DAF-16/FoxO activity in part by causing it to be localized to 
the nucleus, where it can alter transcription of downstream target genes.  Our group has 
discovered the EAK pathway, which inhibits nuclear DAF-16/FoxO activity.  Mutations 
in eak genes enhance the constitutive dauer arrest phenotypes caused by mutation of the 
conserved gene akt-1.  To identify downstream components of the EAK pathway we 
performed a forward genetic screen for suppression of dauer entry in eak-7;akt-1 
mutants. This screen unexpectedly identified a novel allele of lin-14, which encodes a 
transcription factor that acts to ensure the proper sequence of developmental events. This 
lin-14 allele [lin-14(dp69)] functions along with lin-14 RNAi to suppress dauer entry in 
both DAF-16/FoxO-dependent and DAF-16/FoxO-independent contexts, suggesting that 
LIN-14 acts downstream of, or in parallel to, DAF-16/FoxO to regulate dauer entry.  
Two groups of transcriptional isoforms of DAF-16/FoxO, DAF-16A and DAF-16F, are 
required for increased lifespan.  To identify downstream mechanisms by which DAF-
16/FoxO activation increases longevity, we used transcriptome profiling to identify 
transcriptional events that are influenced by DAF-16A and F in both daf-2/IGFrmutants 
and mutants lacking a germline.  We discovered that CEST-1, a previously unstudied 
member of the carboxylesterase family, is required for full lifespan extension in daf-
2/IGFr mutants. CEST-1 expression is induced in daf-2/IGFr mutants, and CEST-1 
  xvii 
localizes to the luminal membrane of the intestine. A conserved catalytic residue in the 
luminal CEST-1 domain is required for it to promote longevity, and CEST-1 
overexpression is sufficient to increase lifespan. This evidence suggests that CEST-1 may 
eliminate a toxic metabolite in the gut or improve digestion of beneficial dietary 
components.  Mammalian carboxylesterase family members are key regulators of 
metabolism, suggesting that carboxylesterase activity could regulate health and longevity 
in a conserved manner. 
  1 
Chapter 1 - Mechanisms governing dauer 
formation in C. elegans 
 
Introduction to C. elegans as a model for developmental 
plasticity 
A central goal of the biological sciences is to understand, at a molecular level, the 
mechanisms which allow a single cell to develop into a complex adult organism 
composed of many interacting cells with identical genomes but diverse physiology and 
function.  Over the last fifty years, studies of the simple nematode Caenorhabditis 
elegans have served as a central tool for elucidating conserved mechanisms underlying 
development.   
C. elegans is a non-parasitic nematode which can be isolated from compost or rotting 
fruit samples around the world (Frézal & Félix, 2015).  Adults are about a millimeter 
long and can be easily cultured in the lab on supplemented agar plates with an E. coli 
food source.  C. elegans is transparent and develops through an invariant series of cell 
divisions into an adult with a fixed number and variety of somatic cells, permitting 
identification of genetic mutants which affect development.  The nematode has two 
sexes, a hermaphrodite and a male, making it an ideal genetic system in which to either 
maintain genetically homogenous populations or perform genetic crosses for epistasis 
analysis (Brenner, 1974; Stiernagle, 2006).  Genetic analysis in C. elegans has identified, 
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or improved our understanding of, numerous signal transduction mechanisms which are 
conserved in vertebrates.   
A key phenomenon complicating development is plasticity-the ability of many organisms 
to alter their physiology and development in response to environmental signals 
(Fielenbach & Antebi, 2008).  Along with other species of nematodes, C. elegans 
displays a dramatic form of developmental plasticity in its ability to stop development 
and undergo a lengthy arrest, or diapause, in an alternative developmental stage called the 
dauer larva.  Under ideal conditions (culture at 15-25°C at low population density, with a 
constant food supply) C. elegans develops from hatching to adulthood in two to three 
days (depending on temperature) and passes through four distinct larval molts (L1-L4).  
Under stressful environmental conditions C. elegans can instead enter an alternative, 
extended, L2 larval phase called L2d-if adverse environmental conditions persist, L2d 
animals will progress to an alternative L3 larval stage called the dauer larva (Cassada & 
Russell, 1975; Golden & Riddle, 1984; Hu, 2007).   
Characteristics of the dauer larval diapause  
Dauer larvae are easily differentiated from developing larvae under a dissecting 
microscope.  Dauer larvae are radially constricted, non-feeding, and do not move unless 
touched (Cassada & Russell, 1975).  Their oral orifices are covered with a plug, and they 
have a specialized cuticle: these characteristics combine to render them resistant to many 
forms of environmental stress (Riddle et al., 1981). Dauer larvae can survive treatment 
with detergents (1% SDS), which enables them to be isolated easily from populations of 
non-dauer animals and facilitates genetic screens for mutants with increased tendency to 
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undergo the dauer life history (Cassada & Russell, 1975).  Animals can persist as dauer 
larvae for months (many times the lifespan of well-fed adults) and then resume 
development to become adults with normal fertility and lifespan, leading to descriptions 
of the dauer larva as a “non-aging” state (Klass & Hirsh, 1976).  Many other nematode 
species, including key human, animal, and plant parasites, undergo a dauer-like life-stage, 
which is often both the infective stage and an obligate part of  development (Riddle et al., 
1981).  Thus, understanding regulation of the dauer life history of C. elegans may also 
lead to insights in combating parasitic nematode infections.   
The developmental decision to undergo the dauer life history (frequently termed the 
“dauer decision”) is influenced by sensory perception of three environmental parameters; 
food availability, temperature, and population density.  C. elegans produces a soluble 
combination of ascarosides, frequently termed “dauer pheromone”; these ascarosides 
serve as a readout of population density (Butcher et al., 2007; Golden & Riddle, 1982; 
Jeong et al., 2005).  Exogenous dauer pheromone can both induce dauer arrest in the 
absence of environmental stress and prevent dauer larvae from resuming normal 
development in replete conditions (Butcher et al., 2007; Golden & Riddle, 1982; Jeong et 
al., 2005). A soluble food signal derived from bacteria and yeast causes dauer larvae to 
resume reproductive development (Golden & Riddle, 1982).  When nematodes are 
cultured on higher concentrations of bacterial food, higher doses of crude extracts 
containing pheromone are required to cause dauer arrest, suggesting that animals 
integrate information about population density and food availability to make the dauer 
decision (Golden & Riddle, 1984).  Temperatures above 27°C cause dauer arrest in wild-
type larvae, and increased temperature enhances dauer arrest in larvae treated with 
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pheromone, suggesting that animals also integrate information about temperature and 
population density to make the dauer decision (Golden & Riddle, 1984).   
Animals exposed to dauer inducing-pheromone undergo a prolonged L2 larval stage 
called the L2d. At pheromone levels that cause dauer entry in only a fraction of the 
population, all animals enter the L2d larval stage, which can be followed by either dauer 
entry or reproductive development, demonstrating that L2d larvae are not fully 
committed to undergo dauer development (Golden & Riddle, 1984). Experiments in 
which animals undergoing development in synchronized populations are shifted from 
non-dauer inducing conditions to dauer-inducing conditions, or vice versa, have been 
used to determine at what developmental stage environmental signals act to control dauer 
arrest.  For example, shifting animals from plates without pheromone to plates with 
pheromone at the L1 larval stage can induce dauer arrest; whereas animals shifted to 
pheromone containing plates during the early L2 stage do not enter dauer (Golden & 
Riddle, 1984).  In contrast, shifting animals from pheromone to non-pheromone 
containing plates can prevent dauer arrest in most animals until the mid L2d larval stage 
(Golden & Riddle, 1984).  These data suggest that the dauer decision is in fact composed 
of two distinct developmental periods during which environmental information is 
integrated before committing to dauer life history.  During the L1 larval stage, perception 
of environmental stresses, including pheromone, low food, and temperature induce 
commitment to undergo the protracted L2d larval stage rather than committing to 
reproductive development through L2.  During the late L2d larval stage information 
about changes in environmental conditions is integrated to either commit to the dauer life 
history or undergo reproductive development.  Signal transduction pathways that regulate 
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the dauer decision may be involved in either or both developmental events, and the need 
to integrate multiple sensory inputs at two life stages to commit to the dauer life history 
may explain the surprising complexity of signal transduction pathways governing 
commitment to the dauer life history.             
Identifying mutations that control the decision to undergo dauer diapause 
Forward genetic screens have been conducted to identify mutations in genes that control 
the decision to undergo the dauer life-history.  These screens have identified two primary 
classes of mutants.  Mutants that are dauer formation constitutive (abbreviated Daf-c) 
enter dauer under conditions in which wild-type animals will undergo reproductive 
development.   Screens for dauer constitutive mutants have primarily identified mutants 
that enter dauer at 25°C, or 27°C in synchronized cultures under non-crowded, fed 
conditions (Ailion & Thomas, 2003; Gottlieb & Ruvkun, 1994; Malone & Thomas, 1994; 
Riddle et al., 1981; Vowels & Thomas, 1992; Vowels & Thomas, 1994).  A second class 
of mutants are dauer formation defective (Daf-d), meaning that they fail to enter dauer 
under dauer inducing conditions.  Dauer formation defective mutants have been isolated 
by screening for mutations that block constitutive dauer formation in Daf-c strains 
(Ailion & Thomas, 2003; Gottlieb & Ruvkun, 1994; Inoue & Thomas, 2000a; Malone & 
Thomas, 1994; Riddle et al., 1981; Vowels & Thomas, 1992; Vowels & Thomas, 1994).  
The genetic epistatic relationships of these mutants have been extensively studied, and 
most dauer arrest mutants arising from initial screens have been mapped and the affected 
genes have been cloned. The dauer decision is regulated by genes that affect the sensory 
perception of dauer pheromone.  Components of the insulin and TGF-β signaling 
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pathways are regulated, in part, by perception of dauer pheromone, and influence the 
dauer decision.  Lastly, components of a steroid signaling pathway regulating the activity 
of the nuclear hormone receptor encoded by daf-12, regulated the dauer decision 
downstream of both TGF-β and insulin signaling (Hu, 2007). 
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Figure 1.1.  Schematic of dauer regulation 
Figure 1.1.  Simplified schematic of the dauer regulatory network.  In stressful 
environments signals from insulin, TGF-β, and steroid hormone biosynthesis pathways, 
converge on the nuclear hormone receptor DAF-12 to promote dauer entry  
 
   
  8 
Perception of environmental stress informs the dauer decision 
via a guanylyl cyclase signaling pathway 
The neural circuits that integrate information about population density, temperature, and 
food availability to commit to either the reproductive or dauer life history are 
incompletely understood.  However, the genes that control dauer pheromone production, 
and some of the initiating events leading from pheromone perception to dauer formation 
have been discovered. 
Three derivatives of the dideoxy sugar ascarylose, which differ only in their fatty acid 
side chains, have been isolated from dauer pheromone by purifying for dauer inducing or 
dauer recovery inhibiting activity (Butcher et al., 2007; Jeong et al., 2005).  Organic 
extracts and culture medium of two mutants, daf-22 and dhs-28, have reduced dauer 
inducing activity (Butcher et al., 2009).  daf-22 encodes a predicted thiolase with possible 
roles in fatty acid β-oxidation and synthesis of bile-acid like molecules, while dhs-28 
encodes a predicted dehydrogenase (Butcher et al., 2009).  Analysis of the molecular 
composition of dauer pheromone extracts from these mutants is consistent with them 
acting in synthesis of the fatty acid side chains of dauer promoting ascarosides (Butcher 
et al., 2009).  
Perception of pheromone is thought to primarily occur in two sensory organs called 
amphids which contain eight neurons which have cilia that are exposed to the external 
environment via a pore in the cuticle (Albert et al., 1981; Bargmann & Horvitz, 1991; 
Schackwitz et al., 1996).  Like most somatic cells in C. elegans, the amphid neurons are 
individually named with a three-letter code.  Ablations of the ADF, ASI, and ASG, 
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neurons cause dauer constitutive phenotypes, indicating that these neurons prevent dauer 
development under replete conditions, while ablation of the ASJ neuron prevents 
recovery from the dauer stage, suggesting that the ASJ is necessary for perception of 
improving environmental conditions to mediate recovery from dauer (Bargmann & 
Horvitz, 1991).  Two mutants, daf-6 and daf-10, were isolated as defective in dauer 
formation and have defects in the amphid pore (daf-6) or in sensory cilia (daf-10) that 
likely prevent sensory cilia from coming into contact with the external environment, 
suggesting that these mutants are defective in perception of dauer pheromone (Patrice et 
al., 2004).  A third sensory mutant, daf-19, is dauer constitutive, and causes all neurons to 
completely lack cilia; however, this phenotype is unlikely to be specific to dauer 
pheromone perception since it affects many types of neurons (Swoboda et al., 2000).   
Loss of function mutants in a transmembrane guanylyl cyclase, daf-11,  that is expressed 
in chemosensory neurons (ASI, ASJ, ASK, AWB, and AWC) are Daf-c, as are mutations 
in two components of a cGMP gated ion channel (tax-2 and tax-4) whose expression 
patterns overlap with that of DAF-11 (Birnby et al., 2000; Coburn & Bargmann, 1996; 
Coburn et al., 1998; Komatsu et al., 1996; Thomas et al., 1993).   Treatment with 8-
bromo cGMP rescues the dauer constitutive phenotype of daf-11, but not tax-4 or other 
most other dauer constitutive mutants, suggesting that the predicted DAF-11 guanylyl 
cyclase activity acts upstream of, or in parallel to other dauer formation mutants (Birnby 
et al., 2000).  Furthermore, the Daf-c phenotype of daf-11 mutants is suppressed by daf-6 
and daf-10 amphid neuron mutants (Starich et al., 1995; Vowels & Thomas, 1992).    
These data suggest that DAF-11 activation in chemosensory neurons is one of the earliest 
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events in a signaling pathway that inhibits dauer arrest under non-dauer inducing 
conditions.  
Exposure to dauer pheromone reduces expression of two other dauer inhibiting genes, 
daf-7 and daf-28 (Li et al., 2003; Schackwitz et al., 1996).   daf-7 encodes a TGF-β 
family ligand; a DAF-7::GFP transgene is expressed in ASI and downregulated by 
exposure to dauer pheromone (Ren et al., 1996; Schackwitz et al., 1996).  daf-28 encodes 
an insulin-like peptide that is expressed in the ASI and ASJ and downregulated by dauer 
pheromone and in daf-11 mutants (Li et al., 2003).  This data suggests that DAF-11 acts 
upstream of both the insulin and TGF-β pathways to control dauer arrest.  
Regulation of the dauer decision by a transforming-growth-
factor-beta pathway 
The DAF-7/TGF-β signaling network was originally defined by five Daf-c genes (daf-1, 
4, 7, 8, and 14) and two Daf-d genes (daf-3 and daf-5) (Patterson & Padgett, 2000).  The 
Transforming Growth-Factor-Beta (TGF-β) family ligand, encoded by daf-7, is inferred 
by homology to bind to a heteromeric cell surface receptor (encoded by daf-1 and daf-4); 
based on homology to mammalian TGF-β pathway components DAF-1 and DAF-4 are 
thought to activate SMAD transcription factors (daf-3, daf-8, and daf-14) (Estevez et al., 
1993; Inoue & Thomas, 2000b; Patterson et al., 1997; Shi & Massagué, 2003). The dauer 
constitutive phenotypes of daf-8 and daf-14 suggest that these genes are required for 
TGF-β pathway activation by DAF-7/ TGF-β to promote reproductive development, 
which is consistent with the known roles of mammalian SMAD transcription factors as 
positive effectors of TGF-β signaling (Inoue & Thomas, 2000b; Shi & Massagué, 2003).  
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In contrast, daf-3, whose mutation suppresses the dauer constitutive phenotypes of daf-1, 
4, 7, 8, and 14, encodes a SMAD transcription factor that appears to be inhibited by  
DAF-7/ TGF-β and to promote entry into the dauer larval stage (Patterson et al., 1997).  
daf-5 encodes a Sno/Ski oncoprotein that binds to daf-3 and appears to be required for its 
dauer inducing activity (da Graca et al., 2004b; Tewari et al., 2004). 
DAF-7::GFP constructs driven by the endogenous daf-7 promoter can be expressed in the 
amphid chemosensory neurons including ASI and ASJ (Meisel et al., 2014; Ren et al., 
1996; Schackwitz et al., 1996).  DAF-7::GFP expression is increased by food and 
reduced by dauer pheromone and increased temperature, suggesting that DAF-7 levels 
influence dauer arrest in response to the environment (Ren et al., 1996; Schackwitz et al., 
1996). Other components of the TGF-β pathway are broadly expressed (Da Graca et al., 
2004a; Gunther et al., 2000; Inoue & Thomas, 2000b; Patterson et al., 1997; Tewari et al., 
2004).    
The TGF-β pathway has a complex relationship with temperature. daf-3 mutants are Daf-
d when a synchronized population of animals is grown at 25°C, the temperature at which 
most Daf-c mutants promote dauer arrest (Thomas et al., 1993).  However, at 27°C, a 
temperature at which wild-type animals begin to arrest as dauer larvae at low penetrance, 
daf-3 mutants have Daf-c phenotypes (Ailion & Thomas, 2003).  This suggests that DAF-
3 can function to either promote or suppress dauer entry, in response to perception of 
environmental temperature. 
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Regulation of the dauer decision by an insulin-signaling 
pathway 
The insulin signaling pathway was originally defined by the Daf-c genes daf-2 and daf-23 
(which is allelic to age-1), which antagonize the Daf-d gene daf-16 (Gottlieb & Ruvkun, 
1994; Riddle et al., 1981; Thomas et al., 1993).  The Daf-d phenotype of daf-16 null 
mutants is epistatic to the Daf-c phenotypes of daf-2 and age-1, suggesting that DAF-2 
and AGE-1 promote reproductive development by inhibiting the dauer promoting activity 
of DAF-16 (Gottlieb & Ruvkun, 1994).  The Daf-c phenotypes of daf-2 and daf-23 are 
not suppressed by daf-3/SMAD mutations, and daf-16 mutation does not prevent dauer 
arrest in Daf-c TGF-β pathway mutants, demonstrating that the insulin signaling and 
TGF-β pathways act in parallel (Gottlieb & Ruvkun, 1994; Vowels & Thomas, 1992).  
Strains carrying null mutations in daf-2 cause maternally rescued embryonic lethality, 
and arrest as dauers and do not recover, suggesting that the insulin signaling pathway 
regulates the decision to exit the dauer life stage as well as the decision to undergo dauer 
arrest (Gems et al., 1998).  daf-2 encodes a predicted transmembrane tyrosine kinase, 
which is the sole C. elegans member of the insulin and insulin-like-growth-factor 
receptor family (Kimura et al., 1997).  age-1 encodes a phosphoinositide-3-kinase 
(Morris et al., 1996).  daf-16 encodes the sole C. elegans member of the FoxO family of 
transcription factors (Lin et al., 1997; Ogg et al., 1997).  
The observation that FoxO family transcription factors interact genetically with insulin 
signaling in C. elegans led to experiments demonstrating that growth factor signaling 
regulated the nuclear localization of both nematode and mammalian FoxO family 
members, and rapid characterization of a conserved signaling pathway by which insulin 
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signaling regulates FoxO activity (Brunet et al., 1999; Brunet et al., 2002; Lee et al., 
2001; Lin et al., 2001).  Insulin family receptors are obligate disulfide linked 
homodimers; when bound by ligand and activated, insulin receptor subunits 
phosphorylate each other and phosphorylate insulin receptor substrate one (IRS-1).  
Activated IRS-1 allosterically activates phospoinositide-3-kinase, which phosphorylates 
plasma membrane phosphoinositides, recruiting the kinases PDK-1, AKT-1 and AKT-2 
to the plasma membrane.  PDK-1 phosphorylates and activates AKT-1 and AKT-2 which 
phosphorylate FOXO family members at conserved RxRxxS/T sites.  Phosphorylated 
DAF-16/FoxO is sequestered in the cytoplasm through a mechanism which requires the 
14-3-3 proteins PAR-5 and FTT-2 and is ubiquitinated and degraded through a 
mechanism which requires the E3 ubiquitin ligase RLE-1 (Berdichevsky et al., 2006; Li 
et al., 2007a; Li et al., 2007b).  Mutants in the phosphoinositide 3 phosphatase daf-
18/PTEN which antagonizes AGE-1/PI3K, have Daf-d phenotypes that suppress the Daf-
c phenotypes of age-1 and daf-2 loss of function mutants (Gil et al., 1999; Mihaylova et 
al., 1999; Ogg & Ruvkun, 1998).   pdk-1 mutants have daf-16/FoxO-dependent dauer 
constitutive phenotypes at 25°C (Paradis & Ruvkun, 1998).  Mutants in akt-1 have daf-
16/FoxO-dependent Daf-c phenotypes at 27°C (Hu et al., 2006; Zhang et al., 2008; Ailion 
& Thomas, 2003).  akt-2 mutation dramatically enhances the penetrance of the Daf-c 
phenotype of akt-1 mutants, causing akt-1;akt-2 mutants to arrest as dauer larvae at 25°C, 
but does not have a Daf-c phenotype in isolation, suggesting that akt-1 and akt-2 act 
partially redundantly in dauer regulation (Alam et al., 2010; Oh et al., 2005; Paradis et 
al., 1999; Paradis & Ruvkun, 1998). Strong loss of function mutations in par-5 and ftt-2 
are lethal; however, RNAi-mediated inactivation of these genes enhances the Daf-c 
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phenotypes of other DAF-16 activating mutants (Alam et al., 2010; Berdichevsky et al., 
2006; Hertweck et al., 2004).   
Like TGF-β pathway components, insulin signaling pathway proteins and DAF-16 are 
broadly expressed.  However, rescue experiments using transgenic mosaic animals, or 
transgenic expression under heterologous promoters, suggest that insulin signaling genes 
and DAF-16 non-cell autonomously, and likely predominantly in neurons, to regulate 
dauer arrest (Apfeld & Kenyon, 1998; Wolkow et al., 2000).   
 
Regulation of dauer entry by insulin family ligands 
DAF-2 activity is regulated by insulin family ligands. The C. elegans genome encodes 40 
insulin like (INS) peptides (Li et al., 2003; Pierce et al., 2001). Genetic studies of insulin 
family genes in C. elegans are complicated by likely functional redundancy of insulin 
family members, and by possible effects of insulin protein overexpression on processing 
of other insulin family members.  Nonetheless, there is evidence that worm insulin-like-
peptides regulate dauer arrest and can both activate and inactivate the insulin receptor.  A 
single semi-dominant Daf-c mutation in daf-28 is the only member of the insulin family 
that has come out of genetic screens for dauer regulators (Li et al., 2003; Malone & 
Thomas, 1994) .  A daf-28 promoter drives GFP expression in the amphid neurons ASI 
and ASJ and is downregulated in response to pheromone and starvation (Li et al., 2003). 
Similarly, to daf-28,  RNAi against ins-7 also enhances the Daf-c phenotype of daf-
2(e1370) mutants, suggesting that, similar to DAF-28, INS-7 activates DAF-2/IGFr to 
promote reproductive development (Murphy et al., 2003). Mutations in ins-4 and ins-6 
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enhance the Daf-c phenotype of daf-28 mutants, suggesting that ins-4, ins-6, and ins-28 
act partially redundantly to promotes reproductive development (Cornils et al., 2011; 
Hung et al., 2014).  A loss-of-function mutation in ins-9 promotes dauer arrest, while 
INS-9 overexpression blocks some DAF-16-dependent Daf-c phenotypes, suggesting that 
INS-9 also activates DAF-2 to promote reproductive development (Delaney et al., 2017).   
In contrast, overexpression of INS-1 and INS-18 enhance dauer arrest in wild-type and 
daf-2/IGFr mutant backgrounds, and ins-1 and ins-18 mutations partially suppress the 
Daf-c phenotypes of ins-4;ins-6;daf-28 compound mutants, suggesting that these peptides 
bind to DAF-2/IGFr and inhibit its activity, to promote DAF-16/FoxO activity and dauer 
entry (Hung et al., 2014; Pierce et al., 2001).   
The eak pathway regulates dauer arrest and DAF-16/FoxO activity in parallel to 
akt-1 
Multiple lines of evidence suggest that the insulin signaling pathway can regulate DAF-
16/FoxO activity through mechanisms other than the canonical PI3K-PDK-AKT-DAF-
16/FoxO pathway, and independently of changes DAF-16/FoxO nuclear localization.  
The transcription activating activity of a constitutively nuclear murine Foxo1 lacking its 
nuclear export signal can be inhibited by addition of insulin to the culture medium to the 
same extent as the activity of wild-type Foxo1, without causing its nuclear export, 
suggesting that growth factor signaling inhibits FOXO activity in the nucleus (Tsai et al., 
2003).  Similarly, in C. elegans, a transgenically expressed DAF-16 protein in which all 
three AKT-1 phosphorylation sites are mutated to alanine, is constitutively localized to 
the nucleus and rescues dauer arrest in daf-2;daf-16 compound mutants, but does not 
have a Daf-c phenotype in wild-type animals, suggesting that DAF-2 activity can inhibit 
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the activity of nuclear DAF-16 independently of AKT phosphorylation and nuclear 
localization (Berdichevsky et al., 2006; Hertweck et al., 2004; Lin et al., 2001).  
Activating mutations in akt-1 and pdk-1, and the weak daf-18/PTEN allele daf-18(e1375) 
suppress the Daf-c phenotype of age-1/PI3K null mutants, but not the Daf-c phenotype of 
strong loss of function mutants in daf-2/IGFr mutants, suggesting that DAF-2 promotes 
reproductive development through outputs that are independent of AGE-1/PI3K (Gil et 
al., 1999; Gottlieb & Ruvkun, 1994; Inoue & Thomas, 2000a; Ogg & Ruvkun, 1998; 
Paradis et al., 1999; Paradis & Ruvkun, 1998; Vowels & Thomas, 1992).   
To identify mutations that increase DAF-16/FoxO activity in parallel to AKT-1, a 
forward genetic screen was performed to identify mutants that cause a Daf-c phenotype 
in an akt-1 mutant background at 25°C rather than 27°C (Hu et al., 2006).  The genes 
identified in this screen are named eak for enhancers of akt-1 dauer arrest.  The eak 
screen identified twenty-one alleles in seven complementation groups, six of which (eak-
2 through 7) have been molecularly characterized (Alam et al., 2010; Dumas et al., 2010; 
Hu et al., 2006; Patel et al., 2008; Williams et al., 2010; Zhang et al., 2008).  eak-2 is 
allelic to hsd-1 and encodes a predicted hydroxysteroid dehydrogenase that functions in 
regulation of the nuclear hormone receptor DAF-12 (see below) activity and regulates 
expression of DAF-16 target genes in a DAF-12-dependent manner, suggesting that two 
major transcription factors regulating the dauer decision coordinate to control expression 
of shared target genes (Dumas et al., 2010).  eak-3 encodes a novel protein (Zhang et al., 
2008).  eak-4 encodes a novel protein with an N-myristoylation motif (Hu et al., 2006).  
eak-5 is allelic to sdf-9, which was identified in another screen for mutations that cause 
synthetic dauer formation in a sensitized genetic background and encodes a predicted 
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catalytically inactive phosphatase-like molecule (Hu et al., 2006; Ohkura et al., 2003).  
eak-6 encodes another catalytically inactive phosphatase-like molecule (Hu et al., 2006).   
eak-7 encodes a conserved protein with an N-myristoylation motif and a conserved 
TLDC domain, and is expressed in an operon with the heat-shock binding protein HSB-1 
(Alam et al., 2010)   
The upstream regulatory regions of eak-2-5 drive expression exclusively in a pair of cells 
in the head, designated the XXX cells (Dumas et al., 2010; Hu et al., 2006; Zhang et al., 
2008).  The eak-6 promoter drives expression in XXX cells and the M1 pharyngeal motor 
neuron (Hu et al., 2006). A promoter upstream of the hsb-1/eak-7 operon drives 
expression in multiple tissues, including neurons, intestine, pharynx, muscle, hypodermis, 
and a group of cells near the anus (Alam et al., 2010). Heterologous expression of an 
EAK-7::GFP transgene under a neuronal ric-19 promoter, or exclusively in the XXX 
cells under the eak-4 promoter, rescues the Daf-c phenotype of eak-7;akt-1 mutants 
(Alam et al., 2010).   These results suggest that all six characterized eak genes influence 
the dauer decision in a non-cell-autonomous manner, with the caveat that this 
interpretation is based, in part, on overexpression of EAK-7::GFP under heterologous 
promoters that could drive low-level expression in unforeseen tissues (Alam et al., 2010). 
Laser ablation of the XXX cells causes a partially penetrant Daf-c phenotype at 25°C, 
establishing that the XXX cells regulate the dauer decision non-cell-autonomously 
(Ohkura et al., 2003).   
In animals that are wild-type for akt-1, eak-2-7 mutants develop reproductively at 25°C 
but have Daf-c phenotypes at 27°C, suggesting that eak mutations can promote dauer 
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formation when the akt-1 branch of the insulin signaling pathway is active (Alam et al., 
2010; Dumas et al., 2013b; Hu et al., 2006; Zhang et al., 2008). The Daf-c phenotypes of 
compound mutants carrying any combination of two eak mutations are not more 
penetrant than the Daf-c phenotypes of single mutants, suggesting that the eak genes act 
in a single genetic pathway to regulate dauer arrest.  The Daf-c phenotypes of all eak 
mutations are blocked by the addition of a daf-16 null mutation, and eak mutants display 
daf-16-dependent transcriptional upregulation of canonical daf-16 target genes, 
suggesting that the EAK pathway acts to inhibit DAF-16/FoxO activity.  eak mutants are 
suppressed by daf-12/NHR mutants, confirming that EAK pathway acts upstream of the 
nuclear hormone pathway (Alam et al., 2010; Dumas et al., 2010; Hu, 2007; Zhang et al., 
2008).   
EAK-3-7 are localized to the plasma membrane and control DAF-16/FoxO activity in the 
nucleus, suggesting that they influence DAF-16/FoxO indirectly.  EAK-7 encodes a 
conserved protein that has a similar expression pattern to DAF-16, and controls DAF-16 
transcriptional activity in multiple tissues (Alam et al., 2010).  A predicted null allele of 
eak-7 increases levels of DAF-16 protein by Western blot and causes DAF-16-dependent 
increases in lifespan in addition to its dauer arrest phenotypes (Alam et al., 2010).  These 
characteristics suggest that EAK-7 may be a downstream component of the eak pathway 
and indicate that it may be useful for identifying gene products that transduce signals to 
DAF-16 in the nucleus. To identify possible downstream genes affecting nuclear DAF-
16/FoxO activity, a forward genetic screen was conducted for mutations which suppress 
the 25°C dauer-constitutive phenotype of eak-7;akt-1 compound mutants, or seak genes 
(Dumas et al., 2013a).  In principle seak genes may act in the eak pathway to control 
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activity of nuclear DAF-16/FoxO, in the canonical insulin signaling pathway to affect 
DAF-16/FoxO localization, or downstream of or in parallel to DAF-16.  The seak screen 
has identified mutations in two genes, dpy-21 and set-4, that have been previously 
reported to act in the dosage compensation pathway (Wells et al., 2012; Yonker & 
Meyer, 2003). Both dpy-21 and set-4 mutations appear to suppress eak-7;akt-1 dauer 
arrest by causing differential regulation of X-linked insulin signaling pathway genes, 
including ins-9 and akt-2 (Delaney et al., 2017; Dumas et al., 2013a). The seak screen has 
also identified a large rearrangement on the X-chromosome, which may suppress the eak-
7;akt-1 Daf-c phenotype by duplicating akt-2, and a novel allele of daf-12 (Itani et al., 
2016a; Itani et al., 2016b).  
 
Dauer regulatory signals converge on the nuclear hormone 
receptor DAF-12 
A steroid hormone signaling pathway that regulates dauer arrest was originally defined 
by Daf-c mutations in the gene daf-9 and Daf-d mutations in the gene daf-12.  daf-12 null 
mutants do not form dauer larvae in starved, high population density cultures, and are 
epistatic to all known Daf-c mutants, suggesting that sensory perception, TGF-β signaling 
and insulin signaling converge on DAF-12 activity to regulate dauer entry (Albert & 
Riddle, 1988; Antebi et al., 2000; Fielenbach & Antebi, 2008; Gerisch et al., 2001; 
Riddle et al., 1981; Thomas et al., 1993).  daf-12 encodes a nuclear hormone receptor, 
which includes a ligand binding and DNA binding domain (Antebi et al., 2000).  While 
daf-12 null mutants are Daf-d, mutations within the daf-12 ligand binding domain have 
Daf-c phenotypes, suggesting that unliganded DAF-12 promotes dauer arrest (Antebi et 
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al., 2000). DAF-12::GFP is expressed in the nucleus in most cells, suggesting that it may 
act cell-autonomously to promote dauer-specific developmental programs (Antebi et al., 
2000).   
Bile acid-like steroids, including Δ7- and Δ1,7-dafachronic acid, have been chemically 
identified as DAF-12 ligands (Mahanti et al., 2014; Motola et al., 2006).  DAF-9 encodes 
a cytochrome P450 family member that is required for biosynthesis of both dafachronic 
acid species (Gerisch et al., 2001; Jia et al., 2002; Mahanti et al., 2014; Motola et al., 
2006) . The Daf-c phenotypes of daf-9 mutants are rescued by administration of 
exogenous dafachronic acids, indicating that DAF-9 antagonizes the dauer promoting 
activity of DAF-12 by promoting dafachronic acid biosynthesis (Mahanti et al., 2014; 
Motola et al., 2006).   
In addition to daf-9, three other genes, hsd-1, daf-36, and dhs-16 have been proposed to 
act in the dafachronic acid biosynthesis pathway.  daf-36 encodes an enzyme with 
homology to Rieske oxygenases, hsd-1 encodes a hydroxysteroid dehydrogenase family 
member, and dhs-16 encodes an enzyme with homology to short chain dehydrogenases 
(Dumas et al., 2010; Patel et al. 2008; Rottiers et al. 2006; Wollam et al. 2012). daf-36, 
hsd-1, and dhs-16 mutants have less penetrant Daf-c phenotypes than daf-9 mutants, with 
daf-36, hsd-1, and dhs-16 mutants undergoing dauer arrest in synchronized cultures at 
27°C but not at lower temperatures, whereas daf-9 null mutants are dauer-constitutive 
regardless of temperature (Dumas et al., 2010; Gerisch et al., 2001; Jia et al., 2002; Patel 
et al., 2008; Rottiers et al., 2006; Wollam et al., 2012).  Compound hsd-1;daf-36, dhs-
16;daf-36, and dhs-16;hsd-1 mutants have an enhanced dauer arrest phenotype at 25°C 
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suggesting that these enzymes may act partially redundantly or in parallel (Dumas et al., 
2010; Patel et al., 2008; Wollam et al., 2012).  Biochemical analysis has revealed small 
decreases in levels of  Δ7- and Δ1,7- dafachronic acids in hsd-1;daf-22 mutants, relative to 
daf-22 controls (which have high levels of dafachronic acids likely due to their defects in 
dauer pheromone biosynthesis), along with the appearance of new steroid molecules 
which may be dafachronic acid precursors (Mahanti et al., 2014).  In contrast, Δ7- and 
Δ1,7- dafachronic acids appear to be absent in daf-36;daf-22 mutants (Mahanti et al., 
2014).  daf-36;daf-22 mutants do produce a dafachronic acid precursor (Δ0-DA) the 
presence of which is correlated with activity in suppressing daf-9 dauer arrest, potentially 
accounting for the less penetrant Daf-c phenotype of daf-36 mutants relative to daf-9 
(Mahanti et al., 2014).   dhs-16 mutation greatly reduced levels of Δ7-dafachronic acid 
and causes a more modest reduction in Δ1,7-dafachronic acid levels (Mahanti et al., 2014).  
These data are consistent with a model whereby DAF-36 and DHS-16 act in the same 
pathway as DAF-9 to produce dafachronic acids, while HSD-1 either modulates this 
pathway, potentially in a cell type specific matter, or regulates dauer arrest through an 
independent mechanism.   
Availability of exogenous dafachronic acids provided the opportunity to test whether 
dafachronic acid biosynthesis functions downstream of the TGF-β and insulin signaling 
in regulation of dauer entry.  Treatment of daf-9/cytochromeP450 mutants with Δ7-
dafachronic acid during a specific temporal window (15 to 33 hours post hatch) within 
the L2d larval stage rescued dauer arrest in a dose dependent manner, suggesting that a 
critical threshold of dafachronic acid must be reached during the L2d stage to commit to 
reproductive development (Schaedel et al., 2012).  Consistent with the observations that 
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forward genetic screens for suppression of TGF-β pathway mutants yield daf-12 
mutations, treatment with Δ4-dafachronic acid rescued the dauer formation constitutive 
phenotype of daf-7/TGF-β mutants, confirming that dafachronic acids act downstream of 
or in parallel to the TGF-β pathway, and suggesting that DAF-7/TGF-β signaling may 
regulate DAF-12 activity by regulating enzymes that synthesize dafachronic acids 
(Motola et al., 2006).  Treatment of strong daf-2 loss of function mutants with Δ4-
dafachronic acid also prevents formation of fully remodeled dauer larvae; however, 
animals do arrest development as L3 larva (Motola et al., 2006).  Interestingly, this L3 
developmental arrest is also observed when some strong loss of function alleles of daf-
2/IGFr are crossed into daf-12(0) backgrounds (Vowels & Thomas, 1992).  These 
observations are consistent with a model in which reduced insulin signaling promotes 
dauer arrest in part by reducing levels of DAF-12 ligands, and in part through DAF-12-
independent activities of DAF-16/FoxO. Studies showing that DAF-16 is required for 
dauer larva to suppress cell differentiation and cell division in the vulva, and for normal 
vulval morphogenesis when dauer larva resume reproductive development are also 
consistent with the hypothesis that DAF-16/FoxO has DAF-12-independent roles in dauer 
development (Karp & Greenwald, 2013).  The role of DAF-16 in other forms of non-
dauer diapause, including the developmental arrest of starved L1 larvae, together with 
observations of DAF-12/NHR independent L3 arrest in strong daf-2/IGFr mutants, 
suggests that DAF-16/FoxO may promote cessation of developmental cell division 
programs during diapause states in a DAF-12-independent manner, while DAF-12 is 
required for dauer-specific developmental patterning events (Baugh & Sternberg, 2006; 
Motola et al., 2006; Vowels & Thomas, 1992).  The observation that the hsd-1 Daf-c 
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phenotype is daf-16-dependent and that hsd-1 mutants exhibit upregulation of direct 
transcriptional targets of DAF-16 in a DAF-12 dependent manner is also more consistent 
with models in which DAF-16 and DAF-12 coordinate and regulate each other’s activity, 
than with models in which DAF-12 is simply downstream of DAF-16 (Dumas et al., 
2010; Patel et al., 2008).   
Unlike DAF-12, which is broadly expressed, expression of the Daf-c genes encoding 
dafachronic acid biosynthesis enzymes is cell-type specific.  A rescuing DAF-9::GFP 
construct driven by the endogenous daf-9 promoter is expressed in the XXX cells, in the 
hypodermis of L2 to L4 larva undergoing reproductive development, and in the 
spermatheca of adult hermaphrodites (Gerisch & Antebi, 2004; Mak & Ruvkun, 2004).  
A rescuing HSD-1::GFP construct driven by the endogenous promoter is expressed 
exclusively in the XXX cells (Patel et al., 2008).  A rescuing DAF-36::GFP construct 
driven by its endogenous promoter is expressed in the intestine, a pair of unidentified 
(non-XXX) neurons in the head, the head mesodermal cell, and the hypodermal seam 
cells of dauer larvae (Rottiers et al., 2006).  It has been suggested that the tissue 
distribution of dafachronic acid biosynthesis genes allows inputs from multiple tissues to 
influence dafachronic acid production and dauer entry (Fielenbach & Antebi, 2008).  
DAF-9::GFP expression is absent in the hypodermis of dauer larva of daf-2/IGFr and daf-
7/TGF-β mutants, though expression persists in dauer XXX cells (Gerisch & Antebi, 
2004; Mak & Ruvkun, 2004).  DAF-9::GFP expression is absent in the hypodermis of 
dauer larvae of daf-2/IGFr and daf-7/TGF-β mutants, though expression persists in dauer 
XXX cells (Gerisch & Antebi, 2004; Mak & Ruvkun, 2004).  Constitutive expression of 
DAF-9 under the hypodermal dpy-7 promoter fully suppressed dauer arrest in daf-7 
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mutants and caused non-dauer L3 arrest in strong daf-2 loss-of-function mutants, 
suggesting that Daf-c mutants in both TGF-β and insulin signaling pathways promote 
dauer arrest, at least in part, by downregulating DAF-9 expression (Mak & Ruvkun, 
2004). Interestingly, DAF-9::GFP expression increased, in a DAF-12-dependent manner, 
during reproductive development under mildly dauer-inducing conditions, such as culture 
of daf-7/TGF-β  and daf-2/IGFr mutants at 20°C, or treatment with sub-dauer inducing 
concentrations of pheromone (Gerisch & Antebi, 2004; Mak & Ruvkun, 2004).  This 
observation may be consistent with a model where accumulation of DAF-12 ligands 
promotes progression from L2d to the reproductive life history under conditions that are 
too stressful for commitment to reproductive development at L1, but not sufficiently 
stressful to induce commitment to the dauer life history.  DAF-36::GFP expression is 
downregulated in daf-2 mutants but not in TGF-β or guanylyl cyclase pathway Daf-c 
mutants, suggesting that reduced insulin signaling may promote dauer arrest, in part, by 
downregulating DAF-36 levels (Rottiers et al., 2006). Effects of Daf-c mutations on 
HSD-1::GFP expression have not yet been reported.  Taken together, the data is 
consistent with a model where guanylyl cyclase, TGF-β and insulin signaling control 
dauer entry by regulating biosynthesis of dafachronic acids, though the precise molecular 
events that lead from reduced insulin and TGF-β signaling to lower levels of dafachronic 
acid biosynthesis enzymes remain to be determined.  
DAF-12/NHR is regulated by direct interaction with DIN-1/SHARP 
Nuclear hormone receptors often mediate transcriptional activation and repression by 
assembling complexes with co-activator and co-repressor proteins that potentiate 
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transcription by promoting histone acetylation, or block transcription by promoting 
histone de-acetylation (Fielenbach & Antebi, 2008).  Unliganded DAF-12 assembles with 
DIN-1, a homologue of the human SHARP co-repressor, to promote dauer formation 
(Ludewig et al., 2004).   Biochemical interaction between DAF-12 and DIN-1 was first 
identified by yeast two-hybrid (Ludewig et al., 2004). DIN-1 is expressed in two 
transcriptional isoforms, DIN-1S and DIN-1L.  Mutations that specifically affect the 
DIN-1S isoform emerged from forward genetic screens for suppression of gonadal 
migration phenotypes of DAF-12 ligand binding domain mutants.  Mutants that affect the 
DIN-1L isoform have a distinct set of unrelated developmental phenotypes, which may 
explain why DIN-1 alleles have not previously come out of dauer suppression screens 
(Ludewig et al., 2004).  din-1s mutants suppress the Daf-c phenotypes of daf-9 and daf-
12 ligand binding domain mutants, indicating that DIN-1S is required for dauer formation 
downstream of or parallel to unliganded DAF-12.  din-1s mutants also suppress the Daf-c 
phenotypes of daf-7/TGF-β mutants and of weaker daf-2/IGFr alleles (e1368, e1369, and 
m41) but do not suppress the Daf-c phenotypes of stronger daf-2 alleles (e1370 and 
e1391), consistent with a model in which TGF-β pathway mutants are fully dependent on 
DIN-1 to promote dauer arrest, while reduced insulin signaling can promote dauer arrest 
through DIN-1-dependent and -independent mechanisms (Ludewig et al., 2004).  
Regulation of dauer arrest by heterochronic genes 
While unliganded DAF-12 is required for dauer entry, liganded DAF-12 plays a role in 
promoting developmental programs specific to the L2 and L3 larval stages of 
reproductive development. Mutations that disrupt dafachronic acid biosynthesis or 
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binding to DAF-12 have defects in gonadal development, establishing a well 
characterized role for liganded daf-12 in gonad morphogenesis during non-dauer 
reproductive development (Antebi et al., 1998; Antebi et al., 2000; Jia et al., 2002).  
Mutations in the DAF-12 DNA binding domain cause repetition of L2 stage specific 
developmental programs in multiple tissues after the transition to the L3 larval stage, 
demonstrating that DAF-12 plays a role in L2 to L3 transitions during normal 
reproductive development, as well as during dauer formation (Antebi et al., 1998; Antebi 
et al., 2000).  
In C. elegans, a network of genes called heterochronic loci, which includes daf-12, acts in 
multiple tissues to control developmental events that are specific to each larval stage 
(Moss, 2007).  Mutations in heterochronic genes alter the sequence of developmental 
stage-specific programs, either skipping stage-specific programs in favor of early 
expression of later developmental stage or adult programs (termed a precocious 
phenotype) or repeating expression of stage-specific programs (termed a retarded, or 
delayed phenotype) (Fielenbach & Antebi, 2008; Moss, 2007).  For example, mutations 
in the heterochronic gene lin-4, which encodes the first discovered microRNA, cause 
repetition of L1 developmental programs, including division of intestinal nuclei which 
normally occurs only at L1, and L1-specific patterns of hypodermal cell divisions at each 
subsequent larval stage (Chalfie et al., 1981; Moss, 2007; Lee & Ambros, 2003).  
Somatic developmental programs that are specific to larval stages after L1 rarely occur in 
lin-4 mutants, though  germline maturation occurs at the normal time in lin-4 and other 
heterochronic mutants (Chalfie et al., 1981; Moss, 2007).  Genetic epistasis analysis of 
heterochronic phenotypes has put the heterochronic genes into a regulatory hierarchy; 
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some but not all of these genetic interactions are understood molecularly (Fielenbach & 
Antebi, 2008; Moss, 2007). Recent work has established that multiple components of the 
heterochronic pathway affect the dauer decision through mechanisms that involve genetic 
or molecular interactions with DAF-12 (Karp & Ambros, 2011; Tennessen et al., 2010).   
LIN-42 is homologous to the circadian transcription factor period. It is expressed 
cyclically during larval development with peak expression within larval stages, while 
expression is reduced at molts, when animals are transitioning between larval stages 
(Tennessen et al., 2006).  Expression of lin-42 is downregulated after molting during the 
dauer diapause (Tennessen et al., 2006; Tennessen et al., 2010).  Like DAF-12, LIN-42 is 
important for hypodermal patterning during the L3 larval stage and proper development 
of the somatic gonad (Tennessen et al., 2006; Tennessen et al., 2010).  lin-42 mutants 
have a Daf-c phenotype when cultured at 27°C, and LIN-42 overexpression during the L2 
larval stage suppresses the Daf-c phenotypes of insulin signaling, TGF-β, dafachronic 
acid biosynthesis, and daf-12 ligand binding domain mutants (Tennessen et al., 2010).  
LIN-42 protein directly binds DAF-12 in yeast, suggesting that that LIN-42 may regulate 
DAF-12 transcriptional activity via a direct physical interaction (Tennessen et al., 2010).  
The hunchback like transcription factor HBL-1 acts in opposition to DAF-12 to promote 
L2-specific developmental programs and inhibit L3-specific programs; hbl-1 mutants 
have precocious phenotypes in which L2 developmental programs are skipped and L3-
specific developmental programs are expressed in L2 larvae, while in daf-12 DNA 
binding domain mutants L2 specific developmental programs are repeated at the L3 
larval stage (Abrahante et al., 2003; Bethke et al., 2009).  Two independent loss-of-
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function alleles of hbl-1 suppress the Daf-c phenotype of a daf-12 ligand binding mutant 
(Karp & Ambros, 2011).  This suggests that hbl-1 promotes dauer entry, either through 
ligand-independent regulation of DAF-12, or through regulation of shared DAF-12/HBL-
1 target genes.  Interestingly the same alleles enhance dauer-constitutive phenotypes of 
insulin and TGF-β pathway mutants, suggesting that HBL-1 regulates dauer arrest 
through distinct, possibly developmental stage-specific activities (Karp & Ambros, 
2011).   
The transcription factor LIN-14 has been placed genetically upstream of DAF-12 in the 
heterochronic pathway (Antebi et al., 1998).  LIN-14 is expressed in fasted L1 larva and 
promotes expression of L1 and L2 specific programs in many somatic tissues (Ambros & 
Horvitz, 1987; Reinhart & Ruvkun, 2001; Ruvkun et al., 1989; Ruvkun & Giusto, 1989).  
Upon feeding lin-14 expression is downregulated by interaction with the micro-RNA lin-
4, resulting in decreasing levels of LIN-14 protein throughout the L1 larval stage (Bagga 
et al., 2005; Ha et al., 1996; Lee et al., 1993; Olsen & Ambros, 1999; Wightman et al., 
1993).  Loss-of-function mutants in lin-14 skip L1-specific developmental programs and 
express L2-specific programs precociously, while constitutive expression of LIN-14 
caused by lin-4 mutation or mutation of the lin-4 binding site in the LIN-14 3’UTR 
results in repeated expression of L1-specific larval programs (Ambros & Horvitz, 1987; 
Olsen & Ambros, 1999).  Interestingly, when placed into Daf-c mutant backgrounds, lin-
14 mutants also arrest as partially remodeled dauer larvae at the L2 larval stage rather 
than at L3 (Liu & Ambros, 1989).  In contrast, lin-4 mutants are incapable of forming 
dauer larvae in starved cultures(Liu & Ambros, 1989).  These results are consistent with a 
model wherein LIN-14 inhibits DAF-12 activity during dauer development as well as 
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during reproductive development and permits expression of dauer developmental 
programs at the L2 to L3, but not the L1 to L2 transition. Alleles of lin-14 that impact the 
direction, rather than the timing, of the dauer decision have not been previously 
identified.   
   
Conclusions and Future Directions 
The C. elegans dauer decision was initially intended to serve as an example of 
developmental plasticity, which could serve to elucidate potentially conserved signaling 
pathways governing developmental decisions.  Over the last 40 years studies of the dauer 
decision have revealed a surprisingly intricate signal transduction network regulating 
dauer arrest. Perception of environmental factors is integrated in the nervous system, to 
regulate the activity of two major, highly conserved signal transduction cascades (the 
insulin signaling and TGF-β pathways), that converge on a nuclear hormone receptor 
DAF-12.  DAF-12 acts as a ligand dependent environmental switch that can promote 
developmental programs specific to either the dauer diapause or reproductive life 
histories. 
Despite the high levels of molecular detail that have emerged from existing studies of the 
genetics of dauer formation, many key questions remain to be answered.  Mechanisms by 
which DAF-12 and DAF-16/FoxO coordinate to specify the dauer life history remain to 
be established, along with the overlapping and unique outputs of these transcription 
factors that enable the fascinating ability of dauer larvae to halt all developmental 
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programs for many times the lifetime of an adult animal, and then resume normal 
development as though nothing had occurred.  The ability of passage through the dauer 
larval stage to rescue aberrant precocious differentiation in some heterochronic mutants 
suggests that a fuller understanding of the quiescence that occurs in dauer larva may 
illuminate conserved mechanisms governing quiescence and cell differentiation, as well 
as novel molecular mechanisms underlying post-dauer development (Karp & Ambros, 
2012).   
Signal transduction pathways that regulate the dauer decision are not fully understood.  
Continued forward genetic screens in sensitized environments or genetic backgrounds 
may continue to reveal novel modulators of dauer arrest with conserved functions in 
insulin, TGF-β or steroid hormone signaling, as well as interactions between the dauer 
decision and other developmental mechanisms.  These studies will be aided by 
advancements in whole genome sequencing and the availability of CRISPR Cas9-based 
gene editing to perform detailed genetic analysis of identified genes (Hu, 2014; Paix et 
al., 2015).  More broadly, physiological studies are needed to fully understand the neural 
circuits which integrate environmental inputs to produce the dauer decision, and to 
understand when each step in the dauer decision signal transduction cascade acts to 
specify commitment to the L2d larval stage and then to undergo the dauer life history.  It 
seems highly likely that studies of the “simple” genetic switch governing C. elegans 
dauer formation will continue to provide insights into conserved mechanisms of 
development and plasticity for years to come.  
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Chapter 2 A novel mutation in lin-14 
suppresses dauer arrest 
 
Introduction 
In the nematode C. elegans, the insulin like growth factor receptor homologue DAF-2 
promotes reproductive development by inhibiting activity of the FoxO transcription 
factor DAF-16 (Fielenbach & Antebi, 2008). Under replete conditions, nematodes 
develop directly to adulthood by traversing four larval stages (L1-L4) after hatching 
(Brenner, 1974; Stiernagle, 2006).  Under conditions of increased temperature, high 
population density, and low food availability L1 larvae can commit to an alternate life 
history, during which they pass through a larval diapause called dauer.  Loss-of-function 
mutations in components of the canonical insulin signaling pathway, including the 
insulin-like-growth-factor-receptor family-member daf-2, the predicted phosphoinositide-
3-kinase age-1, pdk-1 and akt-1, all have dauer constitutive phenotypes when cultured at 
25°C or 27°C(Kimura et al., 1997; Lin et al., 1997; Morris et al., 1996; Ogg et al., 1997; 
Paradis et al., 1999; Paradis & Ruvkun, 1998).  The dauer-constitutive phenotypes of daf-
2/IGFr mutants are fully suppressed by null mutations of the sole C. elegans member of 
the FoxO transcription factor family, daf-16, suggesting that activity of the C. elegans 
insulin signaling pathway promotes reproductive development by inhibiting DAF-16 
activity (Gottlieb & Ruvkun, 1994; Vowels & Thomas, 1992).   
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Activity of the insulin signaling pathway inhibits DAF-16/FoxO activity, in part, by 
triggering phosphorylation of DAF-16/FoxO by the serine threonine kinases AKT-1 and 
AKT-2, at conserved RxRxxS/T sites, which leads to DAF-16 being exported from the 
nucleus and degraded (Berdichevsky et al., 2006; Brunet et al., 1999; Brunet et al., 2002; 
Hertweck et al., 2004; Lin et al., 2001).  However, translocation to the nucleus is not 
sufficient to fully activate DAF-16/FoxO, or mouse FOXO1, suggesting that DAF-2/IGFr 
also regulates nuclear DAF-16/FoxO in parallel to canonical insulin signaling (Lin et al., 
2001; Tsai et al., 2003).  Forward genetic screens for mutations that enhance the dauer 
arrest phenotype of akt-1 mutants (or eak mutations) identified components of the eak 
pathway, which regulate activity of nuclear DAF-16/FOXO (Alam et al., 2010; Dumas et 
al., 2010; Hu et al., 2006; Williams et al., 2010; Zhang et al., 2008).  EAK-7 is a 
conserved plasma membrane protein which regulates the nuclear pool of DAF-16/FoxO 
protein through unknown intermediary molecules (Alam et al., 2010).   
We attempted to identify downstream components of the eak pathway by conducting a 
forward genetic screen for mutations which suppress the 25°C dauer constitutive 
phenotype of eak-7;akt-1 compound mutants (Dumas et al., 2013).  In principle, seak 
genes could include novel components of the eak pathway, novel regulators of canonical 
insulin signaling, or genes that act downstream of or in parallel to both pathways to 
regulate dauer arrest.   In our previously published work we identified two mutations in 
dosage compensation pathway genes that suppress eak-7;akt-1 dauer arrest by causing 
differential regulation of two X-linked insulin signaling pathway genes, ins-9 and akt-2.  
We also identified a large rearrangement of the X chromosome which likely suppresses 
eak-7;akt-1 dauer arrest by duplicating the insulin signaling pathway gene AKT-2, and a 
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novel mutation in DAF-12 (Delaney et al., 2017; Dumas et al., 2013; Itani et al., 2016a; 
Itani et al., 2016b).   
Here we describe a novel intronic mutation in the heterochronic gene lin-14 that was 
identified in our screen for suppressors of eak-7;akt-1 dauer arrest. LIN-14 has been 
previously identified as a component of the heterochronic pathway; it promotes execution 
of developmental programs specific to the L1 and L2 larval stages (Ambros & Horvitz, 
1984, 1987; Reinhart & Ruvkun, 2001; Ruvkun et al., 1989). The lin-14 transcript is the 
target of the first discovered interaction between a gene product and a micro-RNA; the 
micro-RNA lin-4 binds to the 3’UTR of the LIN-14 transcript and both inhibits its 
translation and targets it for degradation, resulting in declining levels of the LIN-14 
protein throughout the L1 larval stage (Bagga et al., 2005; Ha et al., 1996; Lee et al., 
1993; Olsen & Ambros, 1999; Ruvkun et al., 1989; Wightman et al., 1993). While lin-14 
lacks obvious sequence conservation to vertebrate genes, the LIN-14 protein has been 
validated biochemically as a transcription factor which binds to a consensus GAACRY 
motif and regulates stage specific expression of target genes downstream of its consensus 
binding site in vivo (Hristova et al., 2005).   LIN-14 acts upstream of DAF-12 in 
patterning the hypodermis during reproductive development (Antebi et al., 1998). Strong 
loss of function mutants in lin-14 enter dauer precociously at the L2 larval stage (Liu & 
Ambros, 1989).  In contrast, lin-4 mutants, which reiterate L1 specific developmental 
programs at subsequent larval stages due to constitutive expression of LIN-14, cannot 
form dauer larvae (Liu & Ambros, 1989).  These data suggest that LIN-14 acts during the 
dauer life history to prevent precocious execution of dauer developmental programs prior 
to the L3 larval stage (Liu & Ambros, 1989).  
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Results 
A genetic screen for suppressors of eak-7;akt-1 dauer arrest 
The seak screen was previously described (Dumas et al., 2013).  Compound mutants 
harboring the predicted null alleles eak-7(tm3188) and akt-1(ok525) constitutively 
undergo dauer arrest in developmentally synchronized cultures at 25°C.  We reasoned 
that a forward genetic screen for mutations which could suppress the Daf-c phenotype of 
eak-7;akt-1 mutants might identify novel activators of DAF-16/FoxO.  Therefore, we 
mutagenized eak-7;akt-1 compound mutants with N-ethyl-N-nitrosourea (ENU) and 
screened for rare F2 suppressors of the eak-7;akt-1 Daf-c phenotype  (seak mutants).  We 
isolated 16 independent seak mutant strains and subjected them to whole genome 
sequencing, and their genomes were compared to an unmutagenized eak-7;akt-1 strain to 
identify mutations introduced by ENU mutagenesis.  The eak-7;akt-1;seak strain 
harboring the lin-14(dp69) mutation was outcrossed to BQ29, a recombinant inbred strain 
containing eak-7(tm3188) and akt-1(ok525) mutations that had been specifically 
introgressed into the polymorphic background CB4856.  Single nucleotide polymorphism 
mapping was used to map the seak phenotype to a region on the X chromosome 
containing lin-14(dp69) and two other mutations (dp68 and dp70).  These mutations were 
separated by outcrossing the eak-7(tm3188);akt-1(ok525);seak strain to an 
unmutagenized eak-7;akt-1 strain on the N2 wild-type background, and dauer assays 
were used to confirm that lin-14(dp69) suppressed eak-7;akt-1 dauer arrest while the 
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dp68 and dp70 mutations did not.  This result suggests that lin-14(dp69) is the causative 
suppressor of eak-7;akt-1 dauer arrest, although we cannot rule out the possibility of a 
closely linked background mutation that was not identified by whole genome sequencing.  
A novel mutation in lin-14 suppresses eak-7;akt-1 dauer arrest 
lin-14(dp69) is an intronic point mutation in the sixth base pair downstream of the 5’ 
junction of the splice site joining exons five and six in the lin-14 locus, the first lin-14 
exons that are  common to all lin-14 isoforms (Figure 2.1). lin-14(dp69) mutation caused 
penetrant suppression of the eak-7;akt-1 Daf-c phenotype (Figure 2.2 panel A, Table 2.2).  
lin-14 RNAi also strongly suppressed the eak-7;akt-1 dauer constitutive phenotype, 
suggesting that reducing levels of LIN-14 transcript or protein prevents dauer arrest in 
eak-7;akt-1 mutants (Figure 2.2 panel B, Table 2.2).   
During the course of performing RNAi dauer assays we observed that a much higher 
percentage of eak-7;akt-1;lin-14(dp69) animals underwent dauer arrest when cultured on 
the E. coli strain HT115 (the strain RNAi clones are propagated in) than when cultured 
on  the E. coli strain OP50. A direct comparison of eak-7;akt-1;lin-14(dp69) animals on 
RNAi plates seeded with OP50 and HT115 bacteria expressing empty vector RNAi at 
equal optical densities was consistent with the interpretation that increased dauer arrest in 
these experiments was caused by culture on the HT115 bacterial strain (Table 2.2). 
. 
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Figure 2.1.  lin-14(dp69) is a novel lin-14 allele 
A. Structure of the lin-14 genomic locus, lin-14 alleles used, sequence of the splice junction between exons 
five and six in wild-type and lin-14(dp69) animals with the mutated base in bold, and lin-14 transcriptional 
isoforms.  B. Changes in splicing caused by lin-14(dp69): arrows indicate isoform specific primers used to 
amplify across splice junctions from cDNA, lines indicate alternative splicing sites from the coding 
sequence of exon five to the exon six splice-acceptor site, resulting in either an out-of-frame or in-frame 
deletion (see table 2.2 for sequences).  
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lin-14(dp69) and lin-14 RNAi additively suppress the dauer constitutive phenotype 
of daf-2(e1368) mutants 
Mutations that suppress eak-7;akt-1 dauer arrest may act in the eak pathway, they may be 
more general regulators of insulin signaling, or they may act downstream of, or in parallel 
to insulin signaling.  To determine whether lin-14 acts in the eak pathway or is a more 
general regulator of the dauer decision, we measured the effects of lin-14(dp69) and lin-
14 RNAi on dauer arrest in other Daf-c mutant backgrounds.  
Neither lin-14(dp69) nor treatment with lin-14 RNAi significantly suppressed the dauer 
constitutive phenotypes of daf-2(e1368) mutants.  Surprisingly treatment of daf-
2(e1368);lin-14(dp69) compound mutant animals with lin-14 RNAi caused an additive 
and highly penetrant dauer suppression phenotype (Figure 2.2C, Table 2.2).  These data 
suggest that lin-14(dp69) and lin-14 RNAi  can suppress the dauer-constitutive 
phenotypes of insulin signaling mutants and are consistent with a model where LIN-14 
promotes dauer arrest independently of the eak pathway.  The data are also consistent 
with a model where modulation of lin-14 transcript levels dramatically impacts the dauer 
decision, with additive changes in levels of functional lin-14 transcript triggered by 
combining lin-14(dp69) mutations and lin-14 RNAi causing a more highly penetrant 
dauer suppressive phenotype than either intervention alone.   
Additive suppression of daf-7/TGF-β mutant dauer constitutive phenotypes by lin-
14(dp69) and lin-14 RNAi 
We next asked whether dauer regulation by lin-14 was specific to the insulin signaling 
pathway.  We crossed lin-14(dp69) into a daf-2(e1372) mutant.  daf-7 encodes a 
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transforming growth factor beta-like peptide, and daf-7 mutants have a dauer-constitutive 
phenotype that depends on daf-3/SMAD, daf-5/SnoN and daf-12/NHR and is 
independent of daf-16/FoxO (Patterson & Padgett, 2000; Shi & Massagué, 2003).  
Neither lin-14(dp69) nor lin-14 RNAi significantly suppressed the Daf-c phenotype of 
daf-7(e1372) mutants (Figure 2.2 panel D, Table 2.2).  We observed highly penetrant 
suppression of the daf-7/TGF-β dauer constitutive phenotype in an experiment in which 
daf-7(e1372);lin-14(dp69) mutants were treated with lin-14 RNAi (Figure 2.2 panel D, 
Table 2.1).  These data are most consistent with a model in which lin-14 regulates the 
dauer decision downstream of or in parallel to both the insulin signaling and TGF-β 
signaling pathways.  
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Figure 2.2.  Effects of lin-14 mutations and lin-14 RNAi on dauer arrest 
A-D.  Effects of lin-14(dp69) and lin-14 RNAi on dauer entry at 25°C in dauer constitutive backgrounds. 
E-G.  lin-14(n536n540) does not suppress dauer arrest.  Dauer constitutive genotype is indicated at the top 
of the panel, X-axis is labeled with additional mutations or RNAi treatments added. See table 2.2 for data. 
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lin-14(dp69) affects splicing of the lin-14 transcript 
The molecular lesion in lin-14(dp69) converts a guanine to thymidine six nucleotides into 
the intron between exons five and six of lin-14, suggesting that it might affect splicing.  
Exons five and six are the first exons that are shared between all lin-14 transcriptional 
isoforms.  Isoform-specific mutations in lin-14 have distinct effects.  The LIN-14A 
isoform is required early in the L1 larval stage to specify L1-specific developmental 
programs instead of precocious L2 developmental programs. The two LIN-14B isoforms 
act later in the L1 larval stage to specify L2 specific developmental programs after the 
next molt, rather than precocious L3 specific programs (Ambros & Horvitz, 1987; 
Reinhart & Ruvkun, 2001).  (Note, the letter designations assigned to LIN-14 isoforms in 
the current annotation of the publicly available worm genome are reversed from those in 
the literature: here we use the naming convention established in prior publications 
(Reinhart & Ruvkun, 2001)).  To test the hypothesis that lin-14(dp69) affects splicing, 
and determine whether it has isoform specific-effects, we collected RNA from mixed 
populations of wild-type and lin-14(dp69) animals and performed reverse-transcriptase-
PCR across the exon-exon junction predicted to be affected in lin-14(dp69) using primer 
pairs specific to both lin-14a and lin-14b transcripts.  We then cloned and sequenced 
individual transcripts.  All sequenced transcripts from wild-type animals had the expected 
exon-exon junction (Figure 2.1B, Table 2.1).  In fourteen sequenced lin-14b transcripts 
and nine lin-14a transcripts from lin-14(dp69) cultures, a novel splice donor site in exon 
five was spliced to the canonical splice acceptor site in exon six, resulting in a five amino 
acid deletion followed by a frameshift and multiple early stop codons.  In an additional 
lin-14a transcript and two lin-14b transcripts, splicing from a different donor site in exon 
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five to the canonical splice acceptor site in exon six resulted in a predicted in-frame 
deletion of nine amino acids followed by a proline to alanine conversion.  This is 
consistent with a model where the lin-14(dp69) mutation reduces LIN-14 transcript and 
protein levels by nonsense mediated decay of affected transcripts, while permitting 
expression of LIN-14 protein harboring a small in-frame deletion, which may be largely 
functional. Therefore, lin-14(dp69) is unlikely to be a null allele. 
A putative lin-14 null allele causes precocious dauer arrest, is not dauer defective, 
and prevents lin-14 RNAi from suppressing eak-7;akt-1 dauer arrest 
Loss-of-function mutations in lin-14 have been previously isolated in screens for mutants 
with precocious developmental phenotypes.  LIN-14 is broadly expressed, and lin-14 
loss-of-function mutants have precocious phenotypes in multiple tissues and cell types 
(Ambros & Horvitz, 1987; Ruvkun & Giusto, 1989).  The lin-14(n536n540) mutant was 
isolated in a forward genetic screen for suppression of the lin-14 gain-of-function 
phenotypes caused by a deletion of the lin-4 binding site lin-14 3’ UTR (lin-14(n536)) 
(Figure 2.1) (Ambros & Horvitz, 1987).  In lin-14(n536n540) lin-14(n536) gain-of-
function phenotypes are entirely suppressed by an early nonsense mutation [lin-14(n540)] 
in exon eight that affects all lin-14 isoforms (Figure 2.1) (Ambros & Horvitz, 1987; 
Reinhart & Ruvkun, 2001).  lin-14(n536n540) is believed to be a null allele based on 
phenocopying a deficiency that deletes the lin-14, locus, and eliminates detectable LIN-
14 protein (Ambros & Horvitz, 1987; Ruvkun et al., 1989).   
daf-7(e1372);lin-14(n536n540) mutants have been reported to undergo precocious dauer 
arrest at the L2 larval stage; however, lin-14(n536n540) does not have a previously 
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reported Daf-d phenotype (Liu & Ambros, 1989).  We generated eak-7;akt-1;lin-
14(n536n540), daf-2(e1368);lin-14(n536n540), and daf-7(e1372);lin-14(n536n540) 
mutants.  Consistent with the published report, we observed that daf-7(e1372);lin-
14(n536n540) animals formed small, partially remodeled, dauer larvae at 25°C, without 
any suppression of the daf-7(e1372) Daf-c phenotype (Figure 2.2 panel G, Table 2.2) 
(Liu & Ambros, 1989).  We also found that daf-2(e1368);lin-14(n536n540), and eak-
7;akt-1;lin-14(n536n540) mutants arrested as dauer larvae precociously without any 
suppression of Daf-c phenotypes (Figure 2.1 panel E-F, Table 2.2).  
 In contrast to lin-14(n536n540), dauer entry in daf-2(e1368);lin-14(dp69), daf-
7(e1372);lin-14(dp69), eak-7;akt-1;lin-14(dp69) animals cultured on E.coli strain 
HT115, as well as in daf-2(e1368) and daf-7(e1372) animals treated with lin-14 RNAi 
appeared to occur normally at the L3 larval stage, based on size and morphology of 
observed animals (Table 2.2). Treatment with lin-14 RNAi did not affect dauer entry in 
daf-2(e1368);lin-14(n536n540) or daf-7(e1372);lin-14(n536n540) animals, suggesting 
that lin-14 RNAi does not suppress dauer arrest in the absence of lin-14 gene products. 
We did observe small numbers of precocious dauer larvae in Daf-c strains treated with 
lin-14 RNAi, in both wild-type and lin-14(dp69) backgrounds, consistent with a model in 
which lin-14 RNAi causes a less penetrant reduction in LIN-14 activity than the strong 
lin-14 loss of function mutation lin-14(n536n540) (Table 2.2.).  
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lin-14(dp69) does not have visible heterochronic phenotypes and does not suppress 
the overt phenotypes of lin-4 mutants   
 lin-14(n536n540) mutants have gross visible phenotypes including reduced body size, 
protruding vulva, defective egg laying, and retention of eggs in the gonad.  lin-4 loss-of-
function and lin-14 gain-of-function animals are elongated, transparent, do not form adult 
alae, and do not form a functioning vulva, causing them to die early in adulthood due to 
internal hatching of progeny (Ambros & Horvitz, 1987; Chalfie et al., 1981). lin-
14(dp69) adults do not have obvious lin-14 loss-of-function or gain-of-function 
phenotypes (data not shown).  Strong lin-14 loss-of-function mutations are epistatic to 
lin-4 heterochronic phenotypes (Ambros & Horvitz, 1987).   lin-14(dp69) did not 
suppress visible phenotypes of lin-4 mutants (Figure 2.3).  Animals exposed to lin-14 
RNAi from egg to adulthood, as was the case in our dauer assays, did not have visible 
heterochronic phenotypes in adulthood, however animals treated with lin-14 RNAi for 
multiple generations has phenotypes including reduced size and protruding vulva that 
resembled lin-14 loss-of-function mutants (data not shown). These observations are 
consistent with models in which lin-14(dp69) and lin-14 RNAi have weaker loss of 
function phenotypes than lin-14 alleles isolated from screens for heterochronic 
phenotypes, and models in which lin-14(dp69) has more complex effects on LIN-14 
activity.  
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Figure 2.3.  lin-14(dp69) does not rescue lin-4(e912) phenotypes 
Figure 2.3.  A. Gonad of wild-type animal. Arrow points to vulva.  B. lin-4(e912) mutant 
with accumulation of eggs in the gonad and no vulva. C lin-4(e912);lin-14(dp69) 
compound mutant with accumulation of eggs in the gonad and no vulva. 
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Discussion 
Despite thorough genetic characterization of genes that regulate the dauer decision and 
extensive study of the heterochronic pathway, the mechanisms by which these networks 
interact to govern dauer life history-specific developmental events remain poorly 
understood.   
The heterochronic transcription factor LIN-14 is an excellent candidate for a gene that 
might control the developmental stage that is permissive for animals to commit to the 
dauer life history.  LIN-14 is expressed in fasted L1 larva and is downregulated upon 
feeding by expression of the lin-4 microRNA which binds directly to its 3’UTR and 
triggers degradation of the LIN-14 transcript (Bagga et al., 2005; Ha et al., 1996; Ruvkun 
et al., 1989; Ruvkun & Giusto, 1989; Wightman et al., 1993).  LIN-14 protein levels fall 
throughout the L1 larval stage (Ruvkun et al., 1989).  LIN-14 does not bear obvious 
sequence similarity to any known genes outside of the nematode family; however, it has 
been biochemically characterized as a transcription factor which binds to a core 
GAACRY motif and regulates developmental stage-specific expression of target genes in 
vivo (Hristova et al., 2005).   In addition to causing precocious expression of 
developmental programs specific to L2 and later stages during reproductive development, 
lin-14 loss of function mutants have also been reported to undergo precocious dauer 
arrest at the L2 larval stage, while mutations which cause constitutive expression of
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LIN-14 are dauer-defective (Liu & Ambros, 1989). Taken together, these data suggest 
that LIN-14 activity prevents precocious commitment to the dauer developmental 
program at the L2 larval stage and is consistent with a model where declining levels of 
LIN-14 protein, relative to those present in early L1 larva, permit expression of the dauer 
larval developmental program.   
We performed a screen for mutations that suppress the 25°C dauer formation constitutive 
(Daf-c) phenotype of eak-7;akt-1 double mutants. The seak screen has identified 
mutations that control dauer arrest by regulating components of the insulin signaling 
pathway, but that did not emerge from previous screens for suppressors of daf-2(e1370) 
dauer arrest, suggesting that the eak-7;akt-1 dauer arrest phenotype is sensitive to 
suppression by mutations that modulate the activity of dauer regulatory pathways but do 
not cause large enough effects to suppress the dauer constitutive phenotypes of more 
highly penetrant Daf-c mutations (Delaney et al., 2017; Dumas et al., 2013).   
The seak screen identified a novel Daf-d mutation in lin-14, dp69, that robustly 
suppressed the Daf-c phenotype of eak-7;akt-1 mutants.  Treatment of eak-7;akt-1 
animals with lin-14 RNAi phenocopied the lin-14(dp69) mutation, initially suggesting 
that the phenotype of eak-7;akt-1;lin-14(dp69) mutants is caused by lin-14(dp69) rather 
than a closely linked background mutation which was not identified by whole genome 
sequencing, and that lin-14(dp69) is a reduction-of-function allele.  We observed that the 
Daf-c phenotypes of daf-2(e1368) animals were suppressed when these mutations were 
placed in a lin-14(dp69) background (daf-2(e1368);lin-14(dp69)) and treated with lin-14 
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RNAi.  Similarly, the Daf-c phenotype of daf-7(e1372) animals was also suppressed 
when they were placed on a lin-14(dp69) background and treated with lin-14 RNAi. The 
Daf-c phenotypes of eak-7;akt-1 animals, daf-2(e1368) animals, and daf-7(e1372) 
animals were not suppressed by the addition of a putative lin-14 null allele lin-
14(n536n540).  An important caveat is that lin-14(n536n540) emerged from a forward 
genetic screen for suppression of lin-14 gain-of-function phenotypes caused by a deletion 
in the lin-14 3’UTR that prevents lin-4 binding (lin-14(n536)).  lin-14(n536n540) is a 
complex allele harboring both the 3’UTR deletion and a premature stop codon in the 
eighth exon of lin-14 suggesting that a truncated LIN-14 protein could be made (Ambros 
& Horvitz, 1987).  While it has been reported that the lin-14(n536n540) heterochronic 
phenotypes closely resemble those of a deficiency that completely eliminates the lin-14 
locus, it was not possible to observe a sufficient number of animals carrying lin-
14(n536n540) in trans to a deficiency to determine whether it rescued any null 
phenotypes, due to technical reasons likely relating to the pleiotropic phenotypes of these 
mutants (Ambros & Horvitz, 1987). Thus, it is possible that lin-14(n536n540) is not a 
true null allele.  The dauer phenotypes of deficiencies eliminating the lin-14 locus have 
not been reported.  Furthermore the dauer larvae that are present in lin-14 loss-of-
function mutants develop abnormally.  While they are SDS resistant and have dauer alae 
lin-14(lf) dauers  arrest after the first larval molt rather than after the second and arrest as 
partially remodeled dauer larvae that appear to have some dauer cell fates and some non-
dauer cell fates within the same animal, suggesting that interactions between lin-14 null 
alleles and dauer arrest are complex and that lin-14 function may be required for dauer 
development in some tissues(Liu & Ambros, 1989).  Nonetheless the fact that we could 
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not reproduce the lin-14(dp69) phenotype with an independent putative lin-14 null allele 
precludes any formal genetic epistasis analysis to place the lin-14 locus into known 
genetic pathways regulating the dauer decision.  It is formally possible that the dauer 
suppression observed in lin-14(dp69) is caused by a closely linked background mutation 
while the dauer suppression caused by lin-14 RNAi is due to an off-target effect; 
however, the observation that lin-14(dp69) and lin-14 RNAi additively suppress the Daf-
c phenotypes of daf-2(e1368) mutants, while lin-14 RNAi is unable to suppress the Daf-c 
phenotypes of daf-2(e1368);lin-14(n536n540) compound mutants seems more consistent 
with models in which lin-14(dp69) and lin-14 RNAi prevent dauer arrest by modulating 
lin-14 activity in some way. Our data could be consistent with multiple models in which 
non-null changes in lin-14 activity modulate dauer entry. 
The lin-14(dp69) mutation causes penetrant suppression of eak-7;akt-1 dauer arrest when 
animals are cultured on the E. coli strain OP50, but not when animals are cultured on the 
E.coli strain HT115.  Levels of LIN-14 protein are regulated by feeding, so it is possible 
that culture on different bacterial strains affects dauer by regulating LIN-14 (Ruvkun & 
Giusto, 1989).  However, culture on HT115 might increase dauer arrest in sensitized 
contexts by upregulating DAF-16 activity, or in parallel to both LIN-14 and DAF-16.  
Culture on HT115 alters DAF-16-dependent lifespan phenotypes, suggesting food type 
may affect DAF-16 activity (Amrit et al., 2016; Chen et al., 2015) .  The hypothesis that 
culture on HT115 generally enhances the Daf-c phenotypes of insulin signaling mutants 
could be tested by performing dauer assays with Daf-c mutants on HT115 and OP50 at 
equal optical densities under sensitized conditions, for example in synchronized cultures 
of daf-2/IGFr mutants at 22.5°C (Gems et al., 1998; Patel et al., 2008).  In several daf-2 
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alleles (including daf-2(m120) and daf-2(m596)) synchronized populations include both 
animals that arrest as dauers and animals that undergo reproductive development when 
animals are cultured  at 22.5°C when on OP50 (Gems et al., 1998).  If culture on HT115 
enhances dauer arrest independently of lin-14 we would expect to see an increased 
percentage of animals arresting as dauers when cultured on HT115 under these conditions 
(Gems et al., 1998).  We could potentially do similar experiments with eak-7;akt-1 
animals or eak-7 and akt-1 mutants individually to determine whether HT115 affects 
dauer entry in these contexts specifically; however, appropriate sensitized conditions in 
which we would expect to observe a significant proportion of dauer and non-dauer 
animals within a population have not been reported for these strains.  These experiments 
could also be done in parallel with strains harboring daf-2;lin-14(dp69) mutations, eak-
7;akt-1;lin-14(dp69) mutations and eak-7;lin-14(dp69) and akt-1;lin-14(dp69) mutations.  
If increased dauer arrest on HT115 is specific to lin-14(dp69) mutants then we would 
expect to see increased dauer arrest in strains harboring lin-14(dp69) mutations only.  The 
observation that lin-14 RNAi suppresses the eak-7;akt-1 Daf-c phenotype, despite culture 
on HT115, and the observation that the combination of lin-14(dp69) and lin-14 RNAi 
cause penetrant dauer suppression phenotypes suggest that changes in LIN-14 activity 
may be able to influence the dauer decision independently of food source.  
All lin-14 transcripts sequenced from lin-14(dp69) mutants contained either frameshifts 
or small in-frame deletions, though it is possible that there is a small population of lin-14 
transcripts with wild-type splice-junction sequences between exons five and six that we 
were not able to identify given the limited number of transcripts we sequenced.  We do 
not observe the severe pleiotropic lin-14 loss-of-function phenotypes that are present in 
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the predicted null mutant lin-14(n536n540) in lin-14(dp69).  Unlike known lin-14 loss-
of-function alleles, lin-14(dp69) does not suppress lin-4(e912) mutant phenotypes and 
does not cause arrest as a partially remodeled dauer larvae after the first larval molt rather 
than after the second (Figure 2.3, Table 2.2).  These observations, together with the 
reported observation that the phenotypes of lin-14(n536n540) closely mirror the 
phenotypes of a deficiency fully eliminating the lin-14 locus, suggest that lin-14(dp69) is 
not a stronger loss of function allele that lin-14(n536n540). 
The observation that lin-14(dp69) animals do not have obvious lin-14 loss-of-function 
phenotypes could be consistent with a model in which the LIN-14 protein encoded by 
transcripts harboring the in-frame deletion is able to perform some developmental 
functions of wild-type LIN-14.  However, the deletion of nine amino acids and the P-A 
conversion in the in-frame lin-14 transcripts we identified could affect the function of the 
LIN-14 protein.  The missing amino acids might, for example, alter the binding of LIN-
14 to co-regulators, resulting in different patterns of expression or localization and 
changes in its downstream effects on transcription (Hristova et al., 2005).  Thus, the 
differences in phenotypes caused by lin-14(dp69) and lin-14(n536n540) could be due to  
neomorphic (change-of-function) effects on the LIN-14 protein caused by lin-14(dp69). 
Since some tissues are more sensitive to RNAi than others, treating lin-14(dp69) with lin-
14 RNAi might exacerbate a neomorphic effect by further altering the tissue distribution 
of LIN-14 protein, resulting in dauer regulatory phenotypes unrelated to those of lin-14 
null alleles.  For example, it is possible that LIN-14 activity in neurons but not other 
tissues could suppress dauer arrest without visible heterochronic phenotypes, and an 
increase in neuronal activity of LIN-14 caused by lin-14(dp69) could cause an increase in 
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neuronal LIN-14 expression, while lin-14 RNAi contributes to the phenotype by reducing 
LIN-14 levels in non-neuronal tissues.  We could test the hypothesis that the molecular 
lesion present in lin-14(dp69) animals causes changes in LIN-14 protein expression 
levels or localization by engineering animals expressing a single copy LIN-14::GFP 
fusion, and an identical mutation to lin-14(dp69) using CRISPR-CAS9.  Single-copy 
LIN-14::GFP fusions have previously been generated and are amenable to examination of 
GFP expression by microscopy (Arribere et al., 2014).  The effects of the lin-14(dp69) 
mutation on LIN-14 mediated transcriptional events could be determined using RNA-seq 
of wild-type, lin-14(dp69), eak-7;akt-1, and eak-7;akt-1;lin-14(dp69) animals at L1 and 
L2 or L2d larval stages, or in a more limited manner by using qPCR of previously 
identified LIN-14 targets.  
We sequenced the splice junction containing lin-14(dp69) using two unique primers 
complementary to the lin-14a specific and lin-14b specific exons and did not detect 
evidence of isoform-specific differences in splicing events (Table 2.1).  RNA that is 
available to be translated.  This could reduce levels of specific lin-14 transcripts or of all 
lin-14 transcripts. The hypothesis that lin-14(dp69) causes reductions in lin-14 transcript 
levels is consistent with the observation that lin-14 RNAi phenocopies lin-14(dp69) 
suppression of eak-7;akt-1 dauer arrest.  An additive reduction in levels of some lin-14 
transcripts caused by lin-14(dp69) and lin-14 RNAi could also be consistent with the 
observation that lin-14 RNAi and lin-14(dp69) additively suppress the Daf-c phenotypes 
of daf-2(1368) and daf-7(e1372) mutants.  lin-14 isoforms have independently mutable 
functions with lin-14a being required during the early L1 larval stage to prevent 
precocious execution of L2 specific developmental programs, while lin-14b is required 
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late in the L1 larval phase to prevent precocious expression of L3 specific programs 
during the L2 larval stage (Ambros & Horvitz, 1987; Reinhart & Ruvkun, 2001).  Given 
the similarity between lin-14a phenotypes and lin-14 null phenotypes, it seems unlikely 
that lin-14(dp69) or lin-14 RNAi are specifically affecting lin-14a.  Our data could be 
consistent with a model in which lin-14(dp69) and lin-14 RNAi affect the lin-14b 
isoform.  Importantly, the L2 larval stage-specific patterning events that are lost in lin-
14b mutants do occur, albeit precociously, in lin-14 null mutants; thus, if lin-14 RNAi 
and lin-14(dp69) caused suppression of dauer arrest through a loss of function in the lin-
14b genetic activity it could explain why the dauer suppression observed in these 
contexts is not observed in putative lin-14 null alleles.  lin-14b affects the second larval 
stage, and loss of lin-14b could prevent L2d specific events such as accumulation of 
dafachronic acids that are critical for dauer entry (Ambros & Horvitz, 1987; Golden & 
Riddle, 1984; Reinhart & Ruvkun, 2001; Schaedel et al., 2012).  A molecular analysis of 
lin-14 isoforms demonstrated that increased lin-14a expression could rescue lin-14b 
phenotypes (Reinhart & Ruvkun, 2001).  The authors hypothesized that the proteins 
encoded by the two lin-14 isoforms do not have distinct molecular functions, but that lin-
14b is required to maintain a critical concentration of LIN-14 protein late in the L1 larval 
stage (when LIN-14 protein levels are falling due to interaction with lin-4) that is 
required for L2 specific developmental events (Reinhart & Ruvkun, 2001).  An 
intervention, such as lin-14 RNAi, that slightly reduces lin-14 transcript levels, might 
produce a phenotype similar to a lin-14b mutant by allowing LIN-14 levels to fall below 
a critical threshold late in the L1 larval stage, and therefore cause events that occur during 
the L2 or L2d larval stage to be skipped, resulting in phenotypes distinct from those 
  60 
observed in lin-14(n536n540) mutants in which L2-specific developmental events occur 
early.  Mutations that specifically affect lin-14b isoforms have not been tested for effects 
on dauer arrest.  We could test the hypothesis that lin-14b alleles have Daf-c phenotypes 
by obtain existing lin-14b mutants and crossing them into Daf-c backgrounds, or by 
generating lin-14b mutants using CRISPR/Cas9-based gene editing and testing these 
mutants for their ability to suppress dauer arrest.  
Published work has revealed roles for two other regulators of developmental timing, hbl-
1/hunchback and lin-42/period, in regulating dauer formation constitutive and defective 
phenotypes.  LIN-42/per is a heterochronic transcription factor that, like DAF-12, is 
important for hypodermal patterning during the L3 larval stage and proper development 
of the somatic gonad (Tennessen et al., 2006; Tennessen et al., 2010).  lin-42 mutants 
have a Daf-c phenotype when cultured at 27°C, and LIN-42 overexpression at L2 
suppresses the Daf-c phenotypes of insulin signaling, TGF-β, dafachronic acid pathway, 
and daf-12(rh273) ligand-binding-domain mutants (Tennessen et al., 2010).  LIN-42 
protein directly was identified as a direct binding partner of DAF-12 by yeast two-hybrid, 
suggesting that that LIN-42 may regulate DAF-12 transcriptional activity directly 
(Tennessen et al., 2010).  LIN-42/Per has a dynamic expression pattern; high levels of 
LIN-42 protein are present during L1 and L2 intermolt periods, while low levels of LIN-
42 protein are detected near molts.  Falling levels of LIN-42 at the L1 to L2d and L2d to 
dauer molts might permit dauer arrest by permitting activity of DAF-12.   
The hunchback-like transcription factor HBL-1, is involved in promoting L2-specific 
developmental programs and inhibiting L3 developmental programs (Abrahante et al., 
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2003).  Two independent loss-of-function alleles in hbl-1 partially suppress dauer 
constitutive phenotypes of daf-12(rh273) ligand-binding-domain mutants and daf-
9/cytochromeP450 dafachronic acid biosynthesis mutants (Karp & Ambros, 2011).  This 
suggests that hbl-1 promotes dauer entry, either through ligand-independent regulation of 
DAF-12, or through regulation of shared daf-12-hbl-1 target genes.  Interestingly the 
same hbl-1 loss-of-function mutations cause enhanced dauer arrest in daf-2/IGFr and daf-
7/TGF-β mutants, through a mechanism that does not require either daf-16 (in the context 
of daf-7 mutation) or daf-5 (in the context of daf-2 mutation) suggesting that HBL-1 acts 
independently of the insulin and TGF-β pathways (Karp & Ambros, 2011).  HBL-1::GFP 
transgenes regulated by the endogenous hbl-1 promoter and 3’UTR are highly expressed 
during the L1 larval stage, with expression declining during L2d and becoming 
undetectable in dauer larvae (Karp & Ambros, 2011).  The authors propose a model in 
which decreasing levels of HBL-1 protein during the L2d larval stage result in two 
separable, stage-specific HBL-1 activities that affect the dauer decision.  During the L1 
larval stage high levels of HBL-1 inhibit dauer formation, possibly by negatively 
regulating DAF-12/NHR in parallel to the insulin signaling and TGF-β pathways.  In 
contrast, the lower levels of HBL-1 present in the L2d stage coordinate with DAF-12 to 
promote dauer formation (Karp & Ambros, 2011). 
As a regulator of L1 specific events, LIN-14 activity occurs prior to activity of LIN-42 
and HBL-1 in the heterochronic pathway.  Events that occur at the L2d larval stage, such 
as dafachronic acid regulation, are critical for dauer entry; HBL-1 and LIN-42 might act 
at the L2 larval stage to regulate the timing of these processes.  It is unclear how L2d 
specific events that regulate the dauer decision occur in LIN-14 null mutants that arrest as 
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dauers after a single larval molt, or how LIN-42 and HBL-1 activities might modulate 
these events in this context.  In lin-14(dp69) mutants and in strains treated with lin-14 
RNAi, dauer entry occurs after the second larval molt.  These perturbations in LIN-14 
activity might modulate L2 specific events, such as HBL-1 and LIN-42 expression, in a 
manner that is distinct from lin-14 null alleles. For example, lin-14(dp69) and lin-14 
RNAi could cause reduction in the lin-14b genetic activity, which affects L2 specific 
patterning events and could affect HBL-1 or LIN-42 expression or dafachronic acid 
accumulation during the L2d larval stage.  For example, loss of the lin-14b activity could 
cause precocious LIN-42 expression at the L1 to L2 transition.  Experiments in which 
constitutive expression of LIN-42 at the L2d larval stage prevented dauer arrest suggest 
that this change might be sufficient to explain the Daf-d phenotypes observed in lin-
14(dp69) and on lin-14 RNAi (Tennessen et al., 2010).  We could test this model by 
determining whether lin-14 RNAi or lin-14(dp69) suppressed the Daf-c phenotypes 
observed in lin-42 loss of function mutants; if lin-42 activity regulates the dauer decision 
downstream of lin-14 we would expect lin-14(dp69) and lin-14 RNAi to be unable to 
suppress the Daf-c phenotypes of lin-42 mutants.  Since lin-14(dp69) and lin-14 RNAi 
are not null alleles, we cannot do formal epistasis analysis using them, and it would be 
important to test any hypothesis we formed with genetic experiments by collecting 
molecular data.  We could, for example, determine whether lin-14(dp69) or lin-14 RNAi 
alters the expression of a LIN-42::GFP transgene.  In contrast we might expect LIN-42 
activity to be absent after the first larval molt in lin-14(n536n540) mutants in Daf-c 
contexts since these animals have entered dauer after the first larval molt and LIN-42 
expression is  downregulated in dauer larvae (Tennessen et al., 2010). 
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In conclusion, we were unable to establish a convincing model for how lin-14(dp69) 
affects LIN-14 activity.  lin-14(dp69) mutants lack obvious lin-14 loss-of-function and 
lin-14 gain-of-function phenotypes. We cannot rule out the possibility that lin-14(dp69) 
causes gain-of-function or neomorphic effects.  In dauer-constitutive backgrounds, strong 
lin-14 loss-of-function mutants enter a dauer-like diapause after the first larval molt, 
suggesting that regulation of the dauer decision is not a primary activity of lin-14 (Liu & 
Ambros, 1989).  lin-14b mutations affect developmental events specific to the L2 larval 
stage in ways that are distinct from lin-14 null phenotypes.  If lin-14(dp69) or lin-14 
RNAi affect lin-14b this could explain why these interventions suppress dauer arrest 
while a putative lin-14 null allele does not (Ambros & Horvitz, 1987; Reinhart & 
Ruvkun, 2001).  While lin-14(n536n540) mutants enter dauer after the first larval molt, 
lin-14(dp69) mutants and animals treated with lin-14 RNAi appear to enter dauer after 
the second larval molt. This suggests that they could suppress dauer arrest by regulating 
L2d specific events, consistent with these interventions affecting lin-14b activity.  Our 
data are consistent with multiple models in which changes in lin-14 function might affect 
dauer entry, including via isoform-specific or neomorphic effects. Numerous additional 
experiments would be required to differentiate between these models.  
More broadly, our data are consistent with other published reports showing that other 
genes which regulate L2 and L3 cell fates, including the hunchback-like transcription 
factor hbl-1 and the period homolog lin-42, can influence the dauer decision, by acting 
downstream of or in parallel to insulin signaling and TGF-β signaling.  Further studies of 
these pathways may help us to achieve a detailed mechanistic understanding of the 
interactions between signaling pathways that influence the dauer decision and genes that 
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coordinate stage specific developmental programs. This may in turn reveal conserved 
mechanisms underlying the coordination between developmental timing and plasticity, 
which are necessary for robust development in changing environmental conditions.   
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Table 2.1.  Splice junctions between exons affected by lin-14(dp69) in wild-type and 
lin-14(dp69) mutant transcripts 
Table 2.1.  Splice junctions affected by lin-14(dp69) in wild-type and lin-14(dp69) 
mutant transcripts.  Number of TOPO cloned LIN-14 cDNAs sequenced with each 
observed splice junction is shown.   
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Table 2.2.  Effects of lin-14 mutations and lin-14 RNAi on dauer entry 
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Table 2.2.  Number of animals with each dauer phenotype, percentage of dauer and non-dauer animals, 
standard deviation calculated based on percentage of animals arresting as dauer larvae on each of three 
plates, strain compared to for measures of significance, paired two tailed students T-tests, and the change in 
the percentage of animals undergoing dauer arrest based on the total.  Representative experiment plotted in 
Figure 2.2 is marked “shown”.  Differences were assessed as significant if P<.05, or if P<0.1 with a greater 
than 50% change in the total percentage of animals forming dauer larvae.   
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Materials and Methods 
Strains and reagents 
The following mutant alleles were used: eak-7(tm3188);akt-1(ok525), lin-14(dp69), lin-
14(n536n540), lin-4(e912), daf-2(e1368), daf-7(e1372) (Alam et al., 2010; Ambros & 
Horvitz, 1987; Chalfie et al., 1981; Dumas et al., 2013; Kimura et al., 1997; Reinhart & 
Ruvkun, 2001; Ren et al., 1996).  lin-4(e912) was maintained and crossed by balancing 
with dpy-10(e128), which is closely linked on chromosome II, and picking heterozygotes 
which lacked either lin-4 or dpy-10 phenotypes: this balanced strain is available from the 
Caenorhabditis Genetics Center (strain CB2627) (Chalfie et al., 1981). RNAi clones 
targeting lin-14 and daf-12 are from the Ahringer library (Kamath & Ahringer, 2003).  
Animals were maintained on nematode growth media (NGM) seeded with E. coli strain 
OP50 at 15°C using standard methods, unless otherwise noted.  Compound mutants were 
generated using standard protocols, genotypes were confirmed with PCR-based 
genotyping assays.   
Mapping 
The screen for suppressors of eak-7;akt-1 dauer arrest was described previously (Dumas 
et al., 2013).  lin-14(dp69) was isolated from an eak-7;akt-1;seak strain designated BQ10.  
BQ10 was outcrossed to BQ29, a recombinant inbred strain generated by introgression of 
eak-7(tm3188) and akt-1(ok525) mutations into the polymorphic CB4856 strain.  Single-
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nucleotide polymorphism mapping was performed using a set of 48 primer pairs (8 per 
chromosome) that flank Dra I restriction site polymorphisms.  This was sufficient to map 
the suppression of dauer arrest phenotype to an interval on the X-chromosome containing 
lin-14(dp69) and two other mutations (dp68, and dp70) identified by whole genome 
sequencing.  BQ10 was then outcrossed 6 times to eak-7(tm3188);akt-1(ok525) on the N2 
background.  The dp68 and dp70 mutations were eliminated by outcrossing to eak-7;akt-
1 and using PCR-based genotyping assays specific to the dp68, dp69, and dp70 
mutations.  eak-7(tm3188);akt-1(ok525);lin-14(dp69) strains had an identical dauer 
suppression phenotype to BQ10, while eak-7;akt-1 strains carrying the dp68 and dp70 
mutations had Daf-c phenotypes indistinguishable from eak-7;akt-1.  lin-14(dp69) was 
crossed into an N2 wild-type background, and then crossed into an un-mutagenized eak-
7(tm3188);akt-1(ok525) strain to eliminate effects of background mutations linked to 
eak-7 or akt-1 in BQ10.  Suppression of dauer arrest in eak-7(tm3188);akt-1(ok525);lin-
14(dp69) animals from this cross compared to eak-7;akt-1 siblings, was similarly 
penetrant to the suppression of eak-7;akt-1 dauer arrest observed in BQ10.    
Transcript sequencing 
Animals from synchronized egg lays of 100+ gravid hermaphrodites were grown at 25°C 
for 24 hours to approximately the L2 larval stage.  Animals were washed twice in M9 
buffer.  Total RNA was extracted using TRIzol reagent (Invitrogen) and purified using a 
RNeasy kit (Qiagen).  cDNA was synthesized using a SuperScript III reverse 
transcriptase kit and random hexamers.  Exon-exon junction containing the lin-14(dp69) 
mutation was amplified from cDNA using a standard PCR protocol.  Bands 
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corresponding to lin-14 transcripts were gel extracted using the QiaQuick gel extraction 
kit (Qiagen) and cloned using the TOPO XL vector and kit (Invitrogen).  Cloned 
transcripts were Sanger sequenced by the University of Michigan sequencing core.   
Dauer assays 
 Dauer assays were performed as previously described (Dumas et al., 2013).  Animals 
from synchronized six-hour egg lays were cultured at 25°C for 60 hours, and dauer and 
non-dauer lava were counted under a dissecting microscope.  Precocious dauer larva were 
identified based on reduced body size and incomplete dauer phenotypes, as described 
(Liu & Ambros, 1989).
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Chapter 3 Mechanisms of longevity 
extension by FoxO transcription factors 
 
Introduction 
Studies of C. elegans genetics were initially intended to elucidate the molecular basis of 
development-the process that turns a single fertilized cell into a complex multi-cellular 
adult organism.  Over the past 30 years, studies of C. elegans have also had a substantial 
impact on understanding the molecular basis of aging-the process which converts young 
robust healthy animals into old, frail animals with increased probability of morbidity and 
mortality.   
It is common to think of aging as a stochastic process involving increasing risk of 
separate pathologies-with mechanisms that drive tumorigenesis being distinct from 
mechanisms causing insulin resistance, atherosclerosis, cataracts, or neurodegenerative 
disease.  However, the conservation of age-related pathologies across vertebrates 
suggests that aging is coordinately regulated (Miller et al., 2011b; Pitt & Kaeberlein, 
2015).  Aged mammals develop similar patterns of co-morbidities, but on vastly different 
time scales: an animal with insulin resistance, cancer, dementia, and cataracts might be a 
ninety-year-old human, or a twelve-year-old dog.  Large differences in species lifespan 
can evolve in closely related species: a house mouse can live for three years, while a deer 
mouse can live for eight, and a brown bat for over thirty (Harper et al., 2007).  This 
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suggests that genetic changes can cause parallel delays in multiple age-associated 
pathologies.  
Several interventions are also able to robustly alter the aging process within species.  
Caloric restriction, a set of interventions that limits nutrient availability without 
malnutrition, extends lifespan from yeast to primates (Colman et al., 2009; Greer et al., 
2007; Kaeberlein et al., 2004; Mattison et al., 2012; McCay et al., 1935).  Treatments 
with drugs including aspirin, rapamycin, acarbose, 17-α-estradiol, and metformin, as well 
as supplementation with NAD+ precursors, have been reported to extend lifespan in 
mice, with the first three drugs having done so reproducibly in multi-site trials (Harrison 
et al., 2014; Harrison et al., 2009; Miller et al., 2011a; Strong et al., 2008; Zhang et al., 
2016).  Rapamycin also extends lifespan in invertebrates and yeast, suggesting that the 
mechanisms of longevity determination it affects are ancient and highly conserved 
(Bjedov et al., 2010; Powers et al., 2006; Robida-Stubbs et al., 2012).  These studies 
suggest that manipulating highly conserved physiological mechanisms can delay multiple 
age-associated morbidities and mortality.   
Emerging evidence suggests that interventions that increase longevity in animal models 
may be useful to treat age-related morbidities in the clinic.  A clinical study has suggested 
that patients treated with metformin have lower all-cause mortality than age-matched 
non-diabetic patients (Bannister et al., 2014; Barzilai et al., 2016).  Another clinical study 
has found that treatment with a low-dose analogue of rapamycin can improve some 
aspects of immune function in elderly patients (Mannick et al., 2014).  Further 
development of interventions that can treat multiple age-related morbidities would be 
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facilitated by a detailed understanding of the molecular mechanisms which lead from 
environmental signals to increased longevity. 
The FoxO family transcription factor DAF-16 promotes 
longevity in C. elegans 
A single gene mutation that controls longevity was first discovered using a forward 
genetic screen for C. elegans strains with increased adult lifespan (Klass, 1983).  The 
longevity phenotype was mapped to a single genetic locus, which was named age-1 
(Friedman & Johnson, 1988; Johnson, 1990).  Subsequent studies determined that 
animals with loss-of-function mutations in the dauer-formation constitutive gene daf-2 
were long lived, and that their long lifespan required the downstream dauer-defective 
gene daf-16 (Dorman et al., 1995; Kenyon et al., 1993).  Cloning of the affected genes 
revealed that daf-2 encodes a receptor tyrosine kinase homologous to mammalian insulin 
and insulin-like growth factor (IGFr) receptors, age-1 encodes a phosphoinositide 3-
kinase, and daf-16 encodes a FoxO family transcription factor (Kimura et al., 1997; Lin 
et al., 1997; Morris et al., 1996; Ogg et al., 1997).  This established insulin and insulin-
like-growth-factor signaling (IIS) as the first signal transduction pathway to regulate 
longevity.   
Insulin signaling regulates DAF-16/FoxO activity through conserved mechanisms. 
Activation of daf-2/IGFr leads to phosphoinositide phosphorylation by AGE-1/PI3K.  
This causes recruitment and activation of PDK-1, which in turn activates the kinases 
AKT and AKT-2. AKT-1 and AKT-2 phosphorylate DAF-16/FoxO at conserved 
RxRxxS/T sites (Brunet et al., 1999; Lee et al., 2001; Paradis et al., 1999; Paradis & 
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Ruvkun, 1998).  Phosphorylated DAF-16 is exported from the nucleus and targeted for 
degradation (Berdichevsky et al., 2006; Brunet et al., 2002; Li et al., 2007).  Loss-of-
function mutations in pdk-1, akt-1, and akt-2 cause DAF-16/FoxO-dependent increases in 
lifespan (Alam et al., 2010; Paradis et al., 1999; Paradis & Ruvkun, 1998).    
DAF-16/FoxO activity is regulated by other kinases in addition to components of the 
insulin signaling pathway.  CST-1/MST-1 phosphorylates DAF-16 and mammalian 
FoxO3, promoting nuclear translocation of mammalian FoxO3, and CST-1 
overexpression extends C. elegans lifespan in a DAF-16/FoxO dependent manner 
(Lehtinen et al., 2006).  Similarly, mammalian c-Jun N-terminal kinase (Jnk) 
phosphorylates and activates FoxO4 and the C. elegans homolog JNK-1 promotes 
longevity in a DAF-16/FoxO dependent manner (Oh et al., 2005).  DAF-16/FoxO is also 
phosphorylated and activated by UNC-43/CAMKII and the phosphate group added by 
UNC-43 is removed by TAX-6/calcineurin, with UNC-43/CAMKII promoting nuclear 
accumulation of DAF-16/FoxO and longevity (Tao et al., 2013).  Murine FOXO3 can 
also be phosphorylated and transcriptionally activated or dephosphorylated and 
inactivated by CAMKII and calcineurin in a conserved manner (Tao et al., 2013).   
Interestingly, nuclear localization of DAF-16/FoxO is not sufficient for full activation 
and lifespan extension.  A DAF-16::GFP transgene with all three AKT-1 phosphorylation 
sites mutated to alanine is localized to the nucleus and is capable of rescuing lifespan in 
daf-2;daf-16 compound mutants but does not extend lifespan in wild-type animals (Lin et 
al., 2001).  Mutations in the conserved gene eak-7 promote activity of DAF-16 without 
any apparent alteration in its nuclear localization and cause a DAF-16 dependent increase 
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in longevity (Alam et al., 2010). Transgenic EAK-7::GFP constructs are constitutively 
localized to the plasma membrane by an N-myristoylation motif, suggesting that they 
regulate activity of nuclear DAF-16/FoxO indirectly through downstream intermediates 
(Alam et al., 2010).  Mechanisms that directly regulate activity of DAF-16/FoxO in the 
nucleus are not fully understood.   
DAF-16/FoxO activity promotes longevity in multiple contexts  
 DAF-16/FoxO promotes longevity independently of reduced insulin signaling.  Ablation 
of germline stem cells, via laser surgery or a temperature-sensitive mutation of glp-
1/Notch, causes an increase in DAF-16/FoxO nuclear localization and a daf-16-
dependent increase in longevity (Arantes-Oliveira et al., 2002; Hsin & Kenyon, 1999; Lin 
et al., 2001).  Importantly, molecular requirements for increased nuclear localization of 
DAF-16 in germline-ablated animals are distinct from IIS.  Nuclear localization of DAF-
16, and longevity, in germline ablated glp-1 mutants requires a conserved ankyrin-repeat 
containing protein KRI-1, and TCER-1, a transcription elongation regulator, as well as 
nuclear hormone receptor DAF-12, and DAF-9, a cytochrome P450 that is necessary for 
production of DAF-12 ligands (Berman & Kenyon, 2006; Gerisch et al., 2001; Ghazi et 
al., 2009). KRI-1, DAF-9, and DAF-12 are dispensable for nuclear localization of DAF-
16 in insulin signaling mutants (Berman & Kenyon, 2006). RNAi targeting kri-1 does not 
reduce lifespan in daf-2 mutants, suggesting that it is not required for increased longevity 
in the context of reduced insulin signaling (Berman & Kenyon, 2006).  Genetic analysis 
suggests that daf-12 and dafachronic acid biosynthesis genes play complex modulatory 
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roles in the lifespan of daf-2/IGFr mutants that may be independent of DAF-16 nuclear 
localization (Dumas et al., 2013; Dumas et al., 2010; Ghazi et al., 2009).   
DAF-16/FoxO also plays roles in longevity mediated by changes in diet.  Mutants that 
are defective in chemosensation due to cilia defects in sensory neurons, and ablations of 
individual gustatory and olfactory neurons extend lifespan through mechanisms that 
depend on DAF-16/FoxO. Extension of lifespan in sensory mutants can be due to 
reductions in the perception of food signals, or changes in perception of food-
independent environmental factors (Alcedo & Kenyon, 2004; Apfeld & Kenyon, 1998).  
A dietary restriction regimen in which worms on solid plates are given low 
concentrations of bacterial food and transferred repeatedly as they exhaust the available 
food on the plate extends lifespan through a daf-16-dependent mechanism; DAF-
16/FoxO activation in this context was proposed to depend on the C. elegans AMPKα2 
subunit homologue AAK-2 rather than reduced IIS (Greer et al., 2007). Importantly, 
other dietary restriction protocols have been described to extend lifespan independently 
of DAF-16/FoxO and dependently on other transcription factors including pha-4/FoxA 
and skn-1/Nrf-2 (Bishop & Guarente, 2007; Houthoofd et al., 2003; Kaeberlein et al., 
2006; Panowski et al., 2007).  Taken together these data suggest that DAF-16/FoxO plays 
important, albeit context dependent, roles in mediating the impact of food perception and 
calorie restriction on lifespan.  
The timing and location of DAF-16/FoxO action in lifespan control  
To understand how reduced insulin signaling and DAF-16/FoxO regulate lifespan it is 
important to understand where they act to control longevity.  Interestingly, evidence 
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suggests that lifespan regulation by reduced insulin signaling and DAF-16/FoxO activity 
may occur in distinct tissues. The long lifespan of daf-2/IGFr mutant animals can be 
reduced by transgenic expression of DAF-2/IGFr under heterologous promoters.  
Expression of DAF-2 under a ubiquitous promoter (dpy-30p) in daf-2 mutants reduces the 
lifespan to nearly that of wild-type animals.  A similar reduction is observed when DAF-
2 is expressed under a neuronal promoter (unc-14p) while a much smaller reduction in 
lifespan is caused by intestinal DAF-2 expression (ges-1p) and no reduction in lifespan is 
caused by expression under a muscle specific promoter (unc-54p) (Wolkow et al., 2000). 
This result was supported by a parallel study that observed animals with mosaic 
expression of wild-type daf-2 within a free chromosomal duplication that can be lost 
mitotically, in daf-2 mutant backgrounds (Apfeld & Kenyon, 1998).   
In contrast to studies rescuing daf-2/IGFr mutant lifepans, a separate study found that 
when the lifespan of daf-2;daf-16 mutants is rescued by transgenic expression of DAF-
16, the lifespan extension conferred by intestinal (ges-1p) expression is much larger than 
the lifespan extension conferred by neuronal expression (unc-119p) (Libina et al., 2003). 
The observation that neither neuronal nor intestinal expression of DAF-16 conferred as 
large an effect on lifespan as expression under its endogenous promoter suggests that 
DAF-16 activity in multiple tissues may be required for full lifespan extension (Libina et 
al., 2003). Importantly, a separate study found that intestinal expression of DAF-16/FoxO 
was sufficient to rescue the dauer diapause phenotypes of daf-16 mutants, while the 
Libina study found that neuronal expression of DAF-16 was critical for dauer 
phenotypes, suggesting that further studies, perhaps using tissue specific knock-outs, will 
be necessary to resolved differences between heterologous expression studies that may be 
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caused by imperfect understanding of promoter specific expression patterns (Hung et al., 
2014).  While the use of different neuronal promoters is a caveat for direct comparison of 
the study by Libina and colleagues to the above study of heterologous DAF-2 expression, 
the results are nonetheless consistent with a model where reductions in neuronal insulin 
signaling control lifespan via non-cell-autonomous regulation of DAF-16/FoxO.   
It is also critical to understand when IIS and DAF-16/FoxO activity act to promote 
lifespan.  An RNA interference study was used to identify timepoints at which 
knockdown of DAF-2/IGFr activity was sufficient to extend lifespan, and timepoints at 
which knockdown of DAF-16/FoxO activity could reduce lifespan in daf-2/IGFr mutants.  
Results showed that knockdown of daf-2/IGFr starting at any time from first larval stage 
to day 4 of adulthood could extend lifespan, while initiation of daf-2 RNAi at day 5 or 
later had little to no impact on lifespan (Dillin et al., 2002).  In contrast, daf-16/FoxO 
RNAi starting as late as day 15 of adulthood caused large reductions in lifespan in daf-
2/IGFr mutants (Dillin et al., 2002).  This study suggests a mechanism through which 
reductions of insulin signaling in young adults produce high levels of DAF-16/FoxO 
activity throughout life, with diminishing DAF-16/FoxO activation when insulin 
signaling is reduced later in life.  The molecular basis for such a mechanism remains 
unknown.  The observations that RNAi is less efficient in neurons (the primary site of 
DAF-2 action) than in intestine (a critical site of DAF-16 action) and that declines in 
feeding in aged animals might reduce the efficiency of RNAi, are important caveats for 
interpretation of this study (Huang et al., 2004; Libina et al., 2003; Timmons & Fire, 
2001; Wolkow et al., 2000).   
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Genetic studies of C. elegans have established an important role for the FoxO 
transcription factor DAF-16 in promoting increased lifespan.  While insulin signaling is 
the most well characterized mechanism of DAF-16/FoxO regulation, other upstream 
regulatory processes including germline ablation and dietary restriction regulate DAF-16 
activity. Evidence suggests that insulin signaling controls DAF-16 activity in part through 
cell non-autonomous mechanisms, with IIS activity in neurons in young adulthood 
establishing DAF-16 activity in multiple tissues during aging.  Overall, an extensive body 
of evidence demonstrates that both reduced IIS and increased DAF-16/FoxO activity can 
dramatically delay onset of age-related mortality and decline, while extending median 
and maximum longevity in C. elegans. 
Insulin signaling and FoxO family transcription factors are 
conserved regulators of longevity 
One reason for performing initial genetic studies in C. elegans is its relative simplicity.  
Having identified insulin-like signaling as a regulator of longevity in C. elegans, it was 
reasonable to ask whether the role of insulin signaling and FoxO activity in aging and 
age-related pathology is conserved in more complex organisms.    
The role of reduced insulin signaling and increased DAF-16/FoxO activity in longevity 
appears to be conserved from nematodes to the fruit fly Drosophila melanogaster.   
Mutation of the Drosophila insulin receptor substrate homologue chico extends lifespan 
through a mechanism that requires the sole Drosophila FoxO family member dFoxo 
(Clancy et al., 2001; Yamamoto & Tatar, 2011).  Overexpression of dFoxo in the 
Drosophila fat body also extends lifespan, suggesting that FoxO activity is sufficient to 
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increase longevity in flies (Hwangbo et al., 2004).  Given the large phylogenetic distance 
between worms and flies, these data suggest that the mechanisms underlying lifespan 
extension by increased FoxO activity may be highly conserved. 
There is evidence that reduced activity of the insulin signaling pathway regulates 
longevity and age-related morbidities in mammals.  Mice in which the insulin receptor is 
knocked out specifically in adipose tissue (Fat-specific-Insulin-Receptor-Knock-Out or 
FIRKO mice) are long lived and resistant to obesity (Blüher et al., 2003).  Mice with 
mutations that block growth hormone signaling by preventing development of growth 
hormone producing cells in the pituitary, or knocking out the growth hormone receptor, 
are long lived and have reduced hepatic expression of IGF-1, reduced circulating IGF-1 
levels, reduced insulin-levels, improved insulin sensitivity, delayed onset an reduced 
incidence of fatal neoplasia, delayed immune aging, and improved maintenance of 
cognitive functions in old animals, suggesting that reduced insulin and IGF-1 signaling 
may contribute to protection from multiple age related morbidities (Bartke, 2011; Flurkey 
et al., 2001; Freude et al., 2009; Ikeno et al., 2003; Ikeno et al., 2009; Killick et al., 2009; 
Kinney et al., 2001a; Kinney et al., 2001b; Masternak et al., 2009; Sharp & Bartke, 2005; 
Vergara et al., 2004).   Knockout of pregnancy-associated-plasma-protein-A (PAPP-A), 
which can function to increase local IGF-1 availability by cleaving IGF-1 binding 
proteins, causes increased lifespan and delayed occurrence of fatal neoplasia in mice, 
further suggesting that reduced IGF signaling can increase lifespan in mammals (Conover 
et al., 2010).   
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The mammalian genome encodes four FoxO transcription factors with overlapping 
expression patterns and critical roles in development, making it difficult to determine the 
contributions of mammalian FoxO transcription factors to longevity.  Phenotypes of 
FoxO knockout mice suggest that FoxO transcription factors may play roles in age-
related pathologies including insulin resistance, osteoporosis and neoplasia (Greer & 
Brunet, 2005; Hesp et al., 2015; Paik et al., 2007).  A recent study found that the 
lifespans of Foxo3 knockout mice are not extended by dietary restriction, suggesting that 
Foxo3 activity promotes longevity in dietary restricted mice (Shimokawa et al., 2015).  
Single nucleotide variants in the human insulin-like-growth-factor I receptor and 
FOXO3A loci are associated with longevity and multiple measures of improved health 
and delayed morbidity in centenarians, suggesting that IIS and FoxO activity may be 
correlated longevity in humans (Flachsbart et al., 2009; Joshi et al., 2017; Li et al., 2009; 
Suh et al., 2008; Willcox et al., 2008).     
Taken together these data suggest that the effects of reduced insulin signaling on 
longevity are highly conserved.  An improved understanding of the molecular 
mechanisms underlying the longevity phenotypes of IIS mutants in invertebrates may 
provide mechanistic insights into the basis of extended longevity and delayed morbidity 
that will be relevant to mammals.   
Phenotypes of long lived insulin signaling mutants 
A first step in finding out why reduced insulin signaling and DAF-16/FoxO activation 
extend lifespan is to study observable phenotypes of IIS mutants.  Perhaps the most basic 
question about IIS and other long-lived mutants, is why changes that improve overall 
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survival are not selected for in natural populations.  Evolutionary theory suggests that 
mutations that extend lifespan are likely to carry pleiotropies that prevent successful 
competition with wild-type animals (Williams, 1957).  While daf-2 mutants appear 
grossly normal, when they are placed in competition with wild-type animals under 
conditions of cycling food availability, they are rapidly lost from the population, 
suggesting that wild-type activity of the insulin receptor is necessary for worms to 
maximize reproduction and survival under conditions of variable nutrition likely found in 
nature (Jenkins et al., 2004).   
Mutations in daf-2 also confer resistance to a variety of environmental stresses, including 
high temperature, treatment with heavy metals, and infection by pathogenic bacteria 
(Barsyte et al., 2001; Garsin et al., 2003; Lithgow et al., 1995).  Resistance to multiple 
types of cellular stress is a common feature of increased lifespan; primary cells from 
long-lived species are generally more tolerant to a variety of cellular stresses than those 
from related short-lived species, and mutations that confer increased longevity in mice 
also frequently cause increases in cellular resistance to various environmental stresses 
(Harper et al., 2007; Salmon et al., 2005).  This suggests that resistance to molecular 
damage caused either by short-term stresses or long-term damage accumulation during 
aging may be a mechanism of lifespan extension.  However, it is difficult to determine 
which stress resistance mechanisms are important for lifespan phenotypes.  RNAi against 
a putative DAF-16 co-factor, smk-1, blocks lifespan extension in daf-2 mutants, while 
reducing their resistance to oxidative stress (paraquat) but not heat (Wolff et al., 2006).  
Similarly, a loss of function mutation in the transcription factor skn-1 suppresses an 
oxidative stress resistance phenotype (arsenite treatment) of strong daf-2 loss-of-function 
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mutants without suppressing their increased longevity phenotype when animals are 
cultured at 20°C (Ewald et al., 2015).  The separability of specific-stress resistance 
phenotypes from longevity phenotypes will make it challenging to make inferences about 
molecular mechanisms of longevity phenotypes based solely upon mechanisms of stress 
resistance.    
In addition to their stress resistance phenotypes daf-2/IGFr mutants have substantial 
changes in energy metabolism relative to wild-type animals.  Mutations in daf-2/IGFr 
cause the intestines of living worms to appear visibly darker under a dissecting 
microscope; this corresponds to increased fat storage, measured both by staining with 
lipophilic dyes and mass spectroscopy (O'Rourke et al., 2009).  Increased fat 
accumulation in daf-2/IGFr mutants may be related to their developmental phenotypes.  
At high temperatures, daf-2/IGFr mutants arrest in the dauer diapause, and even at 
permissive temperatures they pass through the pre-dauer L2D larval phase which drives 
increased fat accumulation; this has been proposed to be responsible for increased fat 
storage in daf-2/IGFr mutant adults (Golden & Riddle, 1984; Wolkow et al., 2000). In 
support of this model, treating animals with RNAi targeting daf-2/IGFr at adulthood was 
reported to reduce fat content, consistent with a role for reduced IIS in mobilizing stored 
nutrients during dietary restriction (Wang et al., 2008).   
In summary, reductions in insulin signaling cause several interesting physiological 
phenotypes in addition to increased lifespan.  These include resistance to a variety of 
environmental stresses, and changes in fat metabolism.  However, many of these 
phenotypes are somewhat context dependent, with different IIS reducing interventions 
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having opposite effects on fat content and resistance to some environmental stressors 
being genetically separable from longevity.  Based on the information available it will 
likely be difficult to reach a mechanistic understanding of lifespan extension using only 
hypotheses based on non-longevity phenotypes of long-lived animals.   
Identification of downstream transcriptional targets of DAF-
16/FoxO that contribute to longevity 
DAF-16/FoxO is a transcription factor, and DAF-16/FoxO-dependent increases in 
lifespan are strongly associated with localization of DAF-16/FoxO to the nucleus, and 
with increased transcriptional activity of nuclear DAF-16/FoxO.  Thiss suggests that 
DAF-16/FoxO activity increases longevity by influencing transcription of downstream 
target genes, though this has not been thoroughly testes using daf-16/FoxO mutants that 
are specifically defective in DNA binding (Alam et al., 2010; Lin et al., 2001; Murphy et 
al., 2003).  Identification of transcriptional targets of DAF-16/FoxO followed by 
functional testing for effects on longevity can provide insights into the downstream 
mechanisms through which increased DAF-16/FoxO activity increases longevity. A 
number of studies have attempted to identify transcriptional targets of DAF-16/FoxO that 
may contribute to longevity using unbiased approaches (Amrit et al., 2016; Chen et al., 
2015; Lee et al., 2003; McCormick et al., 2012; McElwee et al., 2003; McElwee et al., 
2004; Murphy, 2006; Murphy et al., 2003; Oh et al., 2006; Schuster et al., 2010). 
To determine whether changes in transcription observed in profiling studies represent a 
DAF-16-dependent transcriptional program, it is critical to identify sites in the genome at 
which DAF-16 is likely to bind, and to validate at least a few direct DAF-16 target genes 
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that can serve as positive controls.  In vitro studies of DAF-16/FoxO binding to random 
oligonucleotides have determined that both DAF-16 and some vertebrate FoxO 
transcription factors bind robustly to a conserved TTGTTTAC motif, referred to as a 
DAF-16 binding element or DBE (Furuyama et al., 2000).  However, this motif occurs at 
least once within 5kb upstream of  78% of annotated genes in the worm genome, 
suggesting that the presence of DBEs alone is a poor method for identifying DAF-16 
targets (Kenyon & Murphy, 2006).   
Published studies have used chromatin immunoprecipitation and DamID to identify 
genomic sites at which DAF-16 binds (Oh et al., 2006; Schuster et al., 2010).  The study 
using DamID was able to correlate genomic sites of DAF-16 binding with existing 
transcriptional profiling data to generate a high priority list of 65 genes whose 
transcription is upregulated by direct binding of DAF-16/FoxO to their promoters 
(Schuster et al., 2010). This set is enriched for genes that are transcriptionally upregulated 
in a DAF-16 dependent manner in daf-2 mutants, suggesting that DAF-16 principally acts 
directly to increase transcription of its target genes (Schuster et al., 2010).  A handful of 
DAF-16 target genes including the superoxide dismutase sod-3, and the metallothionein 
family member mtl-1 have been validated as transcriptionally upregulated DAF-16 
targets in multiple studies (Murphy, 2006; Murphy et al., 2003).  Importantly, there are 
statistically significant overlaps between genes that are transcriptionally regulated or 
bound by DAF-16 and orthologous genes that are bound or transcriptionally regulated by 
Drosophila dFOXO, suggesting that some transcriptional outputs of DAF-16/FoxO 
activity, such as its effects on lifespan, are broadly conserved (Alic et al., 2011). 
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The field of identifying DAF-16/FoxO transcriptional targets that are involved in 
longevity has been defined by a seminal study performed by Cynthia Kenyon and 
colleagues (Murphy et al., 2003).  This study used microarrays to compare transcriptomes 
of animals carrying multiple alleles of daf-2/IGFr and age-1/PI3K to wild type, as well as 
comparing a single daf-2 mutant to compound daf-2;daf-16(0) mutants.  Importantly, the 
study controlled for genetic background by also comparing isogenic animals treated with 
daf-2 RNAi or daf-2 and daf-16 RNAi.  They also compared multiple time points to 
control for systematic errors introduced by longitudinal changes in the early adult 
transcriptome.   
The Kenyon study identified two classes of target genes: genes that were consistently 
upregulated in a DAF-16/FoxO-dependent manner in daf-2 mutants were termed Class I 
DAF-16 targets and genes that were consistently downregulated in a DAF-16/FoxO-
dependent manner in daf-2 mutants were termed Class II DAF-16 targets.  By identifying 
putative DAF-16/FoxO targets that changed robustly over many arrays they were able to 
prioritize a relatively small subset of 58 genes to test for lifespan effects using RNAi.   
RNAi of Class I DAF-16 targets was tested for the expected suppression of extended life 
span in daf-2/IGFr mutants, while RNAi of genes that were transcriptionally 
downregulated in long-lived strains in a DAF-16-dependent manner was tested for 
lifespan extension in wild type animals.  Strikingly, fifty out of fifty-eight genes that were 
tested affected lifespan, with 49 doing so in the expected direction.  Most effects were 
small in magnitude (under twenty percent reductions in lifespan compared to daf-2 
mutants on vector RNAi for DAF-16 upregulated genes); however, RNAi against one 
target, dod-1, reduced lifespan of daf-2 mutants by 30% to 40% in two trials.  Biological 
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functions of DAF-16 targets affecting lifespan will be discussed below.  The magnitude 
of the effects observed led the authors to speculate that DAF-16 activity extends lifespan 
through additive effects of many target genes.  It is worth noting that the high percentage 
of tested DAF-16 targets with effects on lifespan observed in this report is not typical of 
subsequent efforts to test candidate DAF-16 targets lifespan effects; this may suggest that 
this study was particularly efficient at enriching for DAF-16 targets with roles in lifespan, 
or that the experimental conditions used were highly sensitized for lifespan effects, or 
some combination of the above (Chen et al., 2015; Murphy, 2006).  The study was 
performed in a sterile (fer-15;fem-1) background to avoid the use of pharmacological 
agents (5-fluoro-2’-deoxyuridine, FUDR, which inhibits DNA synthesis) to inhibit worm 
fertility, and the controls had shorter lifespans than are usually observed in wild-type 
worms which could have sensitized these animals to lifespan effects (Murphy et al., 
2003). 
Unexpectedly, the Kenyon study identified two putative transcription factor binding sites 
that were enriched upstream of genes with DAF-16-dependent changes in transcriptional 
changes using an unbiased algorithmic approach; in addition to the expected DBE being 
enriched in the promoters of both Class I and Class II targets, they identified another 
motif (CTTATCA) that was enriched in the upstream regulatory region of both Class I 
and Class II targets, in various combinations with the DBE.  They named this putative 
transcription factor binding site the DAF-16 associated element or DAE. A recent study 
was able to identify this motif as the binding site for another transcription factor, PQM-1 
(Tepper et al., 2013).  A PQM-1::GFP transgene is exported from the nucleus under 
reduced IIS, and its nuclear localization is anti-correlated with nuclear localization of 
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DAF-16, suggesting that PQM-1 may predominantly act to promote the transcription of 
Class II genes which are downregulated when PQM-1 is absent during reduced IIS 
(Tepper et al., 2013).  Importantly, the ChIP-seq data sets used to identify PQM-1 show 
that the promoters of both Class I and Class II targets are highly enriched for PQM-1 
binding, suggesting that the PQM-1 may influence lifespan, at least in part,  altering 
transcription of both Class I and Class II targets (Tepper et al., 2013).  
Several other studies have attempted to identify transcriptional targets of DAF-16 that are 
involved in longevity (Amrit et al., 2016; Chen et al., 2015; Halaschek-Wiener et al., 
2005; Lee et al., 2003; McCormick et al., 2012; McElwee et al., 2003; McElwee et al., 
2004).  Most of these studies have involved comparisons of daf-2/IGFr mutant animals to 
daf-2;daf-16/FoxO compound mutants (Chen et al., 2015; Halaschek-Wiener et al., 2005; 
McElwee et al., 2003; McElwee et al., 2004).  Germline ablated animals have also been 
profiled (Amrit et al., 2016; McCormick et al., 2012), and one study has 
bioinformatically identified targets based on the presence of DBE’s in the promoter of C. 
elegans and orthologous Drosophila genes (Lee et al., 2003). Many of these studies did 
not perform robust filtering to remove false positives, all have reported testing fewer 
targets than the initial profiling study and have found a lower proportion of targets with 
lifespan in effects in the direction that would be expected from the change in transcription 
(Murphy, 2006).   
A major issue in identifying a consensus set of genes that are transcriptionally regulated 
by DAF-16 has been low agreement among published microarray studies. For example, 
out of 3032 putative DAF-16 transcriptional targets identified by the first three published 
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profiling studies, only ninety were identified in all three (McElwee et al., 2003; McElwee 
et al., 2004; Murphy, 2006; Murphy et al., 2003).  Differences between datasets 
generated by different groups may vary due to lab-to-lab changes in how worms were 
cultured and RNA was collected.  Subtle differences in genetic background, 
developmental stage, and synchronization could also affect the DAF-16 transcriptome 
(Kenyon & Murphy, 2006).  Despite differences between studies, many “gold standard” 
DAF-16 targets have been identified in multiple studies.  These include genes that have 
been identified both based on binding of DAF-16 to their promoters and DAF-16 
dependent transcriptional regulation.  A meta-analysis has used an unbiased voting 
algorithm to identify a rank-ordered list of DAF-16 targets that are consistently 
differentially regulated in various micro-array studies (Murphy, 2006; Schuster et al., 
2010; Tepper et al., 2013).   
Most studies that have functionally tested candidate DAF-16 target genes for effects on 
lifespan have done so by inactivating them using feeding RNAi starting at young 
adulthood.  While RNAi permits high throughput studies on identical genetic 
backgrounds, the approach has major caveats.  RNAi can cause off-target knockdowns of 
multiple genes or can fail to fully inactivate the target gene (Qiu et al., 2005).  Some 
tissues, including neurons, which are critical regulators of lifespan, are refractory to 
RNAi (Timmons & Fire, 2001).  In addition, while performing RNAi at adulthood rather 
than using mutants prevents developmental defects from confounding lifespan studies, it 
may cause false negatives when testing genes that are principally expressed prior to 
adulthood but do affect lifespan.  Whole genome sequencing of mutagenized strains has 
made loss of function mutations in many genes publicly available, and CRISPR/Cas9-
  94 
based gene editing now permits straightforward creation of targeted knockouts (Friedland 
et al., 2013; Thompson et al., 2013).  In the future it will be important to perform 
functional studies of DAF-16/FoxO targets that regulate lifespan using mutants in 
addition to RNAi.     
To perform detailed genetic studies of DAF-16 targets in longevity, it will be necessary 
to prioritize DAF-16/FoxO targets that are likely to be involved in lifespan determination.   
A method of prioritizing DAF-16 targets has been revealed by recent studies 
demonstrating that transcriptional isoforms of DAF-16 have distinct roles in lifespan 
determination (Chen et al., 2015; Kwon et al., 2010; Lee et al., 2001).  We conducted an 
analysis of isoform-specific DAF-16 mutants which demonstrated that DAF-16A and 
DAF-16F isoforms act hierarchically to promote lifespan.  Mutations that specifically 
eliminate DAF-16A partially suppress the long lifespans of daf-2/IGFr mutants, while 
mutations that specifically eliminate DAF-16F do not reduce lifespan, suggesting that 
function of the DAF-16F isoform only becomes critical for daf-2/IGFr mutant longevity 
when daf-16a is absent (Chen et al., 2015).   
The transcriptomes of daf-2/IGFr mutants were then compared to daf-2;daf-16 compound 
mutants harboring isoform-specific daf-16 mutations, to identify target genes whose 
transcription was influenced strongly by daf-16a or equally influenced by DAF-16A and 
DAF-16F. Importantly, this analysis verified multiple “gold-standard” DAF-16 target 
genes that have identified by multiple previous profiling studies, and several DAF-16 
target genes that have been previously validated to have lifespan effects.  A set of twenty 
DAF-16A specific, nine DAF-16A/F redundant, and two DAF-16F targets was tested for 
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lifespan effects, using genetic mutants rather than RNAi.  RNAi of two genes, a single 
DAF-16 upregulated Class I target (gst-20) and a single DAF-16 downregulated Class II 
target (srr-4), affected lifespan in the expected direction. Interestingly, both effects were 
observed when worms were cultured on the bacterial strain HT115 (used in RNAi 
experiments) but not on the bacterial strain OP50 (the standard for non-RNAi studies), 
highlighting a potential caveat of translating lifespan effects from RNAi-based studies to 
studies using mutants (Chen et al., 2015).       
Due to the substantial, and potentially conserved, effects of DAF-16 activity on lifespan, 
delineating the transcriptional program that promotes longevity downstream of DAF-16 
activation has been a subject of intense interest.  At this point a large body of studies have 
used genome wide transcriptomic approaches to identify genes that contribute to lifespan 
extension downstream of DAF-16.  Identifying a consensus set of DAF-16 target genes 
has been difficult, due, in part, to the sheer number of DAF-16 dependent transcriptional 
changes that can be identified.  Nonetheless, multiple approaches including direct 
analysis of DAF-16 binding sites in the genome, genetic studies of daf-16 isoforms, 
individual studies that robustly enrich for DAF-16-dependent regulatory events over 
multiple transcriptomic experiments, transcriptomic profiling of specific tissues, and 
meta-analyses of publicly available data have identified many consensus DAF-16/FoxO 
transcriptional targets, some of which do affect lifespan (Chen et al., 2015; Kaletsky et 
al., 2016; Murphy et al., 2003; Schuster et al., 2010; Tepper et al., 2013).  At this point it 
is reasonable to ask what biological processes have been found to contribute to increased 
longevity.   
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Downstream mechanisms of longevity regulation by DAF-
16/FoxO activity 
Multiple studies have identified transcriptional targets of DAF-16 that contribute to the 
long lifespans of daf-2/IGFr mutants.  An increasing number of functional studies are 
now moving beyond identifying individual target genes that are critical for longevity to 
characterizing the biological processes they are involved in.  This work may provide 
insight into conserved cellular functions that can be targeted to extend lifespan and delay 
or prevent age-related morbidity. Here we will classify biological processes that are 
regulated by DAF-16 that are likely to contribute to longevity in C. elegans, and that may 
be conserved. 
DAF-16/FoxO regulates signaling genes  
DAF-16 activation alters expression of several genes that are recognizable components of 
conserved signaling pathways, including genes that alter its own activity. DAF-16 
activity robustly increases transcription of AKT-2, which acts in IIS to inhibit DAF-16 
activity (Chen et al., 2015; Paradis & Ruvkun, 1998). akt-2 mutants are long-lived, 
suggesting that transcriptional upregulation of AKT-2 by DAF-16 acts in a negative 
feedback loop to increase the sensitivity of DAF-16 to downregulation by IIS and limit 
longevity (Alam et al., 2010).   
In contrast, DAF-16 also activates transcription of aakg-4, an atypical AMP-kinase γ-
subunit that has been shown to act in a positive feedback loop to increase DAF-16 
activity (Chen et al., 2015; Chen et al., 2013; Tullet et al., 2014).  A predicted aagk-4 null 
mutation completely abrogated lifespan extension in a daf-2/IGFr mutant background and 
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also caused reduced upregulation of other canonical DAF-16 target genes in a daf-2/IGFr 
mutant background, suggesting that it influences lifespan by positively regulating DAF-
16 activity (Tullet et al., 2014).   
scl-1 is another gene that is transcriptionally upregulated by DAF-16/FoxO and that may 
function in both lifespan and signaling.  The scl-1 locus encodes a predicted secreted 
protein with homology to the mammalian cysteine rich secreted protein family (Ookuma 
et al., 2003). Though it was originally identified in a targeted qPCR study rather than a 
transcriptomic approach, the scl-1 transcript is reproducibly upregulated in IIS mutants 
(Hsu et al., 2003; Ookuma et al., 2003; Tullet et al., 2014).  Strikingly, scl-1 RNAi was 
reported to completely abrogate the lifespan extension observed in long-lived daf-
2(e1370) mutants (Ookuma et al., 2003).  The function of scl-1 remains obscure; 
however, its annotation as a secreted protein suggests that it could function in cell non-
autonomous signaling (Ookuma et al., 2003). 
Increased DAF-16/FoxO activity also controls longevity by downregulating signaling 
molecules. The insulin-like peptide INS-7 is transcriptionally downregulated in daf-
2/IGFr mutants in a DAF-16-dependent manner, and ins-7 RNAi increases lifespan (Chen 
et al., 2015; Murphy et al., 2003). An INS-7::GFP transgene under the control of its own 
promoter is expressed in the intestine and neurons, and constitutive expression of INS-7 
in the intestine prevents constitutive intestinal DAF-16/FoxO expression from 
upregulating transcriptional activity of DAF-16/FoxO in other tissues, suggesting that 
disinhibition of INS-7 expression permits FoxO-to-FoxO signaling from intestine to other 
tissues (Murphy et al., 2007).   
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DAF-16 activity has also been found to downregulate activity of daf-15/Raptor (Jia et al., 
2004).  daf-15/Raptor mutants have reduced TOR activity and are long lived, suggesting 
that downregulation of daf-15/Raptor by DAF-16/FoxO may promote increased longevity 
through the TOR pathway.   
In sum, longevity regulation by DAF-16 depends in part on differential expression of 
genes in multiple signaling pathways, each of which likely has downstream effects on 
transcription.  This is consistent with the observation that many genes that are 
transcriptionally regulated by DAF-16 are not observed to have DAF-16 bound to their 
promoters (Schuster et al., 2010). 
DAF-16/FoxO regulates other transcriptional regulators 
 In addition to upstream signaling genes, many DAF-16 targets with effects on lifespan 
are themselves direct regulators of gene expression. SKN-1/Nrf-2 has been reported to be 
transcriptionally upregulated in a DAF-16/FoxO-dependent manner in germline ablated 
glp-1 mutants, and skn-1 mutation fully abrogates lifespan extension in germline ablated 
glp-1 mutants, suggesting that DAF-16 may extend lifespan in part through indirect 
activation of SKN-1 targets in germline ablated animals (McCormick et al., 2012; 
Steinbaugh et al., 2015). 
Another transcription factor, mdl-1, is homologous to the mammalian Mad family of 
transcription factors and is both a target of DAF-16 direct binding to its promoter, and 
DAF-16 dependent transcriptional upregulation in daf-2/IGFr mutants (Chen et al., 2015; 
Riesen et al., 2014; Schuster et al., 2010).  A predicted null mutation in mdl-1 partially 
suppresses the lifespan extension phenotype of a daf-2/IGFr mutant, suggesting that 
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transcriptional upregulation of MDL-1/Mad by DAF-16/FoxO promotes increased 
lifespan through activation of MDL-1 target genes (Riesen et al., 2014).   
Germline-ablated glp-1 mutant animals also transcriptionally upregulate a transcription 
elongation factor, TCER-1, and an RNA binding protein, PHI-62, in a manner that 
depends on both DAF-16/FoxO and DAF-12/NHR (Ghazi et al., 2009; McCormick et al., 
2012).  RNAi targeting either phi-62 or tcer-1 blocks the long lifespan of germline-
ablated mutants and downregulates transcription of some other DAF-16 target genes, 
suggesting that TCER-1 and PHI-62 promote increased lifespan by promoting 
transcriptional regulation of other DAF-16 targets (Amrit et al., 2016; Ghazi et al., 2009; 
McCormick et al., 2012).  Interestingly, both of these genes are dispensable for lifespan 
in the context of daf-2/IGFr mutants, suggesting that DAF-16 can initiate the 
transcriptional events that are required for increased longevity independently of these co-
regulators when it is activated by reduced IIS (Amrit et al., 2016; Ghazi et al., 2009; 
McCormick et al., 2012).  
The DAF-16-dependent upregulation of both signaling pathway genes and other 
transcription regulators may help explain the large number of genes that are differentially 
regulated in a DAF-16/FoxO dependent manner, as well as the observation that many 
genes that are robustly transcriptionally regulated by DAF-16 do not appear to be direct 
targets of DAF-16 binding.  In general, this evidence may suggest that DAF-16/FoxO 
acts as a master regulator of transcription, controlling the activation of signaling 
pathways and transcriptional programs in response to environmental stresses, and 
promoting increased longevity through indirect activation of downstream responses. 
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DAF-16/FoxO activity alters fat metabolism  
While the observation that DAF-16 may influence longevity through activation of 
downstream signaling and transcription related proteins is interesting from the 
perspective of understanding the regulatory logic of pro-longevity responses, it is also 
somewhat disappointing for those of us who hope that understanding an enzymatic 
program that is sufficient to increase lifespan and delay multiple aspects of age-related 
functional decline could provide insights into the molecular causes of aging.  
Interestingly, an emerging body of work has begun to identify DAF-16 target genes that 
may contribute more directly to longevity, improving to our understanding of biological 
processes that may delay aging.   
DAF-16/FoxO activity extends longevity in part by upregulating members of the lipase 
family, encoded by the genes lipl-1-4.  lipl-4 was first identified in an RNAi screen for 
genes that increase fat accumulation in germline-ablated animals; however, subsequent 
transcriptomic profiling studies have confirmed that it is regulated in a DAF-16-
dependent manner in germline-ablated and daf-2/IGFr mutant strains (Chen et al., 2015; 
Wang et al., 2008).  RNAi targeting lipl-4 reduces lifespan extension in both daf-2/IGFr 
mutants and germline-ablated glp-1 mutants, suggesting that LIPL-4 activity promotes 
longevity (Wang et al., 2008).  Strikingly, overexpression of LIPL-4 in the intestine 
increases lifespan of wild-type worms, demonstrating that LIPL-4 activity is sufficient to 
increase lifespan (Wang et al., 2008). Excitingly, overexpression of LIPL-4 has been 
shown to drive increased expression of polyunsaturated fatty acid species that are 
sufficient to induce autophagy in both worms and mammalian cells (O'Rourke et al., 
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2013).  Furthermore, components of the autophagy machinery are necessary for lifespan 
extension in LIPL-4 overexpressing animals, suggesting that LIPL-4 activity extends 
lifespan by directly activating turnover of damaged proteins and cellular organelles via 
inducing macro-autophagy (Lapierre et al., 2011).  However, the longevity extension 
caused by LIPL-4 has also been reported to require a signaling mechanism involving a 
lipid chaperone, LBP-8, translocating to the nucleus and activating nuclear hormone 
receptors (NHR-49 and NHR-80) suggesting that a downstream transcriptional response 
is also involved in LIPL-4 mediated lifespan extension (Folick et al., 2015).   
Interestingly, other members of the lipase family are also involved in longevity 
regulation.  DAF-16/FoxO activity has been reported to upregulate lipl-1, lipl-2, and lipl-
3 in addition to lipl-4 in daf-2/IGFr mutants (Chen et al., 2015).  LIPL-1 and LIPL-3 have 
been reported to be transcriptionally induced upon fasting, and overexpression of LIPL-1 
or LIPL-3 modestly extends lifespan in wild-type animals (O’Rourke & Ruvkun, 2013).  
A predicted null mutant in lipl-2 partially suppressed lifespan in daf-2/IGFr mutants, and 
lipl-2 RNAi reduced longevity in germline-ablated glp-1 animals (Ghazi et al., 2009) 
(unpublished data).  A robust genetic analysis to determine the contribution of each lipase 
to the longevity of daf-2/IGFr or germline ablated mutants has not been reported.   
A recent analysis of the transcriptome of germline-ablated animals revealed DAF-
16/FoxO-dependent upregulation of both lipid anabolic and catabolic genes, including 
multiple genes encoding predicted diacyl-glycerol-acyl-transferase (DGAT) enzymes, 
which are involved in synthesizing triglycerides from free fatty acids (Amrit et al., 2016). 
Strikingly both mutation and RNAi against two DGAT-encoding genes, dgat-2 and acs-
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22, suppressed lifespan extension in germline ablated glp-1 animals (Amrit et al., 2016).  
The lifespan effects of the mutations were dependent on bacterial food source; 
suppressing longevity when worms were cultured on E.coli strain HT115 but not on 
OP50 (Amrit et al., 2016).  Food source differences in the effects of downstream lifespan 
regulators have now been reported in multiple studies (Amrit et al., 2016; Chen et al., 
2015).     
Several other putative fat metabolism genes have been reported to be regulated by DAF-
16/FoxO, including fatty acid desaturases and lipid binding proteins (Murphy, 2006). 
RNAi against fatty acid desaturases was reported to reduce lifespan in daf-2/IGFr 
mutants (Murphy et al., 2003).   
The initial insight that daf-2/IGFr and glp-1/Notch germline ablated animals have 
differences in fat storage relative to wild-type mammals has now been supported by a few 
mechanistic studies suggesting that fat metabolism enzymes contribute to increased 
longevity. Since the insulin and IGF pathways broadly regulate metabolism in mammals, 
these insights may ultimately reveal conserved mechanisms that increase longevity and 
delay age-related functional decline.  Robust genetic and metabolic studies of multiple fat 
metabolism genes will be useful to identify specific lipid species that modulate longevity 
and identify the mechanism by which they affect downstream cellular processes such as 
autophagy.          
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DAF-16/FoxO activity promotes autophagy and mitophagy  
Autophagy is induced in multiple contexts of increased lifespan, including daf-2/IGFr 
mutants, germline-ablated mutants, and dietary restriction (Gelino & Hansen, 2012; 
Hansen et al., 2008; Jia & Levine, 2007; Lapierre et al., 2011; Lapierre et al., 2015; 
Meléndez et al., 2003).  RNAi-based knock-down of core components of the autophagy 
machinery abrogates lifespan extension in daf-2/IGFr mutants, and in many other long-
lived contexts, suggesting that recycling of damaged proteins and organelles through 
autophagy may be a core mechanism of lifespan extension downstream of multiple 
pathways (Hansen et al., 2008; Lapierre et al., 2011; Meléndez et al., 2003).  
DAF-16/FoxO-dependent upregulation of DCT-1, an orthologue of mammalian 
NIX/BNIP3L and BNIP3 mitochondrially expressed receptors that target mitochondria 
for autophagic degradation (termed mitophagy), has been observed in daf-2/IGFr mutants 
(Palikaras et al., 2015).  RNAi against DCT-1 reduces lifespan in daf-2/IGFr mutants, as 
does RNAi against another core component of the mitophagy machinery, the PTEN 
induced mitochondrial kinase PNK-1 (Palikaras et al., 2015). This data suggests that 
increased expression of DCT-1 and PNK-1, and subsequent increased turnover of 
damaged mitochondria, promote lifespan downstream of reduced insulin signaling and 
DAF-16/FoxO.  Interestingly dct-1 and pnk-1 deletion mutants had reduced resistance to 
heat and oxidative stressors (paraquat) relative to wild-type siblings, suggesting that 
increased mitophagy may be responsible for some aspect of increased stress resistance in 
daf-2/IGFr mutants (Palikaras et al., 2015).    
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Reduced insulin signaling may regulate autophagy through multiple mechanisms. daf-
2/IGFr mutants have been observed to induce autophagy independently of DAF-16/FoxO 
in some tissues.  In addition, it remains unclear whether induction of autophagy by lipase 
activity interacts specifically with mitophagy to promote longevity.  Nonetheless, 
alterations in autophagy which produce delays in age-related accumulation of molecular 
damage, may provide a mechanistic basis for lifespan extension by DAF-16/FoxO.   
DAF-16/FoxO activity promotes proteostasis and stress response  
Increased autophagy may contribute to proteostasis by eliminating damaged proteins.  
Other proteostasis mechanisms have also been shown to contribute to lifespan extension 
downstream of DAF-16/FoxO activation.  HSF-1/Heat-shock-factor promotes 
proteostasis by upregulating expression of molecular chaperones called heat-shock-
proteins, whose functions include binding to unfolded proteins to prevent them from 
aggregating.  RNAi against HSF-1 fully abrogates lifespan extension in daf-2/IGFr 
mutants, and DAF-16/FoxO and HSF-1 act together to transcriptionally upregulate 
expression of several small heat shock proteins, including hsp-16.1, hsp-16.49, hsp-12.6, 
and sip-1 (Hsu et al., 2003).  RNAi against each of these small heat shock proteins 
partially reduced lifespan in daf-2/IGFr mutants, and heat shock protein overexpression is 
sufficient to extend lifespan, strongly suggesting that increased DAF-16/FoxO activity 
extends lifespan, in part, through promoting expression of chaperones that prevent 
protein aggregation (Hsu et al., 2003; Walker & Lithgow, 2003).  Strikingly, RNAi 
against each of these heat shock proteins also accelerated the age-related aggregation of 
Huntington’s-like polyglutamine-repeat containing proteins expressed in C. elegans 
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muscle, suggesting that heat-shock protein expression may both increase lifespan and 
protect against an age associated morbidity (Hsu et al., 2003).   
Several other classes of genes that could protect against or repair damage to proteins are 
upregulated in a DAF-16/FoxO-dependent manner in long lived mutants.  These include 
genes encoding glutathione-S-transferases, which can protect against oxidative damage, 
as well as genes such as metallothionein that may detoxify xenobiotics (Murphy, 2006).  
RNAi against gst-4, and a loss of function mutation in gst-20 have been reported to 
slightly reduce lifespan in daf-2/IGFr mutants, suggesting that these genes contribute to 
longevity (Chen et al., 2015; Murphy et al., 2003).  As these genes may act partially 
redundantly, it would be of interest to construct compound mutants eliminating multiple 
DAF-16/FoxO regulated glutathione-S-transferases to determine whether greater effects 
on longevity are observed than in single mutants. 
Overall, a substantial body of evidence supports the hypothesis that DAF-16/FoxO 
activity may promote longevity by improving proteostasis and preventing protein 
aggregation.  Studies of these mechanisms, including studies of whether aggregation of 
endogenous proteins limits lifespan in C. elegans, may provide opportunities to connect 
the mechanistic basis of lifespan extension in nematodes to important mammalian 
pathologies.    
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Conclusions and Future Directions: the end of the beginning of 
identifying downstream longevity genes 
Over twenty years since the cloning of daf-2/IGFr, age-1/PI3K, and daf-16/FoxO 
revealed that an insulin-like signaling pathway extends lifespan and delays visible signs 
of aging in C. elegans, an extensive body of work has begun using this pathway as a key 
to understand the fundamental biological mechanisms regulating the aging process.  
Studies of the signaling pathways upstream of DAF-16/FoxO activity, and the signaling 
and transcription genes it regulates, have outlined a complex regulatory system in which 
various stresses such as dietary restriction and germline-stem-cell arrest activate DAF-
16/FoxO. DAF-16 in turn activates downstream stress response regulators, such as skn-
1/Nrf-2, that combine to produce short term stress responses and long-term increases in 
longevity.  
Both unbiased transcriptome profiling and hypothesis-based experiments have begun to 
reveal the downstream molecular program that dramatically delays aging in daf-2/IGFr 
mutants.  These studies can help us both reject and confirm hypotheses about the 
molecular mechanisms that delay mortality and functional aging.  Genetic analysis of 
compound mutants has largely disproven the hypothesis that daf-2/IGFr mutations extend 
lifespan by upregulating superoxide dismutase genes to protect against free radical 
damage (Doonan et al., 2008). Conversely, the hypotheses that triglyceride catabolism, 
autophagy, autophagic degradation of damaged mitochondria, and chaperone-mediated 
protection from aggregation-prone misfolded proteins, play roles in longevity extension 
seem to, thus far, be consistent with the available evidence. (Although a recent study 
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suggests that the benefits of autophagy may be context-dependent (Wilhelm et al., 
2017)).     
While the existing body of work has begun to produce fascinating insights, much work 
remains to be done.  There is substantial variation in the results when transcriptomes of 
similar long-lived and short-lived strains are profiled in different labs.  From a practical 
perspective, profiling strategies that robustly eliminate false positives over multiple 
experiments have had the most success at identifying target genes with lifespan effects 
(Murphy, 2006).  Availability of affordable RNA-seq now makes it reasonable to conduct 
many profiling experiments and facilitates direct comparison between data sets.  DAF-16 
targets should be profiled using multiple combinations of long-lived strains, in the same 
hands, to identify targets that are robust across long-lived strains, and targets that are 
context unique.  These experiments should be conducted in multiple labs and compared 
directly to eliminate systemic artifacts.  Ultimately, using this approach, longevity target 
gene profiling can be “finished”; it will be possible to look up the degree to which any 
transcript is changed in various long-lived context, and to perform meta-analyses to 
identify new classes of longevity targets.   
There is also substantial variation between labs in methodologies for testing target genes 
for longevity effects.  Most groups use RNAi as a first pass to knock down genes of 
interest, but candidate testing for reduced longevity is performed using several different 
daf-2/IGFR alleles.  There is substantial variation in lifespan between daf-2/IGFr alleles, 
and it is unclear whether different long-lived contexts will be equally responsive to 
lifespan effects.  One might imagine that longer-lived daf-2/IGFr mutants will be more 
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sensitive to measurable reductions in lifespan, simply due to the larger phenotypic 
difference from wild-type in which to see an effect, or that they will be less sensitive, for 
example due to higher expression of many partially redundant pro-longevity programs.  
This type of understanding can best be developed by testing longevity regulating genes in 
multiple long-lived backgrounds using null-mutations.  Given that both large numbers of 
null mutations are available, and that gene-editing approaches are available to make 
targeted mutations, it makes sense to test longevity targets using null alleles, unless there 
is a reason to suspect that a developmental pleiotropy will necessitate the use of RNAi at 
adulthood.   
In addition, many enzymes that may play roles in longevity, such as lipases, fatty acid 
desaturases, and glutathione-S-transferases, represent potentially functionally redundant 
gene classes.  The best way to determine whether a class of enzymes may be involved in 
lifespan extension will be to make compound mutants harboring multiple null mutations 
in potentially redundant genes, and test for lifespan effects. Finally, new technologies, 
including gene-editing mediated recombineering to generate single copy insertions of 
genes under heterologous promoters, or with rationally designed gain-of-function 
mutations, will enable more robust identification of genes that are sufficient to increase 
lifespan (Paix et al., 2016).  This program represents a great deal of effort, perhaps 
eventually made less tedious by the availability of automated systems for performing 
lifespans (Stroustrup et al., 2013).  However, the prize may be a detailed understanding of 
the molecular mechanisms underlying lifespan extension, and in turn normal aging.  This 
will ultimately be vital to develop rational interventions to increase the portion of human 
lifespan that we can enjoy in good health. 
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Chapter 4 The Caenorhabditis elegans 
carboxylesterase family member CEST-1 
promotes longevity 
 
Abstract 
Although the role of FoxO transcription factors in promoting longevity is well established, how 
they do so is poorly understood. In the nematode Caenorhabditis elegans, the FoxO transcription 
factor DAF-16 extends life span in the contexts of reduced insulin-like signaling (ILS) and 
germline ablation. To gain insight into mechanisms underlying DAF-16/FoxO-dependent 
longevity, we used whole transcriptome profiling to define a set of 46 dal (DAF-16/FoxO target 
associated with longevity) genes that are concordantly regulated in animals with either reduced 
ILS or absent germlines. One such gene, cest-1, is induced in a DAF-16/FoxO-dependent manner 
in daf-2 mutants with reduced ILS and glp-1 mutants that lack a germline. cest-1 was both 
necessary for full life span extension in the context of reduced ILS and sufficient to extend life 
span when overexpressed. cest-1 encodes a protein with a predicted signal peptide, a central 
domain with homology to carboxylesterases, and a putative transmembrane domain near the 
carboxyterminus. A functional CEST-1::GFP fusion protein is expressed specifically in the 
intestine and localizes to the apical plasma membrane. We propose that CEST-1 influences life 
span by acting within the intestinal lumen to either degrade a substance that shortens life span or 
generate a metabolite that promotes longevity. As human carboxylesterases are hypothesized to 
play roles in xenobiotic and lipid metabolism, understanding how CEST-1 promotes longevity in 
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C. elegans may yield insights into potential roles of carboxylesterase family members in 
influencing aging in humans. 
Introduction 
FoxO transcription factors (TFs) have emerged as important regulators of the aging process. They 
extend life span across taxa and influence phenotypes associated with aging-related pathology in 
mouse models of human disease (Bartke, 2011; Blüher et al., 2003; Clancy et al., 2001; Joshi et 
al., 2017; Lin et al., 1997; Shimokawa et al., 2015; Yamamoto & Tatar, 2011). Common genetic 
variants at the human FOXO3 locus are associated with longevity and protection against aging-
associated diseases, suggesting that the longevity-promoting function of FoxO TFs that has been 
established in experimental organisms may also be conserved in humans (Joshi et al., 2017). 
Therefore, understanding how FoxO TFs extend life span will likely lead to general insights into 
the aging process and new approaches to improve healthy aging. 
The role of FoxO TFs in life span control was discovered in the nematode Caenorhabditis 
elegans, where the FoxO TF DAF-16 is the major target of the DAF-2 insulin-like signaling (ILS) 
pathway (Kenyon, 2010). DAF-2, the C. elegans ortholog of mammalian insulin and insulin-like 
growth factor (IGF) receptors, controls development and aging through a conserved PI3-
kinase/Akt module that promotes the phosphorylation and nuclear export of DAF-16/FoxO 
(Kimura et al., 1997). In animals with reduced ILS, unphosphorylated DAF-16/FoxO translocates 
to the nucleus and regulates gene expression (Kimura et al., 1997; Murphy & Hu, 2005). Loss-of-
function daf-2/IGFR mutations extend life span in a manner that is entirely dependent upon daf-
16/FoxO, indicating that DAF-16/FoxO promotes life span extension in animals with reduced 
DAF-2 ILS (Kenyon et al., 1993). DAF-16/FoxO is also required for life span extension animals 
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lacking a germline as well as in some models of dietary restriction (Greer et al., 2007; Hsin & 
Kenyon, 1999). 
The mechanistic basis for life span extension by DAF-16/FoxO remains poorly understood. 
Expression profiling by multiple groups has identified thousands of DAF-16/FoxO-regulated 
genes  (McElwee et al., 2003; McElwee et al., 2004; Murphy, 2006; Murphy et al., 2003). It is 
likely that multiple DAF-16/FoxO-dependent gene regulatory events contribute to DAF-16/FoxO-
dependent longevity (Kenyon & Murphy, 2006). However, the majority of DAF-16/FoxO targets 
have not been interrogated for their influence on organismal longevity. Progress in this area has 
been impeded by the prodigious number of genes that are regulated by DAF-16/FoxO. By using 
filtering approaches to narrow the broad set of DAF-16/FoxO-regulated genes down to more 
tractable gene sets that are amenable to detailed functional analysis, several groups have succeeded 
in elucidating specific roles in life span control for a small number of DAF-16/FoxO target genes 
(Chen et al., 2015; Kaletsky et al., 2016; Lee et al., 2003; Tepper et al., 2013; Tullet et al., 2014).   
Although the molecular requirements for DAF-16/FoxO regulation in the contexts of 
reduced ILS and germline ablation differ, we hypothesized that DAF-16/FoxO extends life span 
in both contexts by concordantly regulating a common set of target genes (Berman & Kenyon, 
2006; Ghazi et al., 2009; Paradis et al., 1999; Paradis & Ruvkun, 1998). Previously reported 
expression profiles revealed little overlap in sets of DAF-16/FoxO target genes regulated by daf-
2/IGFR and the germline (McCormick et al., 2012; Murphy et al., 2003). However, the 
interpretation of these studies is confounded by their use of different profiling platforms, which 
can be a source of variability in such experiments (Murphy, 2006). To clarify this issue, we used 
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whole transcriptome profiling to define sets of genes regulated by DAF-16/FoxO in daf-2/IGFR 
mutants and in germline-ablated animals.  
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Figure 4.1.  Transcriptome profiling strategy for identifying DAF-16/FoxO targets 
associated with longevity (dal genes) 
Figure 4.1.  To delineate a set of DAF-16/FoxO target genes in the context of ILS we profiled daf-2(e1368) and daf-
2(e1370) strains and identified genes that were differentially regulated in each daf-2 strain relative to WT, and 
oppositely regulated in each daf-16;daf-2 vs daf-2 comparison. To delineate DAF-16/FoxO target genes in the 
context of germline ablation we identified genes that were differentially regulated in each glp-1 vs daf-16;glp-1 
comparison.  We then prioritized 46 dal genes that were regulated concordantly in all long-lived vs short-lived 
comparisons.   
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Results 
A genetic filtering strategy to identify DAF-16/FoxO target genes associated with longevity 
We previously performed whole transcriptome profiling in several daf-16/FoxO mutant 
backgrounds to define the roles of specific DAF-16/FoxO isoforms in the control of development 
and longevity (Chen et al., 2015). Here we employed a similar strategy to identify DAF-16/FoxO 
target genes in the contexts of reduced ILS and germline ablation (Figure 4.1; see Materials and 
Methods for details). To delineate the set of DAF-16/FoxO target genes in animals with reduced 
ILS, we identified genes that were differentially expressed in the daf-2/IGFR mutant vs. wild-
type comparisons and differentially regulated in the opposite direction in the daf-16;daf-2 vs. 
daf-2 comparisons. To increase the specificity of identifying genes regulated by ILS, we 
compared wild-type profiles to those of animals harboring either of two distinct daf-2/IGFR loss-
of-function alleles: the strong Class II loss-of-function allele e1370, which is a missense 
mutation in the cytoplasmic tyrosine kinase domain, and the weaker Class I loss-of-function 
allele e1368, which is a missense mutation in the extracellular ligand binding domain (Gems et 
al., 1998; Kimura et al., 1997). To profile animals lacking a germline, we utilized the 
temperature-sensitive glp-1(e2141) mutant, which fails to develop a germline when raised at the 
restrictive temperature of 25°C (Arantes-Oliveira et al., 2002; Priess et al., 1987). Embryos 
harboring the glp-1(e2141) mutation were grown at 25°C to ablate the germline prior to RNA 
isolation. DAF-16/FoxO target genes were identified by comparing the expression profiles of 
glp-1(e2141) mutants to that of daf-16;glp-1 double mutants. We did not compare profiles of 
germline-ablated animals with those of wild-type animals, as many differentially expressed 
genes in this comparison would be germline-specific and embryonic genes. To enrich sets of 
DAF-16/FoxO target genes for regulatory events that coincide with life span control, we used 
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two distinct daf-16/FoxO loss-of-function mutants: the mu86 null allele (henceforth referred to as 
“daf-16(null)”and the mg54 nonsense allele which abrogates the function of the daf-16a and daf-
16f isoforms but does not affect the daf-16b isoform (henceforth referred to as “daf-16(a/f)”) 
(Lin et al., 1997; Ogg et al., 1997). We and others previously showed that daf-16a and daf-16f 
are the isoforms that promote longevity in the context of reduced ILS (Chen et al., 2015; Kwon 
et al., 2010). Therefore, we reasoned that genes specifically regulated by DAF-16A and/or DAF-
16F would be more likely to play roles in life span control than DAF-16B-regulated genes. Life 
span assays on a subset of animals from each cohort profiled revealed the expected phenotypes 
(Figure 4.2).   
A set of 46 dal (DAF-16/FoxO target associated with longevity) genes are concordantly 
regulated by DAF-16/FoxO in the contexts of reduced insulin-like signaling and germline 
ablation 
To identify DAF-16/FoxO-dependent gene regulatory events that correlate with longevity, 
we collated sets of genes the regulation of which was influenced by both daf-16(null) and daf-
16(a/f) alleles. This analysis yielded 149 genes in the daf-2(e1368) context, 480 genes in the daf-
2(e1370) context, and 237 genes in the germline-ablated glp-1(e2141) context that were differently 
regulated in the wild-type and mutant backgrounds and differentially regulated in the opposite 
direction in both daf-16(null) and daf-16(a/f) mutants (Figure 4.1). Combining these gene sets 
revealed a set of 46 DAF-16/FoxO target genes that are concordantly regulated in all three contexts 
(Table 4.1). As these gene regulatory events are associated with the DAF-16/FoxO-dependent life 
span extension phenotype, we refer to these genes as dal (DAF-16/FoxO target associated with 
longevity) genes. According to prior classifications of DAF-16/FoxO-regulated genes, 42 of 46 
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dal genes were Class I genes (induced in a DAF-16/FoxO-dependent manner), and four were Class 
II genes (repressed by DAF-16/FoxO) (Table 4.1) (Murphy et al., 2003; Tepper et al., 2013). 
We compared our dal genes to a list of over three thousand DAF-16/FoxO-regulated genes 
that emerged from a meta-analysis of expression profiling experiments designed to identify 
consensus DAF-16/FoxO targets (Tepper et al., 2013). 39 of 42 Class I dal genes were identified 
as Class I DAF-16/FoxO targets by Tepper et al. (Table 4.1) (Tepper et al., 2013). Fourteen of the 
top 50 and six of the top ten consensus Class I DAF-16/FoxO targets identified by Tepper et al. 
are dal genes (Table 4.1)(Tepper et al., 2013). Three of four Class II dal genes were identified as 
Class II consensus targets by Tepper et al., and two of these are among their top five Class II 
consensus targets (Table 4.1) (Tepper et al., 2013). Taken together, these data indicate that our 
filtering strategy has succeeded in prioritizing a small set of bona fide DAF-16/FoxO target genes.  
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Table 4.1.  dal genes overlap with consensus DAF-16/FoxO targets 
Gene Annotation Fold 
increase 
in daf-
2(e1370) 
vs. wild-
type 
Fold decrease  
in daf-
16(mg54);daf-2 
vs. daf-2 
Tepper 
rank 
dal-1/F56D6.9  >200 >200  
dal-2/T12D8.5  >200 >200 54 
cest-1 carboxylesterase 200 >200 13 
dal-3/Y6G8.9 F-box-associated domain 112 >200  
mtl-1 metallothionein 111 74 1 
dal-4/Y39G8B.7 ShKT domain 79 87 294 
dct-8  72 >200 445 
dal-5/R05H10.7  59 91 442 
dal-6/F15B9.6  48 95 158 
dal-7/F21C10.11  36 172 366 
sdz-24 OB-fold domain 24 175 134 
lipl-2 triacylglycerol lipase 23 33 333 
dal-8/C08E8.4 NADAR domain 22 25 21 
dal-9/K03D3.2  21 12 186 
dod-3  20 18 7 
dlhd-1 dienelactone hydrolase 18 34 733 
dal-10/C08F11.3  17 100 46 
sod-3 superoxide dismutase 15 12 41 
dal-
11/Y20C6A.1 
F-box, DUF38 14 60 209 
dal-12/Y6G8.2 F-box, DUF38 14 60 15 
lys-7 lysozyme 13 16 5 
ftn-1 ferritin heavy chain 12 29 4 
gst-29 prostaglandin D synthase 12 24 292 
hen-1 LDL receptor motif 11 9 49 
sru-40 serpentine receptor 9 >200 1071 
glb-1 globin 7 8 97 
spp-2 antimicrobial peptide 7 13 1421 
dal-13/Y34F4.2 claudin-like tight junction 
protein 
6 4 288 
dal-
14/M01B2.13 
PHYHIPL ortholog 6 18  
btb-16 BTB/POZ domain 5 8 8 
btb-17 BTB/POZ domain 5 8 58 
cpg-7  4 6 316 
cutl-24 zona pellucida domain 4 4 465 
dal-
15/Y38C1AA.6 
RING/FYVE/PHD-type 
zinc finger 
4 4 1116 
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ttr-44 transthyretin-like 4 3 38 
icl-1 isocitrate lyase/malate 
synthase 
4 6 -1598 
dal-16/F48D6.4  4 2 2 
hsp-12.6 -crystallin/heat shock 
protein 
3 3 123 
hda-5 histone deacetylase 3 3 711 
akt-2 Akt/Protein Kinase B 3 3 241 
ttr-5 transthyretin-like 3 3 50 
dal-17/Y2H9A.4 DUF713 2 3 5465 
dal-18/K12B6.11  0.05 0.06  
irg-5 CUB-like domain 0.18 0.09 -5 
dod-23  0.29 0.13 -1 
srh-70 serpentine receptor 0.29 0.23 -1660 
Table 4.1.  List of DAF-16/FoxO targets associated with longevity.  Fold changes in two right 
columns are based on sequencing read counts. Left column shows comparison to a meta-analysis 
which ranked DAF-16/FoxO targets from profiling experiments.  Green boxes denote Class I 
DAF-16/FoxO target genes (upregulated in a DAF-16-dependent manner) that are in the top 50 
consensus targets from the meta-analysis.  Red boxes denote Class II DAF-16/FoxO target genes 
(DAF-16/FoxO dependent downregulated) that are in the top 50 consensus targets from the 
meta-analysis (Tepper et.al, 2013).      
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Figure 4.2.  daf-16a and f isoforms are required for lifespan extension in daf-2 mutants and 
germline ablated glp-1 mutants 
 
 
 
 Figure 4.2.  A. Schematic of the daf-16 locus.  Exons specific to isoform groups are labeled in 
green orange and purple, predicted DNA binding domain of DAF-16 is labeled in yellow.  daf-
16(mu86) is a deletion that effects all daf-16 isoforms and is predicted to be a null allele, daf-
16(mg54) is a premature stop mutation that affects the daf-16a and daf-16f isoform groups.  Both 
alleles fully eliminate lifespan extension in B. daf-2(e1368), C. daf-2(e1370) and D. glp-
1(e2141) germline ablated animals.   
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The carboxylesterase family member CEST-1 is required for DAF-16/FoxO dependent 
lifespan extension 
To identify dal genes that play roles in life span control, we obtained publicly available C. 
elegans strains harboring predicted strong loss-of-function mutations in Class I dal genes and 
performed life span assays in the context of reduced ILS. If a Class I dal gene (which is induced 
by DAF-16/FoxO)contributes significantly to DAF-16/FoxO-dependent life span extension, then 
reduction of dal gene activity should shorten life span specifically in the context of reduced ILS, 
where DAF-16/FoxO is active (Murphy et al., 2003). In our initial screen we subjected 23 dal 
mutants to life span assays after initiating daf-2 RNAi to reduce ILS. Mutant strains in which daf-
2 RNAi extended life span to a significantly lesser degree than in the wild-type background were 
outcrossed three times prior to repeat life span assays.  
After retesting, two dal mutants exhibited reduced life span extension by daf-2 RNAi 
compared to wild-type animals. One mutant contained a loss-of-function mutation in lipl-2, which 
encodes a lipase previously implicated in lifespan regulation and response to fasting (Amrit et al., 
2016; O’Rourke & Ruvkun, 2013). The other strain contained a mutation in cest-1, which encodes 
a member of the carboxylesterase family of enzymes that hydrolyze carboxyl esters to yield a 
carboxylic acid and an alcohol as products (Lian et al., 2017; Redinbo & Potter, 2005). 
Transcription of cest-1 was confirmed to be robustly upregulated in daf-2(e1370) mutants in a daf-
16 dependent manner by qPCR (Figure 4.3).  CEST-1 contains a putative signal peptide, a domain 
with homology to the carboxylesterase family of alpha/beta hydrolases, and a predicted 
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carboxyterminal transmembrane domain (Figure 4.4). Members of the carboxylesterase family 
have a conserved serine, glutamate, and histidine catalytic triad that is conserved CEST-1. 
To verify our initial results, we tested the effect of cest-1 mutation on the life spans of daf-
2 and glp-1 mutants. We used the cest-1(tm5130) allele, which contains an out-of-frame deletion 
within the carboxylesterase domain that is predicted to introduce a premature stop codon 3’ to the 
deletion (Figure 4.4). Since the protein predicted to be encoded by cest-1(tm5130) lacks a 
significant portion of the carboxylesterase domain, it is likely a null allele and will henceforth be 
designated “cest-1(null).” cest-1(null) suppressed the life span extension phenotype of two daf-2 
alleles: e1368 (Figure 4.5A) and m577 (Figure 4.5B).  cest-1(null) did not significantly influence 
life span in the context of wild-type DAF-2 ILS, suggesting that the reduction in life span caused 
by cest-1(null) is not a consequence of general sickness. In contrast, cest-1(null) did not affect life 
span extension caused by daf-2(e1370) (Figure 4.5C) or germline ablation (Figure 4.5D). In these 
two contexts, the regulation of other DAF-16/FoxO target genes may suffice to compensate for 
loss of CEST-1 activity.  
As the catalytic triad in carboxylesterases is conserved in CEST-1, we sought to determine 
the effect of specifically abrogating CEST-1 enzymatic activity on longevity by engineering a 
point mutation affecting one of the conserved putative catalytic residues into the cest-1 genomic 
locus (See Figure 4.9 for alignment). We used CRISPR/Cas9-based genome editing to generate 
cest-1(dp683), which harbors a point mutation predicted to change serine 213 in wild-type CEST-
1 to alanine (henceforth designated as “cest-1(S213A)”; Figure 4.4). this mutation has been shown 
to abolish enzymatic activity in human Ces1d (also known as Triacyl-glycerol hydrolase) (Alam 
et al., 2002). As observed with cest-1(null), cest-1(S213A) partially suppressed the life span 
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extension caused by daf-2(e1368) (Figure 4.5E). Intriguingly, in the context of wild-type DAF-2 
ILS, cest-1(S213A) caused a modest extension in life span (Figure 4.5E).  
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Figure 4.3.  cest-1 is transcriptionally induced in a DAF-16/FoxO dependent manner in daf-
2(e1370) mutants 
  
Figure 4.3.  Quantitative-Real-Time-PCR measuring cest-1 transcript levels in daf-2(e1370),  
daf-16(null);daf-2 and daf-16a/f;daf-2 mutants. 
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Figure 4.4.  cest-1 encodes a carboxylesterase family member   
Figure 4.4.  A. cest-1 genomic locus. We utilize two cest-1 alleles: cest-1(tm5130) is a predicted 
null allele, and cest-1(dp683) is a missense allele in which the conserved catalytic serine residue 
at position 213 is mutated to alanine.  B. Domain structure of CEST-1 protein. Abbreviations: 
SP: signal peptide; TM: transmembrane domain.   
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Figure 4.5.  cest-1 activity is required for lifespan extension in daf-2/IGFr mutants  
Figure 4.5.  Survival assays of cest-1 mutants in long-lived backgrounds.  A-B. cest-1(tm5130) 
suppresses lifespan extension phenotypes of daf-2(e1368) and daf-2(m577).  C-D. cest-
1(tm5130) does not robustly suppress lifespan extension phenotypes of daf-2(e1370) or germline 
ablated glp-1(e2141) mutants.  E. Targeted cest-1 mutation converting the predicted catalytic 
serine to alanine suppresses the lifespan extension phenotype of a daf-2(e1368) mutant.   
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CEST-1::GFP is expressed in the intestine and localized at the luminal membrane  
To determine the spatiotemporal expression pattern and subcellular localization of CEST-1, we 
generated transgenic animals expressing a CEST-1::GFP fusion protein under the control of the 
endogenous cest-1 promoter and 3’UTR.  We observed no visible GFP expression in two 
independent wild-type lines harboring the CEST-1::GFP transgene despite robust expression of 
the mCherry co-injection marker (Figure 4.7A).  The CEST-1::GFP construct also had no effect 
on wild-type lifespan (Figure 4.6A).   
Expression of the CEST-1::GFP transgene rescued lifespan extension in daf-2(e1368);cest-
1(tm5130) animals, suggesting that CEST-1::GFP recapitulates endogenous CEST-1 expression 
and function in the tissues where it is required for lifespan extension (Figure 4.6A).  Expression 
of CEST-1::GFP also enhanced the lifespan extension phenotypes of daf-2(e1370) but not daf-
2(e1368) mutants (Figure 4.6A-B). Given the higher expression levels of DAF-16 targets, 
including cest-1, in daf-2(e1370) compared to daf-2(e1368), this is consistent with a model 
whereby high levels of cest-1 expression can enhance lifespan extension of daf-2 mutants.  In daf-
2(e1368) or daf-2(e1370) backgrounds we observed expression of CEST-1::GFP in the intestine, 
consistent with the expression pattern reported for wild-type cest-1 transcripts in recently reported 
single-cell transcriptomic analyses (Blazie et al., 2017; Cao et al., 2017).   
To assess the subcellular localization of CEST-1 we performed confocal microscopy on daf-
2(e1370) animals expressing CEST-1::GFP (Figure 4.7).  We observed that CEST-1::GFP was 
enriched at the luminal membrane of intestinal cells (4.7 B-E).  Outside of the luminal membrane, 
CEST-1::GFP is present in punctae (Figure 4.7B).  This expression pattern, along with analysis of 
the predicted CEST-1 protein sequence, is consistent with a model where CEST-1 is targeted to 
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the secretory pathway by its signal peptide, trafficked to the luminal membrane of the intestine, 
and is retained in the luminal membrane via it’s transmembrane domain, with its catalytic domain 
facing into the intestinal lumen.     
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Figure 4.6.  CEST-1::GFP rescues the lifespan phenotype of daf-2(e1368);cest-1 mutants 
and enhances the lifespan extension phenotype of daf-2(e1370) mutants 
Figure 4.6.  Lifespan of strains expressing a  C-terminal GFP tagged CEST-1 construct under its 
endogenous promoter with its endogenous 3’UTR and their non-transgenic siblings on A. wild-
type, daf-2(e1368);cest-1(tm5130) and daf-2(e1368) backgrounds or B. the daf-2(e1370) 
background Aggregated data from three biological replicates.  See Table 4.2 for summary data.     
 
 
A 
 
B 
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Figure 4.7.  CEST-1::GFP is enriched at the intestinal lumen in daf-2 mutants 
Figure 4.7.  A. Wild type animal harboring a transgene expressing CEST-1::GFP under its own 
promoter and mCherry co-injection marker expressed under the pharyngeal myo-2 promoter.  B-
E. Confocal images of daf-2(e1370) animals expressing CEST-1::GFP under its endogenous 
promoter and 3’UTR.  B. CEST-1::GFP is present in punctae with increased density near the 
lumen (white arrows) consistent with vesicular trafficking of CEST-1 to or from the membrane.  
C-E. CEST-1::GFP is present at the lumen, white arrows in panel E point to lumen . 
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CEST-1 expression is sufficient to extend lifespan 
To test the hypothesis that expression of CEST-1 in the intestine is sufficient to extend lifespan, 
we generated transgenic lines expressing CEST-1 under promoters specific for the intestine (pelt-
2) along with body wall muscle (pmyo-3) as a negative control.  We observed that expression of 
CEST-1 in intestine was sufficient to slightly extend lifespan on a wild-type background, while 
expression in muscle did not extend lifespan. (Figure 4.8).    
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Figure 4.8.  CEST-1 expression is sufficient to extend lifespan 
Figure 4.8.  A. Lifespan of daf-2(e1370) expressing CEST-1::GFP under its endogenous 
promoter and 3’UTR compared to non-transgenic siblings. B. Lifespan of wild-type with 
expression of CEST-1::SL2::mCherry in muscle (pmyo3) compared to non-transgenic siblings.  
C. Lifespan of wild-type with expression of CEST-1::SL2::mCherry in intestine (pelt-2).     
 
A 
 
B  
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Figure 4.9.  Alignment of CEST-1 to human brain carboxylesterase 
Figure 4.9.  Comparative sequence analysis with human proteins reveals that CEST-1 is most homologous to brain 
carboxylesterase (hBr2). A. Alignment of CEST-1 and hBr2 coding sequences, predicted catalytic residues in bold 
B. CEST-1 protein coding sequence, putative carboxylesterase domain and transmembrane domain underlined, 
catalytic residues in bold.   
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Discussion 
C. elegans has become a key model for understanding signal transduction pathways and cellular 
mechanisms that regulate organismal aging.  Starting with seminal work demonstrating that daf-2 
loss-of-function mutations extend lifespan by activating DAF-16/FoxO, worm gerontologists have 
identified a variety of signal transduction pathways that regulate lifespan (Kenyon et al., 1993; 
Kenyon, 2010).  These pathways converge on a small number of transcription factors whose 
activation can delay visible signs of aging and dramatically extend lifespan (Kenyon, 2010).  
Despite this body of work, and despite evidence that interventions such as calorie restriction and 
reduced insulin signaling extend lifespan in a conserved manner, the downstream transcriptional 
changes that are necessary and sufficient to delay aging remain poorly understood.  This gap in 
knowledge is due in part to the sheer number of transcriptional changes caused by longevity 
promoting interventions such as DAF-16 activation.  This has slowed down identification and 
detailed analysis of specific transcriptional targets that are critical for lifespan effects.   
Here we have established a framework for identifying and characterizing genes that regulate 
lifespan downstream of DAF-16/FoxO activation.  Reasoning that it would be most parsimonious 
if multiple contexts of DAF-16-dependent lifespan extension regulated longevity through the same 
transcriptional changes, we profiled three distinct long-lived strains and performed robust filtering 
for transcriptional changes that were both common to all three contexts and dependent upon the 
DAF-16 transcriptional isoforms that regulate lifespan.  We identified a small set of daf-16 targets 
associated with longevity (dal genes) and tested their role in lifespan regulation using publicly 
available mutants, avoiding caveats of RNAi-based candidate testing (Murphy, 2006).  This 
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strategy enabled us to identify a  novel DAF-16 target gene, CEST-1, as a new longevity regulator, 
and to follow up with a genetic characterization of cest-1.   
CEST-1 encodes a previously unstudied member of the evolutionarily conserved carboxylesterase 
family of enzymes.  CEST-1 has been independently identified as a consensus DAF-16 target gene 
in a meta-analysis of published profiling data but has not been tested for an effect on lifespan in 
published studies, highlighting the importance of unbiased genetic filtering strategies to prioritize 
targets for functional testing (Tepper et al., 2013).   
In contrast to previous profiling studies, which usually focus on a single long-lived context, we 
tested a predicted cest-1 null allele for suppression of lifespan in each of the three long-lived strains 
profiled (daf-2(e1368), daf-2(e1370), and glp-1(e2141)) as well as third daf-2 mutant, daf-
2(m577).   We found a robust genetic interaction between cest-1 and the insulin signaling pathway, 
with cest-1 mutation partially suppressing the lifespan increases caused by daf-2(e1368) and daf-
2(m577).  Interestingly, cest-1 mutation did not suppress the much larger lifespan increase of daf-
2(e1370) mutants.  We note that published work suggests that daf-2(e1370) and (e1368) mutants 
may have different causes of death, with longer lived daf-2(e1370) mutants being more resistant 
to colonization by intestinal bacteria than daf-2(e1368), suggesting that CEST-1 might protect 
from bacterial colonization in daf-2(e1368) mutants but be dispensable in daf-2(e1370) mutants  
(Podshivalova et al., 2017).  Alternatively, CEST-1 may be redundant with other DAF-16 targets 
within the large set of genes that are differentially regulated in daf-2(e1370) mutants but not daf-
2(e1368) mutants.  
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cest-1 mutation did not suppress the lifespan extension of germline-ablated glp-1 animals.  This is 
consistent with previous work which has suggested that the requirements for long lifespan in glp-
1 animals may be different than in daf-2, with glp-1 animals requiring tcer-1, kri-1, and daf-12 for 
increased longevity while daf-2 animals do not (Amrit et al., 2016; Berman & Kenyon, 2006; 
Ghazi et al., 2009).  We also note that the unique demographic characteristics of glp-1 animals, 
with a bi-modal lifespan distribution including a high rate of early death, may complicate 
identifying interactions with downstream mutations, such as cest-1, that primarily cause earlier 
onset of mortality.  Overall, our data are consistent with a model where cest-1 is necessary for full 
lifespan extension by reduced insulin signaling and suggest that understanding interactions 
between longevity effectors and multiple long-lived contexts in which they are induced will be 
important to provide insight into longevity mechanisms.   
Consistent with our profiling data, we found that expression of a CEST-1::GFP translational fusion 
under its endogenous promoter is robustly induced by daf-2(e1368) and daf-2(e1370) mutation 
and is expressed in the intestine. The intestine has emerged as a major tissue regulating metabolism 
and aging in C. elegans. DAF-16 expression in intestine is sufficient to partially or fully rescue 
lifespan in daf-2;daf-16 and glp-1;daf-16 mutants, supporting the hypothesis that the intestine is 
the major site of DAF-16 action (Libina et al., 2003).  Other well characterized downstream 
effector enzymes that promote increased longevity, including lipase family members downstream 
of DAF-16 and the flavin containing monooxygenase family member FMO-2 downstream of 
hypoxia and dietary restriction, are predominantly expressed in the intestine (Leiser et al., 2015; 
Wang et al., 2008).  The intestine has diverse physiological roles including defense from 
pathogenic bacteria, digestion, metabolism, and adaptation to changing nutritional environments, 
that may be important for delayed mortality (McGhee, 2013).   
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Confocal microscopy shows that CEST-1::GFP is enriched at the luminal membrane of the 
intestine.  Together with a predicted transmembrane domain in the CEST-1 protein, these data are 
consistent with a model where CEST-1 is targeted to the secretory pathway by its signal peptide, 
trafficked to the luminal membrane of the intestine, and is retained in the luminal membrane via 
its transmembrane domain, with its catalytic domain facing into the intestinal lumen. 
CRISPR/Cas9-mediated mutation of the predicted CEST-1 catalytic serine suppressed lifespan 
extension in a daf-2(e1368) mutant to a similar extent as cest-1(null), suggesting that catalytic 
activity is required for CEST-1 to mediate lifespan extension.  
Surprisingly, we found that expression of the CEST-1::GFP construct is sufficient to further extend 
the lifespan of long lived daf-2(e1370) mutants.  We also observed a modest lifespan extension 
when CEST-1 was expressed under an intestine-specific promoter in wild-type animals, suggesting 
that CEST-1 activity is sufficient to promote longevity in the absence of reduced insulin signaling 
or increased DAF-16 activity.  Overexpression of another DAF-16 target, the triglyceride lipase 
LIPL-4, extends lifespan through a mechanism that involves increasing levels of fatty acids which 
bind to and activate the transcription factors NHR-49 and NHR-80 (Folick et al., 2015).  CEST-1 
expression may similarly contribute to digestion of a dietary component that contributes to 
downstream signaling.  
It remains unclear how CEST-1 activity promotes longevity.  The localization of CEST-1::GFP at 
the luminal membrane is consistent with models in which CEST-1 is situated upstream in 
metabolic changes that promote longevity downstream of DAF-16/FoxO.  For example, CEST-1 
might function to aid in digestion of beneficial metabolites, such as precursors to the longevity 
extending polyunsaturated fatty acid species that are enriched in LIPL-4 (Folick et al., 2015; 
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O'Rourke et al., 2013).  Alternatively, CEST-1 might function to break down toxic xenobiotics in 
the gut; the slight lifespan extension observed in wild-type animals expressing a predicted 
catalytically inactive CEST-1 protein is consistent with a model in which this protein is binding to 
and sequestering a toxic metabolite.  Ultimately unbiased metabolomic studies may be of use in 
generating hypotheses about CEST-1 function by identifying CEST-1 substrates (Edison & 
Schroeder, 2010). 
CEST-1 has sequence homology to mammalian esterases including members of the mammalian 
carboxylesterase (CES) superfamily which includes human CES-1-5 and members of the murine 
Ces-1,2,3,4a,and5a families (Lian et al., 2017). Mammalian carboxylesterases are expressed in 
intestine, liver, and adipose tissue and, in addition to detoxifying xenobiotics, hydrolyze 
endogenous lipids and other substrates including acetylcholine (Lian et al., 2017).  Mouse models 
in which Ces family members have been knocked out suggest that these enzymes regulate obesity, 
energy expenditure, hepatic steatosis, and insulin sensitivity, suggesting that interactions between 
insulin signaling and carboxylesterase family members may be conserved and relevant to 
mammalian disease (Ko et al., 2009; Lian et al., 2017; Quiroga et al., 2012; Redinbo & Potter, 
2005) .  Published work has singled out the carboxylesterase family as one of a small number of 
gene families that are under selection during evolution of changes in vertebrate lifespan-suggesting 
that carboxylesterases could be conserved regulators of aging (Harel et al., 2015). To our 
knowledge this is the first functional study of a carboxylesterase family member in the regulation 
of lifespan.   
Overall our study has established a novel method of enriching for DAF-16 target genes that are 
involved in longevity and characterized a previously unstudied member of the carboxylesterase 
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superfamily that is both necessary for lifespan extension in the context of reduced insulin signaling, 
and sufficient to extend the lifespan of wild type and daf-2 mutant animals. Future studies will 
establish whether CEST-1 interacts with other contexts of increased lifespan and explore 
potentially conserved downstream mechanisms through which CEST-1 contributes to lifespan 
extension.     
Materials and Methods 
C. elegans strains and maintenance 
Animals were maintained at 15°C on nematode growth media NGM seeded with Escherichia coli. 
strain OP50.  Compound mutants were constructed using standard genetic techniques.  Genotypes 
were confirmed by using PCR followed by restriction digestion to detect restriction fragment 
length polymorphisms or using three primer PCR assays to detect deletions based on product size.  
Percival incubators were used for maintenance and lifespan assays. 
RNA isolation 
Lifespans were performed on all strains profiled to confirm the expected phenotypes.  The 
remaining animals from populations raised for life span assays were washed twice in M9 buffer. 
Total RNA was isolated using TRIzol reagent (Invitrogen) and purified using a RNeasy kit 
(QIAGEN Inc., Valencia, CA) according to manufacturers’ instructions. 
Whole transcriptome profiling (RNA-Seq) 
Transcriptome profiling was performed in collaboration with the University of Michigan 
sequencing core.  Five experimental replicates were used for each genotype.  We used the Tuxedo 
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Suite for alignment, differential expression analysis, and post-analysis diagnostics.  Gene 
expression output comprised eight comparisons in three groups: (1) daf-2(e1370) compared to 
wild-type, daf-16(mu86);daf-2(e1370), and daf-16(mg54);daf-2(e1370), (2) daf-2(e1368) 
compared to wild-type, daf-16(mu86);daf-2(e1368), and daf-16(mg54);daf-2(e1368), and (3) glp-
1(e2141) compared to daf-16(mu86);glp-1 and daf-16(mg54);glp-1. We defined DAF-16 targets 
in the daf-2 context as meeting all of the following criteria: (1) test status = “OK”, (2) fold change 
(FC) ≥ ±1.5 for wild-type vs. daf-2, (3) FC ≥ 1.5 in the opposite direction as wild-type for both 
daf-2 vs. daf-16(mu86);daf-2 and daf-2 vs. daf-16a/f(mg54);daf-2, and (4) FDR < 0.05 for all three 
comparisons. The criteria for glp-1 animals was similar except there was no wild-type comparison. 
We noted that many genes previously validated as DAF-16/FoxO targets did not meet our FDR 
criteria, and that RNA-seq is biased against short, low-expressed genes even if normalized for 
length. Therefore, we also included genes that did not meet the FDR requirement but did fulfill a 
more stringent FC > 3 criterion for all comparisons. Data are available at GEO with the accession 
number GSE111338. 
Quantitative Real-Time reverse transcriptase PCR 
cDNA was synthesized using a SuperScript III Reverse Transcriptase kit and random hexamers 
(Invitrogen, Carlsbad, CA). Real-time PCR was performed in triplicate using Power SYBR 
Green PCR master mix (Applied Biosystems, Warrington, UK) and a Mastercycler ep realplex 
thermal cycler (Eppendorf North America, Westbury, NY). 10ng of cDNA was used as a template 
in a 15µl reaction volume. Relative expression levels and technical error were determined by the 
ΔΔ2Ct method. Gene expression levels were normalized to actin (act-1), and the ratio of expression 
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relative to act-1 was then compared to the same ratio in N2 Bristol wild-type. Statistical analysis 
was performed in GraphPad Prism (GraphPad Software, La Jolla, CA) using the paired ratio t-test. 
Life span assays 
Lifespans were performed as described previously with minor modifications (Chen et al., 2015).  
Animals derived from a synchronized 6-hour egg lay were grown at 15°C until the L4 larval stage 
to prevent any dauer formation, transferred to 20°C until day one of adulthood, then placed on 
plates containing 25ug/ml 5’-fluoro-2’-deoxyuridine (FUDR) to prevent progeny production and 
0.001% nystatin to inhibit fungal growth.  For lifespans including strains harboring CEST-1::GFP 
transgenes, animals were grown at 20°C from egg, which was determined empirically to increase 
visible expression of the GFP transgenes relative to culture at 15°C, potentially due to the 
temperature sensitivity of daf-2 mutants, and animals with visible expression of the transgene were 
selected under a fluorescent dissecting scope at 48 hours post egg lay for inclusion in the assay.  
glp-1 mutant animals were raised at 25°C for 48 hours from egg lay to ablate the germline and 
then switched to 20°C.  Animals were scored as dead if they did not respond to being touched with 
a platinum wire pick, and animals with ruptured vulvas were censored.  Statistical significance 
was assessed using the standard chi-square-based log rank test in GraphPad Prism.    
Transgenic strain construction 
CEST-1::GFP constructs were generated by fusing the CEST-1 coding sequence and a 513 bp cest-
1 promoter to GFP, followed by the CEST-1 3’UTR using overlap extension PCR and cloned into 
the TOPOXL vector, then injected along with pmyo-2::mCherry::unc54utr (pJK343) as a co-
injection marker.  To generate the polycistronic tissue-specific overexpression constructs, 
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intestinal (elt-2) and muscle (myo-3) specific promoters were fused to CEST-1 and the 
intercistronic genomic fragment between gpd-2 and gpd-3, followed by mCherry::unc-54utr and 
injected as linear PCR products.  All constructs were verified by Sanger sequencing prior to 
injection.   
CRISPR/CAS9 based gene editing 
 cest-1(dp683) was generated using recombinant crRNA and tracrRNA (Dharmacon), Cas9 
(PNABio) and a 100bp repair oligo (IDT) and injected with a dpy-10 co-CRISPR marker as 
described previously  (Paix et al., 2015).   
Sequence of the cest-1(dp683) repair oligo is  
5’ GAAATTGAAAACTTTGGAGGAAATAAAAACAGAATTACATTGGCAGGGCATGCC 
GCTGGAGCAAGTATGATAGTAGCGGTAGGTCACATAAATGATACATTTTTG 3’ 
Sequence of the 20-nucleotide gene specific sequence in the cest-1(dp683) crRNA is 
5’ ACCTACCGCTACTATCATAC  3’ 
Confocal microscopy 
Animals were immobilized with 1 mg/ml Tricane (ethyl 3-aminobenzoate methanesulfonate salt) 
and 0.1mg/ml of tetramisole hydrochloride (TMHC) dissolved in M9 buffer as described 
previously (Green et al., 2011). Animals were mounted on slides layered with a thin 3% agarose 
in H2O pad and images were captured on a Leica inverted SP5X Confocal microscope using LAS 
AF software. 
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Table 4.2.  Summary data from lifespans   
Table 4.2.  Survival curves shown in figures ae comprised of aggregated from three biological replicates.  Table 
(next 4 pages) includes median number of deaths, number censored due to rupture, and statistical comparisons by 
log rank test for individual lifespans and aggregated lifespans.   
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Chapter 5 Conclusions 
Overview   
This dissertation started with the goal of identifying both novel mechanisms of DAF-
16/FoxO regulation, and critical genes that work downstream of DAF-16/FoxO activity 
to regulate lifespan.  In Chapter Two we used an unbiased forward genetics approach that 
was intended to identify novel regulators of DAF-16/FoxO. We unexpectedly identified a 
novel mutation lin-14 that regulates the developmental decision to enter the dauer 
diapause and may act downstream of or in parallel to insulin-signaling and DAF-
16/FoxO.  In Chapter 4 we used an unbiased transcriptome profiling approach to identify 
DAF-16/FoxO target genes that are associated with longevity in multiple long-lived 
contexts.  We then followed this up with a robust genetic characterization of a previously 
unstudied gene, cest-1, that contributes to longevity in the context of reduced insulin 
signaling.  Both lines of inquiry have raised interesting questions for future study. 
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A novel mutation in lin-14 regulates dauer entry     
In order to activate a transcriptional program that delays aging, DAF-16/FoxO must be 
present in the nucleus of the cell and must bind to regulatory elements through which it 
controls the expression of downstream target genes.  Many studies have established 
different molecular mechanisms that regulate the localization of DAF-16/FoxO; however, 
comparatively little is known about the requirements for full activity of nuclear DAF-
16/FoxO.  In addition to regulating lifespan, increased DAF-16 FoxO activity promotes 
developmental arrest in the dauer diapause: thus, screening for mutations that make 
worms more or less likely to enter dauer can identify new mechanisms of DAF-16/FoxO 
regulation.  We had previously characterized EAK-7, a conserved plasma membrane 
protein that acts to inhibit activity of nuclear DAF-16/FoxO; we then attempted to 
identify molecules that act downstream of EAK-7 to regulate nuclear DAF-16/FoxO 
activity by performing a forward genetic screen for mutations that suppress the dauer 
constitutive phenotype of eak-7;akt-1 compound mutants (Alam et al., 2010; Delaney et 
al., 2017; Dumas et al., 2013).   
Forward genetics is a powerful tool which enables us to “ask the animals a question” and 
obtain an “answer” without guessing in advance what that answer might be.  It frequently 
produces unexpected results.  In this case our forward genetic screen identified a novel 
allele of lin-14, a well characterized regulator of the sequence in which early 
developmental events occur, that suppressed eak-7;akt-1 dauer arrest.  Interestingly, the 
lin-14(dp69) mutation we discovered was phenotypically distinct from strong lin-14 loss-
of-function alleles identified in screens for heterochronic phenotypes, both in the sense 
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that it lacked characteristic lin-14 heterochronic phenotypes observed during non-dauer 
development and in the sense that it suppressed dauer-constitutive phenotypes rather than 
affecting the timing of dauer entry.   Nonetheless both molecular analysis of the lin-14 
transcript and the observation that the lin-14(dp69) dauer suppression phenotype was 
phenocopied by lin-14 RNAi are most consistent with the hypothesis that lin-14(dp69) is 
a novel class of lin-14 reduction-of-function allele.  lin-14(dp69) and lin-14 RNAi might 
affect activity of the lin-14b isoform, since mutations that affect lin-14b also have 
phenotypes that are entirely different from lin-14 null phenotypes and affect the second 
larval stage, which can progress to either a dauer or reproductive L3 during the dauer life 
history.  Alternatively, lin-14(dp69) might have neomorphic or change-of-function 
effects, for example altering the expression pattern of the LIN-14 protein.  Genetic 
analysis has suggested that lin-14(dp69) and lin-14 RNAi can suppress the DAF-
16/FoxO-independent dauer constitutive phenotype of daf-7/TGF-β mutants, indicating 
that lin-14(dp69) may influence dauer arrest independently of DAF-16/FoxO.  Studies in 
the literature suggest that lin-14 interacts genetically with daf-12 which encodes a 
transcription factor that acts downstream of DAF-16/FoxO to influence the dauer 
decision.  Other heterochronic genes regulate dauer through interactions with daf-12.  
These data suggest that lin-14(dp69) and lin-14 RNAi could impinge upon mechanisms 
that integrate regulation of dauer entry with regulation of developmental timing.   
Additional experiments could help to clarify the interactions between lin-14(dp69) and 
known regulators of the dauer decision.  We could determine whether lin-14(dp69) and 
lin-14 RNAi can singly or additively suppress the Daf-c phenotypes of daf-12/NHR 
ligand binding domain mutants, mutants defective in the biosynthesis of DAF-12 ligands, 
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and mutants in lin-42/period which acts in the heterochronic pathway and regulates the 
dauer decision through direct binding to DAF-12  If lin-14(dp69) and lin-14 RNAi can 
suppress dauer arrest in dafachronic acid pathway mutants but not lin-42/per mutants, this 
might suggest that lin-14 acts in a pathway with lin-42/per to regulate DAF-12 activity.  
Since lin-14(dp69) and lin-14 RNAi are not null alleles and we cannot do formal genetic 
epistasis studies using them, we would need to bolster such inferences with molecular 
data, for example by determining whether lin-14 RNAi or lin-14(dp69) affected 
expression of LIN-42/period protein.  
We could also test the hypothesis that lin-14(dp69) and lin-14RNAi affect LIN-14 protein 
levels.  Andrew Fire’s lab has generated single copy LIN-14::GFP translational fusions at 
the endogenous lin-14 locus and demonstrated that single copy LIN-14 expression is 
detectible by fluorescence microscopy (Arribere et al., 2014).  We could use 
CRISPR/Cas9-based gene editing to engineer a mutation identical to lin-14(dp69) into 
the lin-14::GFP locus.  Strains expressing LIN-14::GFP with and without the lin-14 
splice site mutation could be crossed into an eak-7;akt-1 and daf-2(e1368) backgrounds 
to confirm suppression of the eak-7;akt-1 Daf-c phenotype by the splice site mutation, 
and to measure effects of splice site mutation, with or without lin-14 RNAi on LIN-14 
expression.   
More broadly, studies of the mechanisms by which heterochronic genes interact with the 
dauer decision may reveal more about the physiological basis for the dauer decision.  
Like many developmental decisions, the decision to enter dauer is tightly regulated in 
developmental time.  To enter dauer animals must integrate environmental information at 
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two critical periods. At the end of the L1 larval stage animals commit to normal 
development or enter the pre-dauer L2d stage, at the end of L2 they either commit to 
undergo the dauer diapause or resume reproductive development (Golden & Riddle, 
1984).  Heterochronic genes may interact with dauer regulatory signaling pathways at 
each critical period to ensure that the proper developmental program is initiated at the 
proper time.  Interestingly, many heterochronic genes have somewhat functionally 
conserved roles in regulating developmental timing in other species, suggesting that these 
studies could reveal broadly conserved mechanisms through which developmental 
plasticity is coordinated with the proper sequence of developmental events (Moss, 2007).    
CEST-1 acts downstream of DAF-16/FoxO to promote 
longevity    
To identify downstream mechanisms through which DAF-16 acts to promote increased 
lifespan, we profiled the transcriptomes of three strains with DAF-16/FoxO dependent 
increases in longevity.  We then compared the transcriptomes of each long-lived strain 
with strains in which the increase in lifespan had been fully suppressed by addition of 
daf-16/FoxO mutations which either completely eliminated all gene products, or 
specifically eliminated daf-16 transcriptional isoforms that contribute to longevity.   
This screen focused our attention on CEST-1, a member of the carboxylesterase family 
that is both dramatically upregulated by DAF-16/FoxO and required for full lifespan 
extension in animals treated with daf-2/IGFr RNAi. Using a predicted cest-1 null mutant, 
we found that CEST-1 was required for full lifespan extension in animals harboring 
relatively “weak” loss of function mutations in daf-2/IGFr but dispensable for lifespan 
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extension in the context of a “strong” daf-2/IGFr mutation.  Experiments with CEST-
1::GFP expressed under its endogenous promoter confirmed that CEST-1::GFP is 
robustly induced in daf-2/IGFR loss-of-function mutants and suggest that it is expressed 
specifically in the intestine and localized to the luminal membrane. Overexpression of 
CEST-1::GFP enhanced the lifespan extension phenotype of a “strong” daf-2/IGFr loss of 
function mutant (daf-2(e1370)), and constitutive expression of CEST-1 under an intestine 
specific promoter modestly extended lifespan in wild-type animals, suggesting that 
CEST-1 activity is sufficient to promote longevity.   
This study has raised several interesting methodological issues which will be important 
for future attempts to identify DAF-16/FoxO targets, or target genes from other 
pathways, that promote longevity.  To our knowledge this is the first study in which 
mutants in a DAF-16/FoxO target gene that promotes longevity has been tested for 
epistatic interactions with multiple long-lived mutants (though a study of this type placed 
FMO-2 downstream of both the hypoxic response and dietary restriction pathways 
(Leiser et al., 2015)).  The observation that cest-1 mutations robustly suppress the 
lifespan extension of some long-lived mutants but not others raises the question of 
whether different interventions may promote longevity through entirely distinct 
mechanisms, or alternatively, whether biochemical functions that are required for lifespan 
extension may be performed by upregulation of partially redundant genes.  Given the 
apparent differences in the magnitude of the reduction in lifespan caused by cest-1 
mutations in the context of daf-2 RNAi, and different daf-2 alleles, along with the 
observation that multiple members of gene classes such as lipases and glutathione-S-
transferases show both DAF-16/FoxO-dependent transcriptional regulation and lifespan 
  165 
effects, we favor the hypothesis that some downstream DAF-16/FoxO targets promote 
longevity through partially redundant functions.  The C. elegans genome encodes 
multiple carboxylesterase enzymes, and, while these enzymes are not transcriptionally 
upregulated by DAF-16/FoxO in our data, at the young adult timepoint profiled, it will be 
important to determine whether other carboxylesterases can be upregulated by DAF-
16/FoxO, perhaps at other developmental time points, and to generate compound mutants 
to test the hypothesis that they might act in parallel with CEST-1 to affect longevity.  
More broadly, it will be important to think critically about the long-lived context that is 
used to test candidate genes for effects on longevity in future studies.  Some long-lived 
contexts are likely more sensitive than others to lifespan effects, and it will be important 
to optimize sensitivity and selectivity to identify true regulators of lifespan while 
screening out false positive effects.  
Previous studies have also mostly used RNAi to perform first pass testing of candidate 
longevity genes.  RNAi is prone to false negatives from incomplete knock-down, false 
positives from off target knockdown, and bacterial strain specific effects.  We were able 
to identify cest-1 as a novel effector of longevity with candidate testing that used publicly 
available mutations and test the hypothesis that a predicted carboxylesterase catalytic 
residue would be critical for longevity using a point mutation that we engineered with 
CRISPR/Cas9-based gene editing.  This suggests that functional testing using mutants is 
a viable standard for future studies of potential longevity regulators.  Importantly, 
candidate testing using available mutants, most of which were generated by random 
mutagenesis, also has important caveats.  During our candidate testing we observed 
several strong effects on lifespan that disappeared upon outcrossing, suggesting that it 
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will be important to control for genetic background in future attempts to identify 
longevity regulators using mutants.  One strategy to minimize false positives might be to 
identify genes that affect lifespan when mutated using available strains, and then proceed 
immediately to generating independent mutations using CRISPR/Cas9-based gene-
editing with multiple independent guide RNAs, to limit effects stemming from using a 
previously mutagenized genetic background or from off-target gene editing.    
Our data suggest that CEST-1 expression can be sufficient to promote longevity.  We do 
not know what the biological function of CEST-1 is.  One strategy to elucidate the 
biological function of CEST-1 might be to determine whether CEST-1 acts in a pathway 
with other downstream longevity regulators using genetic epistasis and molecular 
experiments.  We also identified a lipase-like enzyme, lipl-2, as a gene that promotes 
longevity downstream of daf-2/IGFr mutations: reports in the literature suggest that 
lipase activity promotes longevity by generating lipid signals that promote autophagy and 
downstream transcriptional events (Folick et al., 2015; Lapierre et al., 2011; O'Rourke et 
al., 2013).  Likewise, some carboxylesterase family members have roles in fat 
metabolism (Redinbo & Potter, 2005).  Unlike carboxylesterase and lipase regulators of 
fat metabolism, which have been characterized to act in lysosomes or in the endoplasmic 
reticulum, CEST-1::GFP seems to be predominantly localized to the luminal membrane 
of the intestine, so it is unclear whether it could have similar roles in fat metabolism to 
enzymes that have been previously characterized. However, it could act in digestion of 
fatty acids. CEST-1 could also function in digestion of cholesterol esters which could be 
precursors for cholesterol derived hormones that might regulate longevity, or in digestion 
of other precursors to beneficial metabolites or signaling molecules.  Mammalian 
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carboxylesterases include enzymes that break down acetylcholine; CEST-1 could 
function in turnover of an acetylcholine-like signaling molecule.  Although it is unclear 
what the function of acetylcholine might be at the lumen of the gut, neurotransmitter-like 
small molecules could bind to and affect receptors expressed in the gut to modulate 
activity of downstream signaling pathways.  We could determine whether cest-1 interacts 
genetically with lipases or lipase overexpressing strains to regulate lifespan, determine 
whether it drives autophagy using reporter strains, and determine whether it is involved in 
similar transcriptional events to lipases using transcriptome experiments in CEST-1 and 
lipase mutant and overexpressing strains.  We could also attempt to identify CEST-1 
substrates using unbiased metabolomic approaches.   For example we could employ s the 
2D NMR methodologies that were used to identify dafachronic acids and looking for 
metabolites that are altered in a daf-16 and cest-1 dependent manner in daf-2 mutants, 
using both null and catalytic dead alleles of cest-1.  Pitfalls of this type of study might be 
identifying the correct developmental timepoint to profile, since metabolite levels can 
change on short time-scales and we do not know when CEST-1 activity is required to 
promote longevity.  It may also be difficult and time-consuming to test individual 
metabolites or biochemically separated groups of metabolites for rescue of lifespan. 
It may also be of interest to study in more detail how cest-1 is transcriptionally regulated.  
Publicly available data suggests that cest-1 is transcriptionally upregulated by 
environmental stresses including ethanol and tunicamycin (Lim et al., 2014; Peltonen et 
al., 2013).  It will be of interest to determine whether cest-1 mutation is epistatic to other 
longevity promoting interventions, such as dietary restriction. CEST-1 has not been 
previously identified as a direct target of DAF-16/FoxO.  The CEST-1 genomic region 
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contains binding regions for other transcription factors including NHR-28 and FOS-1 
identified by the modENCODE project using ChIP-SEQ.  It may be of interest to 
determine whether DAF-16/FoxO regulates CEST-1 activity through these transcription 
factors by crossing mutants into CEST-1::GFP reporter lines or by using gene editing to 
remove putative transcription factor binding sites (Gerstein et al., 2010; Niu et al., 2011; 
Schuster et al., 2010).  Forward genetic screens for DAF-16/FoxO regulators have largely 
used dauer arrest as a readout: this is less than ideal since dauer arrest and longevity 
require DAF-16/FoxO activity in different tissues at different times, and not all genes 
with effects on dauer arrest will have expected or predictable effects on lifespan.  CEST-
1::GFP reporters are  generally undetectable under a fluorescence dissecting scope in 
wild-type animals but are robustly induced and easily observable under a fluorescent 
dissecting scope in daf-2/IGFr mutants.  Integrated transgenic strains with cest-1 
regulatory elements fused to GFP could enable rapid forward genetic screens for 
mutations that increase CEST-1 activity; this screen would identify mutations in 
components of the insulin signaling pathway such as daf-2 but might also identify novel 
regulators of DAF-16/FoxO and other longevity pathways. CEST-1::GFP reporters could 
also be used to identify drugs that might increase lifespan.  
Conclusions   
This dissertation opened by asking how DAF-16/FoxO activity can delay aging and 
mortality.  Predictably, we do not yet have a mechanistic answer to that question.  
However, we have both identified a new DAF-16/FoxO target gene with interesting and 
potentially conserved effects on longevity and validated a strategy for identifying and 
testing downstream longevity regulating genes that will likely represent a substantial 
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improvement on strategies that were available previously.  We hope that the observations 
and tools described here will go on to aid in studies which further elucidate the 
mechanisms of longevity extension, and design interventions to delay or prevent age 
associated morbidities in humans. 
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